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Cerebral small vessel disease 
Cerebral small vessel disease (SVD) comprises a collective of pathological 
changes affecting the small vessels of the brain.2 The most prevalent form of 
sporadic SVD is due to age and vascular risk-factor related changes, such as 
hypertension, predominantly affecting the deep perforating arteries of the 
brain.3 The second most common type of sporadic SVD is cerebral amyloid 
angiopathy (CAA), which is characterized by the accumulation of the protein 
amyloid β (Aβ) in the superficial perforating arteries, including cortical and 
leptomeningeal vessels.3
SVD is currently identified by its consequences on the brain, as the smallest 
blood vessels cannot yet be visualized on magnetic resonance imaging (MRI) 
during lifetime.4 Ischemic MRI markers of SVD include white matter hyper-
intensities (WMH), lacunes of presumed vascular origin, diffusion-weighted 
imaging-positive (DWI+) lesions (or recent small subcortical infarcts), and 
cortical microinfarcts. Hemorrhagic MRI markers of SVD include spontaneous 
intracerebral hemorrhage (ICH), cerebral microbleeds, and cortical superficial 
siderosis (Panel 1.1). Other non-hemorrhagic MRI markers of SVD include brain 
atrophy and enlarged perivascular spaces. In this thesis, we aim to provide a 
deeper understanding of the ischemic and hemorrhagic MRI markers of SVD. 
In part I (chapter 2) we present an outline on ischemic and hemorrhagic MRI 
markers of SVD by investigating their perilesional and remote effects on the 
brain based on the most recent literature. In chapter 3 we explore the spatial 
distribution of ischemic and hemorrhagic MRI markers in patients with lacunar 
stroke and patients with non-lobar ICH.  
Acute ischemia and cerebral small vessel disease
Although SVD is present to some extent in virtually every elderly individual,5 
our understanding of its pathogenesis is still limited. Classically, acute ischemia 
due to the acute occlusion of a small blood vessel is believed to be the main 
cause of lacunar infarcts.6,7 However,  recent studies have suggested that acute 
ischemia, operationalized as DWI+ lesions, might also play a role in the origin 
of other MRI markers of SVD.8,9 Because DWI+ lesions are often small in size 
and only visible within approximately the first four weeks after appearance,10 
they are usually not detected on MRIs performed in routine clinical practice 
with relatively limited spatial resolution. The detection of a single DWI+ lesion 
large enough to be discovered on DWI may indicate hundreds of incident DWI+ 
lesions per year.11 Therefore, DWI+ lesions are hypothesized to together have 
an important role in SVD progression. 
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Recent serial MRI studies have demonstrated acute subcortical DWI+ lesions 
evolving into a WMH, a lacune, a microbleed, or disappearing on follow-up 
scans.4,8,9,12,13 It is unknown to what extent the progression of MRI markers of 
SVD is preceded by the occurrence of DWI+ lesions. Furthermore, smaller (<5 
mm) DWI+ lesions also appear in the cerebral cortex. However, they rarely 
evolve into chronically MRI-detectable lesions.14 Recently, it has been suggested 
that acute small cortical DWI+ lesions may be more easily detected on follow-up 
MRI using imaging sensitive to brain iron concentration.15
 In part II (chapter 4) of this thesis, we investigate the prevalence and long- 
term evolution of DWI+ lesions in individuals with SVD. In chapter 5 we study 
to what extent DWI+ lesions can explain the progression of various MRI markers 
of SVD. In chapter 6 we assess whether quantitative brain imaging of iron 
improves the in vivo detection of small cortical DWI+ lesions.  
Risk factors and MRI markers in intracerebral hemorrhage
SVD related  intracerebral hemorrhage (ICH) is one of the most deadliest 
subtypes of stroke; 40% of the patients do not survive past the first month.16 
A large proportion of lobar ICH (including the frontal, temporal, parietal or 
occipital lobe) in elderly patients (>55) is attributed to CAA.17 Spontaneous 
ICH in non-lobar locations, including the basal ganglia, thalamus, brainstem, 
and cerebellum is often caused by vascular changes secondary to hypertension 
and other vascular risk factors.18 Recent studies suggest that specifically cerebellar 
ICH located in the superficial parts of the cerebellum may be related to CAA.19,20 
Identifying location-specific vascular risk factors might improve our under -
standing of the etiology of ICH according to location. 
Survivors of ICH are reported to be at increased risk for recurrent stroke (both 
recurrent ICH and ischemic stroke) and other vascular events,21-23 causing 
uncertainties about the potential benefits and hazards of antithrombotic 
medication.24 Identification of patients at risk for these future events could 
aid in personalized secondary prevention. The presence of a DWI+ lesion on 
MRI after acute ICH has been associated with an increased risk of recurrent 
ICH, ischemic stroke, and vascular death,25,26 suggesting that DWI+ lesions 
may identify high-risk individuals.  
The prevalence of DWI+ lesions among patients with spontaneous SVD related 
ICH ranges from 15% to 41%.27 This prevalence is considerably higher than in 
individuals with sporadic SVD but without acute ICH or lacunar stroke (<5%).28,29 
It is uncertain whether the high frequency of DWI+ lesions is secondary to the 
acute ICH, or the result of the underlying SVD.30 Hence, the etiology of DWI+ 




In part III (chapter 7) we evaluate whether SVD-related risk factors differ by ICH 
location by means of a systematic review and meta-analysis of the literature. 
In chapter 8 we present the results of a post-hoc sub-group analysis of the 
RESTART trial, assessing whether the presence of DWI+ lesions in ICH survivors 
can identify those at future risk by investigating the association with recurrent 
stroke. In chapter 9 we investigate the etiology of DWI+ lesions among patients 
with spontaneous SVD related acute ICH. In part V (chapters 10-12) I summarize 
and discuss the most important findings of our research.
14
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Panel 1.1 | The spectrum of ischemic, hemorrhagic, and non-hemorrhagic MRI 
markers of SVD. (A) White matter hyperintensities. (B) Lacunes of presumed vascular 
origin. (C) Diffusion-weighted imaging lesion (or recent small subcortical infarct). 
(D) Cortical microinfarct. (E) Spontaneous intracerebral hemorrhage. (F) Cerebral 
microbleeds. (G) Cortical superficial siderosis. (H) Brain atrophy. (I) Enlarged 
perivascular spaces.
The ischemic (e.g.microinfarcts) and hemorrhagic (e.g. micorbleeds) manifestations 
of SVD share many common epidemiological factors, and often co-occur in the 
same patient. However, whether these MRI manifestations share similar or distinct 
underlying pathophysiological pathways remains undetermined. Therefore, why 
some patients with the similar form of sporadic SVD due to age and vascular risk-factor 
related changes present with an ischemic lacunar stroke and others present with a 
non-lobar ICH, represents a major knowledge gap in the understanding of SVD.1 
Therefore, the factors predisposing one affected vessel to bleeding and another to 
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Cerebral small vessel disease (SVD) is commonly observed on neuroimaging 
among elderly individuals and is recognized as a major vascular contributor 
to dementia, cognitive decline, gait impairment, mood disturbance and stroke. 
However, clinical symptoms are often highly inconsistent in nature and 
severity among patients with similar degrees of SVD on brain imaging. Here, 
we provide a new framework based on new advances in structural and 
functional neuroimaging that aims to explain the remarkable clinical variation 
in SVD. First, we discuss the heterogeneous pathology present in SVD lesions 
despite an identical appearance on imaging and the perilesional and remote 
effects of these lesions. We review effects of SVD on structural and functional 
connectivity in the brain and discuss how network disruption by SVD can 
lead to clinical deficits. We address reserve and compensatory mechanisms 
in SVD and discuss the part played by other age-related pathologies. Finally, 
we conclude that SVD should be considered a global rather than a focal disease, 
as the classically recognized focal lesions affect remote brain structures and 
structural and functional network connections. The large variability in clinical 
symptoms among patients with SVD can probably be understood by taking 
into account the heterogeneity of SVD lesions, the effects of SVD beyond the 
focal lesions, the contribution of neurodegenerative pathologies other than SVD, 
and the interaction with reserve mechanisms and compensatory mechanisms.
Key points
• Cerebral small vessel disease (SVD) is associated with a remarkable degree of variation 
in clinical symptoms — both in nature and in severity — that cannot be explained 
fully by conventional markers of SVD.
• Conventional MRI does not capture the heterogeneity present in SVD lesions with 
a similar appearance and reveals only the tip of the iceberg of the total SVD-related 
brain damage.
• SVD affects brain tissue beyond the commonly recognized focal lesions by inducing 
a cascade of events that spread from the initial lesion to remote brain areas, which 
probably contributes to clinical outcome.
• SVD disturbs structural and functional network connectivity and thereby disrupts 
efficient communication in brain networks, which is necessary for functional 
performance.
• Brain resilience protects against clinical deterioration caused by SVD via reserve 
and compensatory mechanisms, which explains the clinical variation observed in 
patients with apparently equal SVD lesion burden.
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Introduction
Life expectancy is higher than ever before and is predicted to increase 
continuously in the future in industrialized countries.31 As a result, age-related 
diseases will increasingly pose challenges to societies and healthcare systems. 
Globally, over 40 million people currently have dementia and this number is 
predicted to almost double every 20 years.32 Cerebral small vessel disease (SVD), 
which was once thought to be innocuous, is now recognized to be the most 
important vascular contributor to dementia.33 Furthermore, this condition 
causes ~20% of all ischemic strokes and is associated with gait impairment 
and mood disturbances.4,34-36 Consequently, a proper understanding of how 
SVD exerts its action on the aging brain and leads to clinical symptoms is 
urgently needed.
SVD is present to some extent in virtually every individual aged 60 years or 
older.5 It affects the smallest cerebral blood vessels, including the perforating 
arterioles, capillaries and venules.3 Although in vivo assessment of the smallest 
blood vessels is not yet possible with conventional imaging techniques, a spectrum 
of radiological manifestations can be detected that are thought to result from 
SVD. Common radiological markers of SVD include white matter hyperintensities 
(WMH), lacunes, enlarged perivascular spaces, microbleeds, recent small 
subcortical infarcts and brain atrophy, and the detection of these features is 
now complemented by the examination of losses in microstructural integrity 
of the white matter and the presence of cortical microinfarcts (Figure 2.1).4
SVD historically has been perceived as a slowly progressing disease that affects 
frontal-subcortical networks, leading to corresponding frontal symptoms.37 
These symptoms include loss of mental processing speed and executive function 
and affect cognitive function, motor performance and mood regulation. 
Compared with the healthy aging population, individuals with SVD are at an 
increased risk of cognitive decline and, ultimately, dementia.36,38 In addition, 
slowing of gait is a frequent observation in people with SVD and can result in 
parkinsonism.34,39-41 Finally, apathy (defined as a lack of motivation expressed 
by reduced initiative, diminished interest and lowered emotional responsiveness 
to stimuli),42,43 and depressive symptoms are common in individuals with 
SVD.35,44,45
At least two reasons support re-evaluation of this classic concept of SVD. First, 
despite loss of executive control and speed in behavioral performance, the 
spectrum of cognitive symptoms attributable to SVD is more diverse than 
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previously thought and can also include deficits in language, memory, attention 
and visuospatial abilities.46-51 These symptoms typically have not been 
attributed to SVD as they are considered to result from cortical lesions rather 
than subcortical lesions. This view is also consistent with findings in case 
studies, which have reported the occurrence of acute memory loss in patients 
with an isolated lacunar infarct in the thalamus52,53 or internal capsule.54,55 
Second, clinicians often observe a remarkable heterogeneity in clinical symptoms 
Figure 2.1 | Features of cerebral small vessel disease on MRI
Cerebral small vessel disease (SVD) is associated with a wide range of tissue alterations 
detectable with MRI, which are reported here according to the STRIVE (STandards 
for ReportIng Vascular changes on nEuroimaging) criteria.4 CSF, cerebrospinal fluid; 










Bilateral hyperintensities (often 
symmetrical) visible on T2-weighted 
sequences (e.g.  FLAIR). They are of 
variable size and are mostly located 
in the periventricular and deep white 
matter. 
Lacunes
Round or ovoid subcortical 
cavitations (3–15 mm in diameter) 
presumed to be of vascular origin. 
Lacunes have a signal intensity 
similar to CSF and often, although 
not always, have a surrounding 
hyperintensive rim. They are 
thought to result from acute, small 
subcortical infarcts or hemorrhages 
in the territory of a single 
perforating arteriole. 
Perivascular spaces
Extensions of extracerebral fluid 
space surrounding the perforating 
vessels. These features are visible 
on MRI as CSF-like fluid-filled 
spaces that follow the course of 
penetrating vessels, with a linear or 
round shape depending on 
whether imaged parallel or 
perpendicular to the vessel 
orientation, respectively. 
Cerebral microbleeds
Small depositions of hemosiderin 
consistent with blood cell leakage 
into brain tissue. Microbleeds
are detectable on paramagnetic-
sensitive sequences (e.g. 
T2*-weighted sequences or SWI),
as small (2–10 mm in diameter) 
hypointense lesions. 
Recent small subcortical infarct
Can be revealed in the first few 
weeks after the infarct by DWI as 
a small (≤ 20 mm on axial slice) 
hyperintensity in the territory of 
a single perforating arteriole.
Lesions < 5 mm (that is, subcortical 
microinfarcts) are detectable only 
with high-resolution (3 T and 
higher field strengths) imaging.87
Brain atrophy
Cortical or subcortical brain 
volume loss unrelated to large 
traumatic injuries or infarctions.
Cortical microinfarct
Small ischemic lesions varying 
between 50 µm and a few 
millimetres235 that are revealed 
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among patients with a similar radiological degree of SVD-associated features on 
brain imaging. In a hospital-based cohort of individuals with SVD, the 5.5-year 
cumulative risk of dementia was 11%, which indicates that SVD might go 
unnoticed or result in only mild functional deficits in the majority of people.56
Advances in structural and functional neuroimaging have now begun to 
shed light on these remarkable clinical observations in SVD. In this Review we 
will summarize these advances and provide a new framework for clinical 
observations in patients with SVD on the basis of an analysis of the latest 
literature on this topic. First, we discuss the heterogeneous pathology present 
in SVD lesions that seem radiologically identical and the effects of SVD on 
perilesional and remote brain regions. Second, we review the effects of SVD on 
structural and functional networks in the brain and provide reasons supporting 
the notion that SVD is a disconnection syndrome. We address the clinical 
variation in SVD from the perspective of brain resilience, comprising brain 
reserve and compensatory mechanisms, and briefly address mixed age-related 
pathologies in SVD. We conclude with a discussion on methodological 
considerations and future perspectives. The focus of this Review is on the most 
frequently occurring, sporadic form of SVD — that is, age-related and vascular 
risk-factor-related SVD3 with predominantly ischemic manifestations (Box 1). 
Illustrative examples of mechanisms of action that have been demonstrated in 
other types of SVD, such as cerebral amyloid angiopathy (CAA) or inherited 
SVD, are sometimes used as a model.
Focal and remote effects of SVD
Heterogeneity of SVD lesions with an identical appearance 
on imaging
MRI-based markers of SVD have a homogeneous appearance on conventional 
imaging. However, post-mortem histopathology studies have shown that 
these markers are in fact heterogeneous with regard to disease severity and 
etiology.57-60 
Pathological examination of WMH has shown different degrees of demyelination, 
gliosis and loss of fibers and oligodendrocytes in different lesions, with more- 
extensive abnormalities in more-severe and confluent lesions.57 Periventricular 
and deep WMH are characterized by vessel wall thickening, enlarged 
perivascular spaces, decreased vascular density, increased vessel tortuosity 
and the presence of plasma proteins. Furthermore, activated endothelial cells 
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within capillaries, especially in deep WMH, and immunologically activated 
microglial cells, in particular in periventricular WMH, have been observed.57 
On the basis of these different pathological observations, ischemia and blood–
brain barrier breakdown have been suggested as mechanisms that contribute 
to the origin of WMH.57 However, new hypotheses on the pathophysiology of 
WMH include the dysfunction of oligodendrocyte precursor cells, which are 
involved in the formation of myelin, and failure of the glymphatic system, 
responsible for clearance of neurotoxic waste products.61,62 In addition, evidence 
increasingly suggests a role for pathological changes of the venules in the origin 
of WMH, especially venous collagenosis.63 Thickening of the walls of venules 
due to collagen deposition could contribute to failure of interstitial fluid drainage, 
Box 1 | Different types of cerebral small vessel disease
Although the pathological processes that underlie MRI markers of cerebral small 
vessel disease (SVD) are incompletely understood, changes that result in disorganization 
of the vessel structure and function of the intraparenchymal and leptomeningeal 
blood vessel walls are key.9 A previous report described six types of SVD.3 The most 
prevalent type of SVD comprises a set of pathological changes under the influence of 
age and vascular risk factors – especially hypertension – that mainly affect the 
perforating arterioles.3,155,156 This type is characterized by arteriolar wall thickening 
(mainly due to deposition of collagen, plasma proteins and inflammatory cells in the 
vessel wall), loss of smooth muscle cells involved in the regulation of arterial pressure 
and blood flow154 and leakage of plasma proteins into the perivascular tissue.3,155,156 
Arteriolosclerosis represents an early stage of the disease, whereas lipohyalinosis and 
fibroid necrosis are observed at later stages — although these early and late stages can 
occur simultaneously in one vessel.3,155,156 The second most common type of SVD is 
cerebral amyloid angiopathy (CAA), which is characterized by the deposition of 
amyloid β in the walls of small arteries, arterioles and, infrequently, capillaries and 
venules, predominantly in the cerebral cortex and leptomeninges.3,155 In addition, 
vasculopathic changes observed in CAA include vessel wall thickening, loss of 
smooth muscle cells, fibrinoid necrosis and exudation of blood breakdown products 
into perivascular tissue.17,155 In both of these types of SVD, the described vessel wall 
alterations are associated with enlarged perivascular spaces.155 Furthermore, 
occlusion or rupture of the blood vessel can occur, which leads to infarction or 
hemorrhage, although CAA is typically associated with lobar hemorrhages.17,155 
Sometimes, microatheroma and microaneurysms are formed, which can also cause 
an infarct or hemorrhage.3,155 The remaining four types of SVD result from 
rare causes, and consist of hereditary forms of SVD (such as cerebral autosomal 
dominant arteriopathy with subcortical infarcts and leukoencephalopathy [CADASIL]), 
inflammatory and immunologically mediated SVD, venous collagenosis and, finally, 
a category of other causes of SVD (such as post-radiation angiopathy).3
23
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and might also increase vascular resistance, which can cause perfusion deficits 
in deep white matter areas.63,64
On histopathological examination, lacunes are irregularly shaped fluid-filled 
cavities that are surrounded by some degree of myelin and axonal loss and 
gliosis.57,65 Different pathological findings have been described with respect to 
the age of the lacune. In contrast to more recently formed lacunes, older lacunes 
are characterized by a decreased concentration of macrophages and necrotic 
waste and an increased density of gliosis.57,65 In addition, a distinct type of 
lacunar infarcts has been proposed; these so-called incomplete infarcts are 
either not cavitated or are only minimally cavitated but show evidence of 
myelin loss and neuronal loss and a variable extent of gliosis.59
MRI-defined microbleeds have also been associated with various degrees of 
gliosis and tissue loss, and different pathological correlates have been identified. 
A pathology study that examined patients with CAA distinguished between 
acute and old microbleeds by the presence of intact red blood cells in acute 
lesions and of hemosiderin-laden macrophages in older microbleeds.58 Histo-
pathological evidence suggests that the majority of microbleeds reflect true 
microhemorrhages caused by vessel wall disruption.57,58,60 However, some 
microbleed mimics have been identified that reflect a vasculopathy rather than 
a parenchymal hemorrhage, including vessel wall dissection, microaneurysms 
or vessel wall thickening due to accumulation of fibrin and red blood cells in 
the vessel wall.57,58,60 Finally, markers of an underlying ischemic process have 
been observed in some microbleeds, suggesting hemorrhage transformation 
of a previous infarct.57,58
These pathological findings indicate heterogeneous SVD lesions with a 
radiologically similar appearance, which is also increasingly being recognized 
in vivo on MRI.66-69 Conventional MRI techniques, such as fluid-attenuated 
inversion recovery (FLAIR), coarsely dichotomize tissue into abnormal and normal 
tissue and do not, for example, reliably reflect the degree of demyelination,70 
whereas quantitative imaging techniques, including magnetization transfer 
imaging and diffusion tensor imaging (DTI), can provide a detailed evaluation 
of the underlying tissue alterations at the voxel level.71 DTI is a technique that 
applies a tensor-based model to acquire diffusion-weighted imaging (DWI) 
scans, an MRI sequence sensitive to the diffusion of water molecules, and 
thereby provides information on the microstructural organization of white 
matter.72 In a study that investigated DTI changes within WMH that had not 
changed on FLAIR imaging over a 3-year period, diffusion metrics showed a 
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significant change over time in these WMH.67 Similarly, within acute or 
subacute incidental DWI-positive lesions, that were suggestive of infarction, 
diffusion metrics were significantly changed on follow-up imaging after 
7 months compared with the pre-lesional scan.66 Interestingly, this ongoing 
change in diffusion parameters occurred irrespective of whether or not an 
infarct remained visible on FLAIR or T1-weighted MRI.66
In addition to showing heterogeneity with regard to disease severity, MRI is 
increasingly able to contribute to our understanding of the various mechanisms 
implicated in the origin of SVD, including perfusion deficits, blood-brain 
barrier breakdown and venous pathology.73-75 Finally, imaging evidence has 
converged on a shared origin of different types of SVD lesions. Acute DWI- 
positive lesions have now been shown to evolve either into a WMH, lacune, 
microbleed or normal-appearing tissue.9,12,66
In summary, the histopathological characteristics of lesions with similar 
appearances on MRI can vary. Consequently, the effects that these lesions have 
on the cerebral tissue can also vary (Figure 2.2a, b).
Perilesional effects of SVD
In addition to overlooking the heterogeneous pathology present in SVD lesions 
with a similar appearance, conventional MRI manifestations of SVD are well 
known to represent only the tip of the iceberg with regards to SVD-related brain 
damage. In fact, DTI studies have shown that SVD lesions, such as WMH, are 
surrounded by areas with altered diffusion metrics that otherwise look normal 
on conventional MRI, the so-called SVD penumbra (Figure 2.2b).76,77 Diffusion 
abnormalities in penumbral areas are associated with the overall WMH load 
and depend on the distance from the WMH, with more severe abnormalities 
in regions proximal to WMH than in distant regions.76,77
A cross-sectional study demonstrated that a gradient of diffusion abnormalities 
also surrounds lacunes and extends up to centimeters from the lacune into the 
white matter tract containing that lacune (Figure 2.2b).78 In a longitudinal study 
on the effect of acute and subacute DWI-positive lesions on the DTI characteristics 
of the perilesional tissue, water diffusion in perilesional tissue was slightly less 
anisotropic at the post-lesional scan than at the pre-lesional scan — albeit not to 
a significant extent, perhaps because only six patients demonstrated a lesion.66 
An autopsy study in six patients with a lacunar infarct suggested the presence of 
a penumbra surrounding the lacunar infarct, confirming previous imaging 
findings. The investigators revealed axonal damage in the penumbral area of the 
25
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Figure 2.2 | What you see is not what you get
a. MRI markers of cerebral small vessel disease (SVD), including white matter hyper-
intensities (WMH; yellow), lacunes, enlarged perivascular spaces, microbleeds (red) and 
cortical microinfarcts (blue) and brain atrophy. b. Pathology studies show heterogeneity 
with regard to underlying disease severity and nature in SVD lesions with a similar 
appearance on MRI (shown for WMH). A penumbra (lighter areas around the lesions) 
can surround SVD lesions. When penumbras of cortical microinfarcts overlap, these 
microinfarcts can coalesce with a resultant larger cortical infarct. In addition to having 
perilesional effects, SVD is also associated with remote effects, such as cortical thinning 
(purple) caused by lacunes and possibly WMH via the disconnection of white matter 
tracts (green). c. SVD lesions can impair structural (left) and functional (right) connectivity 
by affecting the nodes of a network or the connections between them. Strategic infarcts 
affect rich clubs (red circles) or rich club connections (red lines). Dotted lines denote 
impaired connectivity. d. A larger total brain volume, increased network efficiency and 
compensatory (increased) functional connectivity can make the brain resilient to a 
certain degree of damage. ACC, anterior cingulate cortex; dlPFC, dorsolateral prefrontal 
cortex; PPC, posterior parietal cortex. 
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lacunar infarct at a distance 1.5 times the diameter of the lacune.79 Changes 
included loss of nodes of Ranvier and increased length between each node. 
Although the axon and myelin sheath were preserved, the investigators argued 
that the injured axons could be susceptible to future axonal degeneration.79
In addition to WMH and lacunes, a penumbra can also surround cerebral 
microbleeds and perivascular spaces, although this phenomenon requires 
further investigation. One case report observed a temporary perilesional edema 
surrounding an acute microbleed, which was thought to cause the transient 
clinical symptoms observed in this individual.80 The dilation of perivascular 
spaces could affect the integrity of surrounding grey or white matter tissue, 
although this idea remains to be proved.
Interestingly, in contrast to conventional markers of SVD such as WMH or 
lacunar volume, which have consistently shown only weak relations with 
clinical symptoms, diffusion metrics generally yield robust relations with 
cognitive, motor and mood symptoms associated with SVD, which remain 
after adjustment for the typical SVD imaging markers in statistical analyses.81-83 
A DTI study demonstrated an association between abnormal diffusion metrics 
in the penumbra surrounding lacunes and deficits on tests of executive 
functioning and information processing speed, independent of the size and 
side (that is, left or right hemisphere) of the lacune and independent of total 
WMH load.78 This finding indicates that cognitive performance is determined 
not only by SVD lesions that are visible on conventional MRI, but also by the 
extent to which diffusion metrics in the penumbra are affected. In the past few 
years, two global brain DTI derived metrics — the peak width of skeletonized 
mean diffusivity (which is based on skeletonization of white matter tracts and 
histogram analysis)84 and the segmentation of DTI images85 — have been 
shown to be strongly related with processing speed84,85 and executive 
functioning85 in patients with SVD, well beyond the associations with classic 
SVD markers such as WMH and lacunar volume. These findings illustrate that 
SVD truly exerts its action outside the visible lesion, which contributes to 
clinical outcome.
A penumbra seems to surround not only conventional SVD markers, but also 
cortical microinfarcts (Figure 2.2b).86-88 Cortical microinfarcts are frequently 
observed at brain autopsy in elderly people, are associated with cognitive 
decline and dementia89 and, within the past few years, have also been 
recognized on MRI.90 Two studies in rodents demonstrated that the occlusion 
of a single penetrating arteriole to induce a cortical microinfarct led to structural, 
27
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functional and hemodynamic changes that were measurable millimeters 
away from the infarct core.86,88 In fact, decreased neuronal activity was 
estimated to extend over a cortical region at least 12 times larger than the 
volume of the microinfarct core itself, whereas MRI could only visualize the 
core.88 Remarkably, when perilesional areas of multiple, isolated microinfarcts 
overlapped, a coalescence of infarcts was observed, resulting in a larger cortical 
infarct (Figure 2.2b).86 An ex vivo study in human brain tissue showed that, 
similar to what was observed in the penumbra surrounding lacunar infarcts, 
cortical microinfarcts caused disruption in the organization of adjacent axons, 
which was characterized predominantly by a loss of axon initial segments and 
increased length between nodes of Ranvier.87 The investigators suggested that 
these changes could ultimately reduce the capability of the axons to conduct 
action potentials.87 The debilitating effect of cortical microinfarcts on axonal 
communication might be yet another mechanism by which the accumulation 
of cortical microinfarcts can induce clinical deficits (Figure 2.2b).87 
Remote effects of SVD
Previous studies have demonstrated suppression of brain function in areas 
far from subcortical infarcts and WMH, as indicated by reduced perfusion 
and glucose metabolism on PET, suggesting the presence of sequelae of SVD 
remote from subcortical MRI markers.48,53,91 In addition to these functional 
changes, a growing body of evidence suggests that SVD is accompanied by 
structural changes remote from the initial SVD MRI markers. Several cross- 
sectional studies have shown negative associations between WMH and 
cortical thickness.83,92,93 More specifically, one study demonstrated a particular 
pattern of frontal–parietal–occipital grey matter atrophy related to WMH 
progression, which was thought to be responsible for the observed decline in 
total brain volume.94 However, among patients less-severely affected with SVD, 
a longitudinal association between progression of WMH and reduction of 
cortical thickness could not be confirmed.92
A study of patients with cerebral autosomal dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL), a genetic form of 
SVD, demonstrated that incident lacunar infarcts cause thinning in cortical 
tissue connected to the infarct area, providing the first direct proof for 
SVD-induced secondary degeneration in remote cortex.95 Cortical thinning 
was most pronounced in areas that had a high probability of connectivity via 
the lacune-affected white matter tract (Figure 2.2b). Indeed, in a subsequent 
study this group demonstrated that infarcts are accompanied by DTI changes 
in white matter tracts connecting to the infarct area, with larger changes of 
28
Chapter 2
white matter microstructure associated with more cortical thinning.96 
Interestingly, cortical thinning was independent of the final infarct fate — that 
is, whether the infarct was cavitating (complete or partial tissue loss) or 
non-cavitating (no visible tissue loss) — suggesting that less-severe infarcts 
can also induce long-term remote effects.96
Brain atrophy is an important predictor of cognitive decline and has been 
shown to mediate the relationship between presence of WMH and cognitive 
decline in individuals.97,98 Similar to lacunar infarcts, WMH can affect the 
cortex via disruption of white matter tracts (Figure 2.2b) and consequently 
can lead to cognitive symptoms, although this hypothesis remains to be proved 
in longitudinal studies. We previously showed that the decreased cortical 
thickness associated with WMH mediated the associations between WMH 
volume and deficits in various cognitive domains (namely global cognition, 
verbal memory, psychomotor speed, and attention and executive functioning).83 
In line with our observations, others have identified an intermediate role for 
cortical thickness of the left medial frontal lobe in the relationship between 
lacunar infarct volume within the anterior thalamic radiation and reductions 
in processing speed whereas anterior thalamic radiation lacunar volume itself 
was not related to processing speed.99 The role of cortical thickness in SVD is 
probably not limited to its effects on cognitive performance: another study 
showed that periventricular WMH affected gait impairment via disruption of 
white matter tracts and cortical thinning.100
Structural and functional connectivity
Functional performance results from the complex interplay between brain 
regions connected with each other through the white matter tracts, together 
forming brain networks. Advances in human connectomics have led to a better 
understanding of how SVD might give rise to clinical symptoms through its 
effects on structural or functional connected brain networks (Box 2).
Structural connectivity in SVD
The white matter tracts are crucial for information transfer between brain 
regions. These tracts can be reconstructed using DTI tractography techniques 
and represent the connections in structural brain networks. Subsequently, 
the organizational properties of a network, such as its global efficiency of 
information transfer (a measure of how well-connected the brain regions are), 
can be quantified using principles from graph theory (Box 2). Several studies 
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demonstrated structural network changes in patients with SVD through the 
application of this approach.101-104 These network changes were characterized 
by a reduction in the number of connections, reduced strength of connectivity 
and decreased local and global efficiency. The degree of brain network 
disruption was associated with the extent of MRI markers of SVD, including 
WMH volume, number of lacunes and number of microbleeds, and with brain 
volume and microstructural integrity.
With respect to the specific connections being disrupted in patients with severe 
SVD, a study revealed a subnetwork comprising the most impaired connections, 
which included predominantly interhemispheric and prefrontal connections.101 
Whereas the distribution of SVD near the ventricles and within the centrum 
semiovale could explain the reduced connectivity of interhemispheric tracts, 
the disruption of frontal connections was interpreted as remote effects of SVD. 
Additional insights into the extent and location of structural network disruption 
in SVD have been provided by rich-club analyses (Box 2). Rich-club organization 
of a network refers to the presence of nodes (brain regions) that are rich in 
connections that are more densely connected to each other than to other 
nodes.105 The connections between the rich-club regions are centrally located 
in the network and are thereby the most important connections for integration 
of information.106 Rich-club nodes identified in SVD comprise the precuneus, 
putamen, thalamus, superior occipital gyrus and regions in the superior frontal 
gyrus.102 Reduced connectivity was predominantly observed for connections 
between the rich-club nodes rather than a generalized, random reduction of 
the white matter connectivity (Figure 2.2c).102 This observation might be 
explained in part by the location of SVD damage, which often overlaps with 
the location of rich clubs.
Several studies in patients with SVD have demonstrated that the degree of brain 
network disruption, reflected by decreased global efficiency, was related to 
increased cognitive impairment101,103,107 and depressive symptoms.108 
Furthermore, decreased global efficiency was linked to an increased risk of 
all-cause dementia over a 5-year period.103 In addition, associations between 
the presence of conventional MRI markers of SVD and decreased cognitive 
functions were, at least in part, mediated through network disruption.83,101,103 
In particular, rich-club connectivity strength mediated the association of 
WMH with processing speed and executive functioning, in that higher  rich- 
club connectivity strength was associated with better cognitive performance.102 
These findings were corroborated by others, who found that only micro-









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































connections, mediated the association between WMH volume and executive 
functioning.109 Owing to their central role in brain networks and high 
connectivity with other nodes, damage to rich clubs or central connections 
might have a more widespread effect on network function than damage to 
peripheral nodes or peripheral connections in a network. Consequently, strategic 
infarctions, even when small in size, could result in a highly heterogeneous 
clinical phenotype that deviates from the typical ‘subcortical’ clinical picture 
when they are located near rich clubs or central connections (Figure 2.2c).110
Functional connectivity in SVD
Functional neuroimaging enables the functional neuroanatomy of specific 
brain functions to be probed. Our brain consists of spatially distributed but 
functionally linked regions that continuously share information with each 
other. Functional connectivity is defined as the temporal dependency of 
neuronal activation patterns in anatomically separated brain regions.111 
Functional connectivity thus refers to correlated activity between functionally 
related brain regions rather than to connections via existing white matter 
tracts, as is the case in structural connectivity based on diffusion tensor 
tractography (Box 2).
Functional neuroimaging studies have reported reduced functional connectivity 
across distributed networks in SVD (Figure 2.2c). Three networks that are 
commonly affected in SVD are the default mode network (DMN), the dorsal 
attention network (DAN) and the frontoparietal control network (FPCN), which 
play an important part in goal-directed attention and executive functions.112,113 
Patients with SVD showed reduced functional connectivity between nodes 
within the FPCN and the DAN,114-119 which was related to SVD severity.114,115,119-122 
These findings suggest that damage to long association fibers, caused by SVD, 
can manifest as reductions in functional connectivity between major nodes of 
the attentional networks. Furthermore, brain regions within the DMN normally 
show highly correlated brain activity during rest and reduced activity during 
attentionally demanding tasks, which is important for the maintenance of 
task-related goals. However, patients with SVD showed hyperactivation or 
impaired DMN deactivation during attentionally demanding tasks.123-126 For 
example, WMH severity was associated with hyperactivation of the anterior 
cingulate cortex, a key structure of the DMN.123 
These alterations to functional networks provide novel insights into the 
mechanisms of cognitive decline in SVD. Several studies have reported that 
reduced functional connectivity within the FPCN, DAN and DMN was related 
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to an increased degree of cognitive impairment.114,120-122,127 Evidence suggests 
that cognitive impairments due to SVD result from disruption of frontal–
subcortical circuits and long association fibers that in turn impairs communication 
between crucial neural networks responsible for cognitive control or attention, 
such as the DMN, FPCN, and DAN (Figure 2.2c).113
Brain resilience
In the previous sections we described the clinical consequences of SVD and 
discussed the mechanisms by which SVD might lead to these clinical deficits. 
Nevertheless, these clinical deficits cannot entirely be explained by SVD alone 
as many individuals remain functionally independent despite a considerable 
burden of SVD. An alternative approach might be to look not only at the sum of 
SVD burden and brain damage, but also explicitly at brain resilience, which is 
the capacity for patients to tolerate a certain degree of brain damage before 
clinical symptoms become manifest. Brain resilience can be separated into 
reserve mechanisms including brain reserve (referring to structural or 
functional metrics of the brain, such as intracranial volume) and cognitive 
reserve (referring to lifetime experiences, such as education), which offer 
protection against brain pathology, and compensatory mechanisms through 
which the brain actively compensates for clinical deterioration in the presence 
of pathology (Figure 2.2d).128
The concept of brain reserve states that individuals with a larger brain reserve 
tolerate a greater burden of pathology before clinical symptoms arise than do 
individuals with lower brain reserve.129 One study reported a lower risk of 
dementia in patients with a larger brain volume130 and another study reported 
that patients with WMH who had no cortical atrophy had a lower risk of 
dementia than did those with cortical atrophy.131 Structural network efficiency 
can also be viewed as a form of brain reserve, whereby more efficient networks 
might protect against clinical deterioration in the presence of brain pathology. 
In other words, patients with highly efficient networks (for example, networks 
with many connections between nodes) could cope well with pathology, as 
these individuals are able to compensate for the disruption of white matter 
tracts by using alternative connections. This hypothesis is supported by the 
finding that patients with SVD who did not develop dementia had higher global 
network efficiency than did patients who converted to dementia, independent 




The concept of cognitive reserve is that high intellectual enrichment or high 
cognitive reserve (usually operationalized as IQ and level of education) offers 
increased protection against age-related brain pathology.128,129,132-134 Specifically, 
in the context of cognitive impairment associated with SVD, several studies 
reported that high cognitive reserve attenuated the negative effects of SVD on 
cognition.129,132,135-140 Higher cognitive reserve was associated with a slower rate 
of decline in processing speed, executive functions and memory, independently 
of WMH severity, which supports the hypothesis that cognitive reserve protects 
against the clinical manifestations of SVD and could partly explain the variation 
in cognitive performance in patients with a similar burden of SVD markers.141
Compensatory functional connectivity refers to the ability of the brain to adapt 
to pathology by the use and development of compensatory networks when 
the primary networks are no longer capable of executing a certain task.133,142 
A functional neuroimaging study reported associations between decreased 
grey matter volume within the primary network and increased use of an 
alternative network to maintain task performance,143 supporting the theory of 
compensatory connectivity. In addition, a ‘less wiring, more firing’ hypothesis 
has been proposed, which states that neurons compensate for age-related 
impairments in white matter via greater synaptic responsiveness.144 Altered 
functional connectivity patterns in patients with SVD have been observed in 
several studies, with compensatory activation in networks being important 
to maintain cognitive performance.114,120-122
Mixed age-related pathologies
The variability in clinical symptoms between patients with apparently similar 
degrees of SVD might also be explained by the presence of other neurodegen-
erative pathologies, such as Alzheimer disease (AD). A neuroimaging study in 
patients with AD has reported reductions in network integrity that were 
associated with increased volume of WMH and lacunes, specifically in networks 
important for cognitive functioning, such as in executive and default-mode 
networks as well as in connections between hippocampus, thalamus, putamen 
and cortical regions.145
The question remains to what extent these pathologies truly interact. Some 
neuroimaging studies have found a synergistic effect between WMH and 
markers suggestive of AD pathology (for example hippocampal volume) on 
cognitive performance.146,147 Studies using AD transgenic mouse models 
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have suggested that neurovascular dysfunction potentiates the production 
of amyloid β.148 However, longitudinal evidence on the directionality of 
associations between vascular pathology and AD pathology in humans is 
limited.148,149 Neuroimaging studies in cognitively normal elderly individuals 
and patients with cognitive impairment have suggested that cerebrovascular 
pathology and AD pathology negatively affect cognition independently of each 
other.139,150 The same conclusion was also reached by two recent reviews.148,149
Methodological considerations
Several methodological considerations must be addressed regarding the 
studies discussed in this article. We will discuss factors related to neuroimaging 
and to study design, as well as possible solutions to tackle these methodological 
issues in future studies.
The reproducibility of SVD imaging markers is a major concern, especially 
across different centers.151 One review identified several aspects — from acquisition 
of imaging data to processing — that influence the reproducibility.151 
Quantification of SVD markers depends on magnetic field strength, choice of 
MRI sequence, image resolution, and the segmentation method used, the latter 
of which can range from qualitative visual rating scales to quantitative 
automatic segmentation routines.151,152 With the publication of the STandards 
for ReportIng Vascular changes on nEuroimaging (STRIVE), which provides 
definitions of visible SVD features and recommendations for image acquisition, 
analyses and scientific reporting to reduce the large variation between studies, 
a higher consistency between studies has been reached.4 Nonetheless, 
variation between studies is still considerable, hampering progress in our 
understanding of how SVD might contribute to clinical symptoms.
In connectivity analyses, the presence of SVD lesions, such as WMH, affects 
the reconstruction of white matter fiber tracts with the use of DTI data and 
consequently affects the investigation of remote effects via white matter 
tracts connected to the lesion or the assessment of structural connectivity. 
In functional connectivity, brain activity is measured by blood-oxygen-level 
dependent imaging that relies on regional differences in cerebral blood flow, 
which is often affected in patients with SVD. Additionally, cerebral blood flow 
can be affected by antihypertensive treatment.153
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With regards to the design of the discussed studies, most are cross-sectional 
and consequently cannot elaborate on causality or on the directionality of the 
associations. Furthermore, studies might be susceptible to selection bias, 
as patients with the most severe SVD lesion load are often institutionalized and 
might not have been able to participate. Finally, study populations vary between 
different studies — ranging from pure SVD to SVD with concomitant AD 
pathology and from population-based studies to studies including patients 
with symptomatic lacunar stroke — and this variability should be considered 
when interpreting results on the clinical consequences of SVD.
Future directions
Comprehensive studies with in-depth phenotyping of patients are warranted 
to further unravel the mechanisms by which SVD might lead to clinical deficits. 
Studies should include patients of a younger age (as currently patients older 
than 60 years of age are often studied), which would enable elaboration on the 
factors involved in the origin of SVD. Future studies should also consider all 
neuroimaging markers of SVD and include advanced multimodal structural 
and functional magnetic resonance sequences with high spatial resolution. 
Moreover, studies with longitudinal designs, including those with short 
inter-scan intervals of weeks or months, are of utmost importance to elucidate 
the directionality of associations and the sequence of events from focal SVD 
towards global remote effects and clinical symptoms. Furthermore, rather than 
solely focusing on vascular dementia or AD as isolated diseases, the field would 
benefit from a focus on the interaction of SVD pathology with other neuro-
degenerative pathologies. Finally, the pathological correlates of MRI-defined 
SVD lesions should be further investigated.
Conclusion
SVD is associated with a remarkable variation of clinical symptoms that differ 
both in nature and in severity. In this Review, we elaborate on how SVD affects 
the brain and we provide a framework to explain the remarkable disparities 
between patients. SVD markers visible on conventional MRI only reveal the tip 
of the iceberg with regards to the changes associated with the disease. Despite 
an identical appearance on MRI, SVD lesions are pathologically heterogeneous, 
and a cascade of events seems to spread from the initial SVD lesion to remote 
areas with a yet unknown time course. Furthermore, SVD disturbs structural 
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and functional network integrity, especially in central connections, thereby 
disrupting efficient communication in brain networks. Consequently, even a 
small focal lesion can lead to widespread effects. In addition, reserve and 
compensatory mechanisms enable patients to maintain cognitive and motor 
performance at the premorbid level until these mechanisms are exhausted and 
functional performance drops. Finally, other neurodegenerative pathologies 
can be present and probably contribute to the clinical presentation.
Although SVD lesions mostly occur in subcortical areas, they exert their effect 
throughout the brain. Consequently, the clinical notion of SVD being a focal 
subcortical disease must be reconsidered. Following the identification of SVD 
markers on MRI, clinicians should be aware that the entire brain is affected, 
despite the presence of focal subcortical lesions. Hence, what we see, is not 
what we get. This notion has also become apparent in other neurological 
diseases – for instance in multiple sclerosis, in which the clinical course is 
increasingly understood from the perspective of a global, rather than a focal 
brain disease.154 
In conclusion, advances in structural and functional imaging and network 
analyses have increased our understanding of the clinical symptoms in SVD 
beyond the classic spectrum and of the heterogeneity of these symptoms 
between individuals. Future prospective studies with in-depth phenotyping of 
patients and multimodal structural and functional MRI with high temporal and 
spatial resolution will shed light on the sequence of events in SVD from the very 
first MRI manifestation of focal SVD to its global remote effects.
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Introduction: It is unclear why cerebral small vessel disease (SVD) leads to 
lacunar stroke in some and to non–lobar intracerebral hemorrhage (ICH) in 
others. We investigated differences in MRI markers of SVD in patients with 
lacunar stroke or non–lobar ICH. 
Patients and Methods: We included patients from two prospective cohort 
studies with either lacunar stroke (RUN DMC) or non–lobar ICH (FETCH). 
Differences in SVD markers (white matter hyperintensities [WMH], lacunes, 
cerebral microbleeds [CMB]) between groups were investigated with univariable 
tests; multivariable logistic regression analysis, adjusted for age, sex, and vascular 
risk factors; spatial correlation analysis and voxel–wise lesion symptom mapping. 
Results: We included 82 patients with lacunar stroke (median age 63, IQR 
57–72) and 54 with non–lobar ICH (66, 59–75). WMH volumes and distribution 
were not different between groups. Lacunes were more frequent in patients 
with a lacunar stroke (44% vs. 17%, adjusted odds ratio [aOR] 5.69, 95% CI 
[1.66–22.75]) compared to patients with a non–lobar ICH. CMB were more 
frequent in patients with a non–lobar ICH (71% vs. 23%, aOR for lacunar stroke 
vs non–lobar ICH 0.08 95% CI [0.02–0.26]), and more often located in non–
lobar regions compared to CMB in lacunar stroke.
Conclusion: Although we observed different types of MRI markers of SVD 
within the same patient, ischemic markers of SVD were more frequent in the 
ischemic phenotype of lacunar stroke, and hemorrhagic markers were more 
prevalent in the hemorrhagic phenotype of non–lobar ICH.  
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Introduction
Cerebral small vessel disease (SVD) is the presumed underlying cause of up to 
25% of all ischemic strokes and 85% of intracerebral hemorrhages (ICH).160,161 
SVD refers to pathological changes of the small vessels of the brain, and can 
manifest itself in hereditary and sporadic forms.3 Cerebral amyloid angiopathy 
(CAA) primarily affects the superficial perforating arteries, whereas the non–
CAA form of SVD mainly affects the deep perforating arteries.3 
It is still poorly understood why some patients with the similar form of non-CAA 
sporadic SVD present with an ischemic lacunar stroke whereas others present 
with a non-lobar ICH.162,163 
Consequences of SVD can be visualized by its markers on magnetic resonance 
imaging (MRI), including white matter hyperintensities (WMH), lacunes and 
cerebral microbleeds (CMB).4 Previously, periventricular WMH burden has 
been associated with a lacunar stroke, whereas presence of CMB was associated 
with a non–lobar ICH.1 This study, however, did not investigate differences 
in spatial distribution patterns of SVD markers on MRI between groups, which 
could be essential for understanding the clinical course of SVD. Our results 
may potentially identify MRI markers of SVD that differentially predispose 
to either ischemia or hemorrhage, that in time may have implications for 
secondary preventive treatment.
Therefore, we aimed to investigate whether presence and spatial distribution of 
WMH, lacunes, and CMB on MRI differ between patients with a lacunar stroke 
and those with a non–lobar ICH. 
Patients and Methods
Study population
We identified patients from two prospective cohort studies; individuals with a 
lacunar stroke from the Radboud University Nijmegen Diffusion tensor and 
MRI Cohort (RUN DMC) and with a non–lobar ICH from the Finding the 
ETiology in spontaneous Cerebral Hemorrhage (FETCH) study. The Medical 
Review Ethics Committee Region Arnhem-Nijmegen approved the RUN DMC 
study and the medical ethics committee of the UMCU approved the FETCH 
study. All patients gave written informed consent.
42
Chapter 3
The RUN DMC is a single–center, prospective, cohort study which investigated 
503 non–demented elderly, aged between 50–85 years old, with evidence of 
SVD on MRI (WMH or lacunes).164 All participants underwent a structural 
interview, clinical assessment, and a 1.5 Tesla (T) MRI protocol. In this study, we 
included patients with lacunar stroke (ischemic stroke or transient ischemic 
attack [TIA]) in their medical history (Supplementary Figure 3.1). Patients were 
excluded if there was evidence for any other presumed cause of ischemia in 
their medical history (i.e. including large artery disease, cardioembolic source, 
or embolic stroke or TIA of undetermined source) or if they had a history of 
ICH. If neuroimaging was available in the patients’ file, subcortical MRI lesions 
consistent with clinical symptoms were used as confirmation that clinical 
symptoms were caused by lacunar infarction.
The FETCH study is a multi–center, prospective, cohort study amongst 204 
adults that presented with a symptomatic spontaneous ICH confirmed by 
computed tomography (CT).165 Patients underwent 3 T and/or 7 T MRI in one of 
three participating centers (University Medical Centers of Utrecht, Leiden or 
Nijmegen). Secondary causes were excluded by CT angiography in all and by 
digital subtraction angiogram if clinically indicated. For this study, we included 
patients of 50 years and older with a 3T MRI and ICH in the basal ganglia, 
thalamus, brainstem or cerebellum.
Demographics and vascular risk factors were assessed and defined as follows: 
age at the time of the MRI; sex; hypertension as the use of antihypertensive 
medication, systolic blood pressure 140mm Hg, or diastolic blood pressure 
90mm Hg, based on the average of three (RUN DMC) or two (FETCH; in medical 
history before the ICH) blood pressure measurements or left ventricular 
hypertrophy on ECG; diabetes mellitus as the usage of oral antidiabetics and/or 
insulin (RUN DMC) or as reported in medical history and/or two fasting glucose 
measurements of >7mmol/l (FETCH); history of smoking as ever or never 
smoked; alcohol overuse as alcohol use 300 g per week; and body mass index 
(BMI) by dividing the weight in kilograms by the height in meters squared.
MRI markers of SVD
MRI data
In the RUN DMC study, participants were scanned using one single 1.5 T MRI 
scanner (Siemens Healthineers, Erlangen, Germany), where as the FETCH 
study used three different 3T MRI scanners (Siemens Healthineers, Erlangen, 
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Germany; Phillips Healthcare, Best, The Netherlands). For a detailed overview 
of the MRI sequences of both studies (and participating centers) please see 
Supplementary Table 3.1. We rated WMH, lacunes, and CMB in accordance with 
the STandards for ReportIng Vascular ChangEs on neuroimaging (STRIVE) 
criteria.4
White matter hyperintensities
WMH segmentation on FLAIR sequences was performed as previously 
published for the RUN DMC dataset,166 and segmented in the ICH-free 
hemisphere for the FETCH dataset, using intensity–based thresholding in 
MRIcro (https://www.mricro.com), and subsequent manual adjustment by one 
of two trained raters. The ICH free hemisphere was used because WMH cannot 
be distinguished from perihematomal edema, if located in neighboring areas. 
WMH volumes were expressed as a percentage of intracranial volume in both 
datasets.
WMH masks were normalized to Montreal Neurological Institute (MNI) 152 
standard space using the Functional Magnetic Resonance Imaging of the Brain 
Software Library (FSL).167 First, we skull–stripped each image using the FSL 
Brain Extraction Tool (BET). Second, we registered FLAIR to T1 images using 
the FSL Linear Image Registration Tool (FLIRT; correlation ratio). Third, we used 
FLIRT and the FSL Non–linear Image Registration Tool (FNIRT) to register T1 
images to the MNI template. Lastly, we applied the resulting transformation 
matrices to the WMH masks. We generated bilateral masks in the FETCH dataset 
by inverting WMH masks and registering them to the contralateral hemisphere. 
All registration steps were checked visually. We generated WMH frequency 
maps displaying the proportion of participants with WMH in any given voxel 
for visualization purposes.
Lacunes
Lacunes were assessed by location by one of two trained raters, and categorized 
as lobar (centrum semiovale, frontal, parietal, insular/subinsular, temporal, 
occipital) or non–lobar (basal ganglia, thalamus, internal and external capsule, 
brain stem, cerebellum).168 Agreement with a second rater in random sub- 
samples was good (Cohen’s kappa >0.7 in both datasets). Final decisions were 
made in consensus involving more experienced raters (FEdL, MD). All lacunes 
were manually segmented on T1 images, and normalized to MNI 152 standard 
space via T1 images using the registration tools ‘FLIRT’ and ‘FNIRT’ from FSL.167 
We created spherical maps, with each sphere representing a single lacune, 




CMB were assessed by one trained rater (RUN DMC) or screened by a semi- 
automatic method after which true CMB were selected by a human rater 
(FETCH).169 Location of CMB was determined by using the Microbleed 
Anatomical Rating Scale (MARS),170 categorizing distribution as lobar (frontal, 
parietal, temporal, occipital, insula) and non–lobar (basal ganglia, thalamus, 
internal and external capsule, corpus callosum, deep and periventricular white 
matter, brain stem, cerebellum). A second rater assessed microbleeds in a 
random subsample (Cohen’s kappa ≥=0.70 in both datasets), indicating good 
inter–rater agreement. Final consensus was reached during meetings with 
experienced clinical neurologists (FEdL, FHBMS). After manual segmentation, 
CMB lesion masks were normalized to MNI 152 standard space via T1 images, 
and spherical maps were created with each sphere representing one single 
CMB. 
Statistical data analysis
All analyses were performed using R (version 3.5.3; https://www.R–project.org). 
We considered two–tailed p values <0.05 to be statistically significant. 
Demographics, vascular risk factors, and MRI markers of SVD were compared 
between patients with a lacunar stroke and a non–lobar ICH using univariable 
tests (independent sample t test, Chi–squared test, and Mann–Whitney U test 
where appropriate). We investigated associations of SVD MRI markers with 
either of the two stroke types using an age– and sex adjusted multivariable 
logistic regression model including vascular risk factors that were significant in 
univariate tests (glm R package). Additionally, for patients with ≥1  lacune or ≥1 
CMB, we compared the percentage of lobar vs non–lobar lesions using non–
parametric  univariate tests (Mann–Whitney U tests).
To compare differences in WMH distribution between groups, we performed a 
spatial correlation analysis and voxel–wise lesion symptom mapping (VLSM). 
For each voxel in MNI 152 standard space, the lesion frequency was compared 
between groups using linear correlation, where a correlation coefficient of 1 
indicates an identical lesion distribution. Furthermore, we investigated whether 
a voxel in standard space more frequently was a WMH (yes/no) in lacunar stroke 
or non–lobar ICH using VLSM in in NiiStat (https://www.nitrc.org/projects/
niistat/). We only included voxels that were damaged in at least 4% of the 
patients,171 and adjusted analysis for age and total WMH volume. Permutation–
based thresholding was used to control for family–wise error (FWE) at 5% 
(p < .05, two–tailed, 5000 Freedman–Lane permutations).
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Results
In total, we included 82 patients with a lacunar stroke (63% males, median age 
63 years, interquartile range [IQR] 57–72, 45 ischemic stroke and 37 TIA). 
Additionally, 54 patients with a non–lobar ICH were included (74% males, 
median age 66 years, IQR 59–75; Supplementary Figure 3.1, 35 deep and 19 
infratentorial). Eight of 54 (15%) patients had more than one ICH. The median 
stroke–MRI interval for patients with lacunar stroke was 198 days (IQR 95–630), 
and for patients with non–lobar ICH 13.5 days (6–38). Patient characteristics 
are summarized in Table 3.1. Patients with lacunar stroke more frequently 
had hypertension and a history of smoking than those with non–lobar ICH 
(Table 3.1).  
MRI markers of SVD
White matter hyperintensities
The median WMH volume was similar in patients with a lacunar stroke (0.3mL 
IQR [0.1–0.8] and a non–lobar ICH (0.4mL [0.2–0.9], p=.227). WMH were 
most prevalent in the periventricular and frontal white matter in both groups 
(Figure 3.1). The spatial correlation analysis demonstrated that the colocalization 
of WMH between groups was strong (R2=0.71; p<2.2e–16). VSLM analysis, 
adjusted for age, sex, and normalized WMH volume, showed a comparable 
distribution of WMH as there were no major clusters of voxels with WMH 
associated with either a lacunar stroke or a non–lobar ICH (Supplemental 
Figure 3.2).
Lacunes
Of 82 patients with a lacunar stroke, 36 (44%) had at least one lacune, in 
comparison with 9 of 54 patients with a non–lobar ICH (17%, p=.001). Presence 
of lacunes was significantly associated with a lacunar stroke after adjustment 
for age, sex, history of hypertension and smoking (aOR 5.69, 95% CI 1.66–22.75, 
Table 3.1). In patients with a lacunar stroke, 51 of 70 lacunes (73%) were in lobar 





Of the patients with a lacunar stroke, 19 (23%) had CMB, in comparison with 
35 of patients with a non–lobar ICH (67%, p < .001). Presence of CMB was 
significantly associated with a non–lobar ICH after adjustment for age, sex, 
history of hypertension and smoking (aOR for lacunar stroke vs non–lobar ICH 
0.08, 95% CI 0.02–0.26). In patients with a lacunar stroke, 59 of 76 CMB (78%) 
were in lobar regions, and in patients with a non–lobar ICH 162 of 302 CMB 
(54%) were in lobar regions (p=.006, Table 3.2, Figure 3.3).







































































Age at MRI, years, median [IQR]
Male sex, N (%)
Vascular risk factors
Hypertension, N (%)
Diabetes mellitus, N (%)
History of smoking, N(%)
Alcohol overuse,  N(%)
BMI, kg/m2, mean (SD) 
MRI markers of SVD
WMH volume, % ICV, median [IQR]
Presence of lacunes, N (%)
Presence of CMB, N (%)
ICV, mL, mean (SD)
Values represent median [IQR], N(%), or mean (SD). Multivariable odd ratios and corresponding 95% 
confidence intervals represent results from the logistic regression analysis for lacunar stroke versus 




Lacunar stroke vs. non-lobar ICH







































































Age at MRI, years, median [IQR]
Male sex, N (%)
Vascular risk factors
Hypertension, N (%)
Diabetes mellitus, N (%)
History of smoking, N(%)
Alcohol overuse,  N(%)
BMI, kg/m2, mean (SD) 
MRI markers of SVD
WMH volume, % ICV, median [IQR]
Presence of lacunes, N (%)
Presence of CMB, N (%)












































































































































































































































































































































































































































































































































































































































































































































































Lacunar stroke vs. non-lobar ICH
Discussion
Patients with a lacunar stroke and patients with a non–lobar ICH have similar 
volume and spatial distribution of WMH. Lacunes were more frequent in 
patients with a lacunar stroke, and CMB were more prevalent in patients with a 
non–lobar ICH. Spatial distribution of lacunes was similar in patients with a 
lacunar stroke and a non–lobar ICH, but CMB were more often non–lobar in 
patients with a non–lobar ICH compared to CMB in patients with a lacunar 
stroke. 
In contrast to our findings of a similar burden and distribution of WMH, in a 
previous study severe confluent periventricular WMH were found to be 
associated with a lacunar stroke compared to a non–lobar ICH.1 However, these 
findings were based on visual ratings of WMH, whereas in our study we made 
use of quantitative measures and a voxel–based approach. In our study, WMH 
were most frequent in periventricular areas, around the anterior and posterior 
horns of the lateral ventricles (Figure 3.1). The periventricular regions are 
known to be specifically vulnerable to ischemia,172,173 as they are located at the 
arterial end zone (the very ends of arterial territories) including the junction of 
the deep and superficial perforating arteries.174,175 Previous data demonstrated 
a strong inverse voxel–wise correlation between resting–state perfusion and 
WMH frequency, in individuals with CAA, mild cognitive impairment, 
Alzheimer’s disease and healthy controls,176 indicating that across these 
Table 3.2 | Lesion counts by lobar and non–lobar brain regions in patients 
with lacunar stroke or non–lobar intracerebral hemorrhage, with at least 






Lacunes, N Total 70 10 
Lobar 51 (73%) 8 (80%) .423
Non–Lobar 19 (27%) 2 (20%) .206
CMB,  N Total 76 302 
Lobar 59 (78%) 162 (54%) .006
Non–Lobar 17 (22%) 140 (46%) .008
Abbreviations: ICH = intracerebral hemorrhage; CMB = cerebral microbleeds. Values represent 
N(%).Lesion counts were compared between groups using univariate Mann–Whitney U tests.
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different populations, WMH are most frequent in regions with relatively lower 
cerebral perfusion.  However, this needs to be confirmed in prospective studies. 
Even though far more frequent in lacunar stroke, patients with a non–lobar 
ICH also had lacunes. Alterations in cerebral hemodynamics, blood–brain 
barrier permeability, release of inflammatory cytokines, and blood pressure 
after an ICH may give rise to a higher frequency of ischemic lesions.177 Likewise, 
the incidence of CMB has been reported to be relatively high after ischemic 
stroke.178 In addition to a similar distribution of WMH, patients with a lacunar 
stroke or a non–lobar ICH showed a large similarity in the distribution of 
lacunes, suggesting a common pathophysiological mechanism. This could be 
explained by previous studies within genetically defined SVD, where incident 
lacunes were found to predominantly occur within the orientation of 
perforating arteries,179 and the majority were localized at the edges of WMH.180 
Another study demonstrated that lobar lacunes were in contact with WMH in 
80% of the cases and were highly correlated with WMH volume, suggesting a 
common origin.168 This might explain the he high proportion of lobar lacunes 
found in our study, as WMH are predominantly located in lobar white matter 
regions, such as the centrum semiovale.
In contrast, CMB were more often lobar in patients with a lacunar stroke 
compared to patients with a non–lobar ICH. The high proportion of CMB in 
lobar brain regions in subcortical SVD remains unexplained. We are not able to 
fully exclude the possibility that CAA might have contributed to the high 
proportion of lobar CMB. Another study found evidence of moderate to severe 
CAA in around 6 of 48 (13%) participants with non-lobar ICH (i.e. arteriosclerotic 
subcortical small vessel disease).183 Furthermore, deep CMB were found to be 
mainly associated with arteriosclerotic small vessel disease, whereas both CAA 
and arteriosclerotic small vessel disease contributed to the risk of lobar CMB.182 
Also, cerebellar hemorrhages might be due to CAA if located in superficial 
regions.20 Collectively, these results suggest that arteriosclerotic SVD and CAA 
often co-exist, possibly resulting in a higher rate of lobar CMB.
SVD can manifest itself as ischemic or hemorrhagic disease, between which 
many risk factors are shared. If we gain more insight into the pathophysiological 
mechanisms that determine whether someone is more prone  to ischemic or 
hemorrhagic disease, this could inform treatment decisions. In clinical practice, 
antiplatelets are prescribed in patients with a lacunar stroke but not after a 
non–lobar ICH, as antiplatelet therapy was considered to increase the risk of 
ICH.184 However, the recently completed RESTART clinical trial found survivors 
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of antithrombotic–associated ICH to have fewer recurrences of ICH when 
antiplatelet therapy was restarted compared to patients in whom antiplatelet 
therapy was avoided.24 In addition, in contrast with previous suggestions, 
cumulative evidence suggests that presence of CMB should not be a reason to 
refrain from antiplatelet therapy. A recent pooled analysis of individual patient 
data of patients with ischemia stroke or TIA, showed that although presence 
of CMB enhance the risk of ICH to a larger extent than that of ischemic stroke, 
the absolute risk of ischemic stroke in these patients is higher than the absolute 
risk of ICH.185 
Strengths of our study are the use of two prospectively collected cohorts, 
the meticulous phenotyping, and the combination of multiple statistical 
approaches, including hypothesis–free voxel–based methods. Our study also 
has limitations. First, as the two etiologies originated from different studies, 
this might have led to a systematic bias. For example, patients with a lacunar 
stroke had a 1.5 T MRI, which may have led to underestimation of SVD burden.185 
Although the impact of MRI field strength on WMH volume measurements 
besides the expected improved resolution is still unclear, a previous study in 
patients with multiple sclerosis demonstrated a 10% higher mean WMH volume 
using 3 T MRI versus 1.5 T MRI.350 Although there are no studies investigating 
the variability of lacunes according to MRI field strength, more CMB are found 
at higher MRI field strengths.151 For instance, a previous study in 25 patients 
with multiple sclerosis, 53 CMB were found using 3T MRI compared to 41 CMB 
using 1.5 T MRI.351 Although the number of CMB increases with field strength 
and resolution,186 the detection of whether any CMB are present or not, generally 
remains consistent across different field strengths. Overall, the severity of 
MRI markers of SVD might have been underestimated on 1.5T MRI scans. 
In addition, different blood-sensitive MRI sequences were used (SWI or 
T2*–weighted imaging), which also affects the number of CMB  detected.151 
Moreover, the timing of the MRI was different between datasets. Whereas 
FETCH patients were scanned in the acute phase, MRI was performed in the 
chronic phase in RUN DMC. Furthermore, differences in patient selection 
could have influenced our results. In the RUN DMC study, patients were selected 
based on the presence of MRI markers of SVD, which might have resulted in an 
overestimation of the prevalence of vascular risk factors and neuroimaging 
markers. Although both studies had a history of hypertension or hypertensive 
treatment as part of their definition, diagnosis of hypertension on the basis 
of blood pressure measurements slightly differed between studies. In the 
non-lobar ICH group this relied upon two independent blood pressure 
measurements (systolic blood pressure ≥140mm Hg or diastolic blood pressure 
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≥90mm Hg) reported in the medical history and did not include data obtained 
during clinical admission. Therefore, individuals in whom hypertension was 
discovered during follow up after the ICH, were not included in this definition. 
This may in part explain the lower prevalence of hypertension in the group of 
non-lobar ICH. Hypertension in the RUN DMC was based on blood pressure 
measurements (systolic blood pressure ≥140mm Hg or diastolic blood pressure 
≥90mm Hg) at the time of inclusion. Furthermore, the finding that there were 
no differences in the prevalence of diabetes mellitus between groups might be 
due to the fact that the RUN DMC did not include fasting glucose  measurements 
obtained during clinical admission, as we know from previous studies that 
diabetes mellitus is strongly associated with lacunar stroke compared to ICH. 
Second, the sample size was relatively small. Third, more severe ICHs are often 
fatal, and therefore less likely to be investigated by MRI, which may have 
resulted in an underestimation of burden of SVD markers on MRI. Fourth, we 
did not investigate the full spectrum of MRI markers of SVD. Future studies 
should investigate the role of other MRI markers of SVD, such as perivascular 
spaces or cortical microinfarcts, in differentiating patients with non-lobar ICH 
or lacunar infarcts.
In conclusion, SVD in patients with lacunar stroke and non–lobar ICH cannot 
be distinguished by WMH burden or distribution. Patients presenting with the 
ischemic phenotype of lacunar stroke more often had lacunes, whereas 
patients with the hemorrhagic phenotype of non–lobar ICH more frequently 
had CMB, which were more often non–lobar than CMB in patients with lacunar 
stroke. Future longitudinal studies in early disease stages should address the 
temporal order and location of the occurrence of ischemic and hemorrhagic 


























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Acute ischemia in 




Wiegertjes K*, ter Telgte A*, Oliveira PB, van Leijsen EMC, Bergkamp MI, van Uden 
IWM, Ghafoorian M, van der Holst HM, Norris DG, Platel B, Klijn CJM, Tuladhar 
AM, de Leeuw FE. 
The role of small diffusion-weighted imaging lesions in cerebral small vessel 
disease. 
Neurology. 2019; e1627-e1634. 
*Shared first authorship
The role of small diffusion- 
weighted imaging lesions in  





Objective: To investigate the prevalence of asymptomatic diffusion-weighted 
imaging-positive (DWI+) lesions in individuals with cerebral small vessel 
disease (SVD) and identify their role in the origin of SVD markers on MRI. 
Methods: We included 503 individuals with SVD from the RUN DMC study 
(mean age 65.6 years [SD 8.8], 56.5% male) with 1.5 T MRI in 2006, and if available 
follow-up MRI in 2011 and 2015. We screened DWI scans (n = 1152) for DWI+ 
lesions, assessed lesion evolution on follow-up FLAIR, T1 and T2* images, and 
examined the association between DWI+ lesions and annual SVD progression 
(white matter hyperintensities [WMH], lacunes and microbleeds).
Results: We found 50 DWI+ lesions on 39/1152 DWI images (3.4%) in 38 different 
participants. Individuals with DWI+ lesions were older (p = 0.025), more 
frequently had a history of hypertension (p = 0.021) and had a larger burden of 
pre-existing SVD MRI markers (WMH, lacunes, and microbleeds: all p < 0.001) 
compared to individuals without DWI+ lesions. Of the 23 DWI+ lesions with 
available follow-up MRI, 14 (61%) evolved into a WMH, 8 (35%) resulted in a cavity, 
and one (4%) was no longer visible. Presence of DWI+ lesions was significantly 
associated with annual WMH volume increase, and yearly incidence of lacunes 
and microbleeds (all p < 0.001). 
Conclusions: Over 3% of individuals with SVD have DWI+ lesions. Although 
DWI+ lesions play a role in the progression of SVD, they may not fully explain 
progression of SVD markers on MRI, suggesting that other factors than acute 
ischemia are at play.
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Introduction
Cerebral small vessel disease (SVD) is the most important vascular contributor 
to dementia.187,188 MRI markers of SVD include white matter hyperintensities 
(WMH), lacunes, and microbleeds.4 It is generally assumed that chronic 
hypoperfusion plays a role in the etiology of SVD, although this has never been 
proven in longitudinal studies.2,189
Previous cross-sectional evidence has suggested that diffusion-weighted 
imaging- positive (DWI+) lesions representing acute ischemia are associated 
with SVD.177,190-192 DWI+ lesions may be clinically silent, with a prevalence 
ranging from < 1% in the general population193,194 to 8% in patients with 
hypertensive SVD and up to 23% in individuals with cerebral amyloid angiopathy 
(CAA).177,190-192  However, the role of DWI+ lesions in SVD progression remains 
unclear.
Recent longitudinal studies have suggested that DWI+ lesions might evolve 
into a spectrum of SVD markers, including a WMH, lacune, or microbleed.8,9,13 
However, these recent studies were small, had a short duration of follow-up 
or did not investigate the whole SVD spectrum. Therefore, the contribution of 
DWI+ lesions to the progression of SVD markers during long-term follow-up 
remains unknown.
Our aims were (1) to investigate the prevalence of DWI+ lesions in individuals 
with SVD, and (2) to identify their role in the origin of the spectrum of SVD MRI 
markers by capturing evolution of the DWI+ lesions during a 9-year follow-up 
and (3) by examining the relation between the occurrence of DWI+ lesions and 
progression of MRI markers of SVD within this time period.
Methods
Study population
We selected 503 participants with SVD aged between 50-85 years from the 
prospective Radboud University Nijmegen Diffusion tensor and Magnetic 
resonance imaging Cohort (RUN DMC) study.164 The clinical manifestation of 
SVD can present in acute (e.g. transient ischemic attack or lacunar syndromes) 
and subacute form (e.g. cognitive and motor impairment).195 However, we based 
the selection of participants on MRI markers of SVD including WMH and/or 
lacunes, as clinical symptoms of SVD are often diverse with a subtle onset.
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Participants were excluded if they had dementia, (psychiatric) disease interfering 
with testing or follow-up, SVD mimics, or MRI contraindications including 
known claustrophobia. We included all 503 participants with MRI at baseline, 
of which 361 participants underwent a first follow-up MRI examination (follow-up 
interval 5.4 years [range 4.6-6.2]) and 296 individuals underwent a second 
follow-up (follow-up interval 3.4 years [range 2.7-4.1]; Figure 4.1).
Standard protocol approvals, registrations, 
and patient consents
The Medical Review Ethics Committee Region Arnhem-Nijmegen approved 
the study, and all participants gave written informed consent.
Magnetic Resonance Imaging
All images were collected on a 1.5 T MR system (2006: Siemens [Munich, Germany], 
Magnetom Sonata; 2011 and 2015: Siemens, Magnetom Avanto), using the same 
head coil. Acquisition details have been described previously.164,196 In short, 
the following whole-brain scans were included: 3D T1 magnetization-prepared 
rapid gradient echo (MPRAGE) imaging (voxel size 1.0 × 1.0 × 1.0 mm); fluid- 
attenuated inversion recovery (FLAIR) pulse sequences (2006: voxel size 0.5 × 
0.5 × 5.0 mm, interslice gap 1.0 mm; 2011 and 2015: voxel size 0.5 × 0.5 × 2.5 mm; 
interslice gap 0.5 mm); diffusion-weighted sequence designed for diffusion- 
tensor imaging (voxel size 2.5 × 2.5 × 2.5 mm, 4 unweighted scans, 30 diffusion- 
weighted scans, b-value 900 s/mm-2); and a transversal T2*-weighted gradient 
echo sequence (voxel size 1.3 × 1.0 × 5.0 mm, interslice gap 1.0 mm).
Detection of DWI+ lesions and their time course
Preprocessing of diffusion data has been described previously.164 This included 
correction for eddy current-induced distortions and participant motion using 
an in-house developed algorithm and echo-planar imaging distortion correction 
by means of normalization to the T1 image in the phase-encoding direction.197 
We used the diffusion data to calculate mean diffusivity (MD) images and 
trace images based on the geometric mean of all diffusion-weighted images. 
DWI images indicative of DWI+ lesions were selected by a blinded rater (P.B.O). 
The intensity of MD maps at the corresponding location was noted (hypo-, 
iso-, or hyperintense) and interpreted as lesion age.198 Interrater agreement 
with an experienced and trained rater (K.W.) in a random sample of 5% (n = 58) 
showed excellent agreement (Cohen’s Kappa = 0.8, 95% CI [0.5-1.0]). Subsequently, 
identified DWI+ lesions were confirmed as definite lesions by two stroke 
neurologists (A.M.T. and FE.d.L.). Lesions were excluded if hyperintense on DWI 
scans at more than one time point as this implied most likely a T2 shine-through, 
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hypointense on initial T2* scans suggesting microbleed related susceptibility 
artifacts, or if any clinical symptoms were reported as we aimed to include 
clinically silent DWI+ lesions.
Figure 4.1 | Flowchart of the study population and prevalence of DWI+ lesions
No. represents the number of DWI+ lesions. BL = baseline; pt = participants; DWI+ = diffusion- 










Excluded (no MRI 2011)
N = 145
Deceased: N = 49
Refused/comorbidity: N = 78
MRI contraindication: N = 15
No DWI: N = 3
The 96 survivors were again 







Excluded (no MRI 2015)
N = 162
Deceased: N = 43
Refused/comorbidity: N = 100
MRI contraindication: N = 15








The appearance of the lesion on follow-up imaging was assessed by two 
experienced raters in consensus (K.W. and A.t.T.) on available FLAIR, T1, T2, and 
T2*-weighted sequences coregistered to the individual’s DWI scan at the time 
of the lesion. Prior to coregistration, all images were skull-stripped using the 
Brain Extraction Tool (BET) from the FMRIB Software Library.167 Using the FSL 
Linear Image Registration Tool (FLIRT; cost, mutual info) we coregistered brain 
extracted T1 images to DTI space and subsequently used the computed 
coregistration parameters to coregister FLAIR, T2 and T2* images to DTI space. 
All images were visually checked for coregistration errors.
Other neuroimaging markers
SVD markers were annotated according to the STandards for ReportIng Vascular 
changes on nEuroimaging (STRIVE) criteria.4 WMH volumes were segmented 
by a semi-automatic in-house developed tool,199 visually adjusted for errors 
by one trained rater (I.v.U), and normalized to baseline intracranial volume 
(ICV) as calculated by SPM12 (https://www.fil.ion.ucl.ac.uk/spm/software/spm12/). 
Number and location of lacunes and microbleeds were rated manually on 
FLAIR/T1-weighted and T2*-weighted images by two trained raters (I.v.U. and 
M.B.) blinded to clinical data. Inter- and intrarater reliabilities were excellent 
(weighted kappa ≥ 0.85 in a random sample of 10%).56 ICV was calculated 
by adding gray matter volume (GMV), white matter volume (WMV), and 
cerebrospinal fluid (CSF) volume.
Vascular risk factors
We assessed the presence of vascular risk factors through standardized structured 
questionnaires and physical examination, including smoking, hypertension, 
body mass index (BMI), diabetes and hypercholesterolemia, as described 
previously.164
Statistical analysis
Statistical analyses were performed in R (version 3.2.2). We compared 
participants with or without DWI+ lesions regarding demographics, vascular 
risk factors and SVD imaging markers. We used independent sample t-tests for 
group comparisons of normally distributed data and the Wilcoxon rank sum 
test (Mann-Whitney U-test) for non-normally distributed data (age, WMH 
volume and scores on the Mini-Mental State Examination [MMSE]). We used 
the Fisher’s exact test for group comparisons of categorical data.
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We investigated the relation between DWI+ lesions and annual SVD progression 
by linear regression analyses (model 1) using R function lm (Package stats 
version 3.2.4). We defined annual SVD progression as the increase in WMH 
volume, number of lacunes or microbleeds over the available follow-up period 
divided by the number of follow-up years. We used multivariable linear 
regression analysis to account for possible age-related effects (model 2). 
Subsequently, we assessed the relations between DWI+ lesions and SVD 
progression, adjusting for pre-existing WMH volume, number of lacunes, and 
number of microbleeds at the time of the DWI+ lesion (model 3).
Finally, we calculated the variance inflation factor (VIF) to assess multicol-
linearity among predictors in model 3, as DWI+ lesions have been shown to 
evolve into WMH, lacunes, and microbleeds over time. The individual VIF 
values for pre-existing SVD markers were all below 2.5 (WMH = 1.3, lacunes = 
1.1, microbleeds = 1.2). We therefore concluded that multicollinearity was 
unlikely.200
Two-tailed p values < .05 were considered statistically significant. Data analysis 
was completed from January 2017 to June 2018.
Data availability
Data from the RUN DMC study including data supporting the findings of this 
study are available from the corresponding author on request.
Results
The 503 participants had a mean age of 65.6 (SD 8.8) and 284 were male (56.5%). 
In total, 1152 DWI scans were collected over the three different time points and 
assessed for DWI+ lesions. A total of 38 participants had one or more DWI+ 
lesion at any MRI time point, with one participant having a DWI+ lesion both 
at baseline and at the first follow-up MRI scan (39/1152; 3.4%; Figure 4.1). 
We identified 50 DWI+ lesions, of which 38 were located in the white matter, 
three in the cortex, four in the deep grey matter, two in the cerebellum and 
three overlapped both the white matter and cortex. The MD signal values at 
lesion locations were hypointense (n = 16) or isointense (n = 28) in most cases, 
suggesting that these lesions were caught in the acute phase.198 Six lesions 
were captured in the subacute phase indicated by a hyperintensity on MD 
scans, which can typically be detected within a few weeks after the event.10
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Differences between participants with and without  
DWI+ lesions
Baseline demographics, vascular risk factors, and SVD imaging markers in 
participants with and without DWI+ lesions are summarized in Table 4.1. 
Participants with at least one DWI+ lesion at any MRI time point (n = 38) were 
older than participants without any DWI+ lesions (p = .025) but groups did not 
differ in sex, educational level, or MMSE score, although a negative trend was 
observed for a lower MMSE in individuals with a DWI+ lesion (p = .052). 
Moreover, individuals with a DWI+ lesion had a higher WMH volume and more 
frequently a lacune or microbleed (all p < .001) at baseline. The proportion of 
individuals with hypertension was higher in the group with a DWI+ lesion 
(p = .021), whereas other vascular risk factors did not differ significantly between 
groups.








Age (years), mean (SD) 65.4 (8.8) 68.8 (8.1) .025
Male (%) 266 (57%) 18 (47%) .239
Educational level, mean (SD) 4.8 (1.4) 5.0 (1.2) .452
MMSE, median [IQR] 29 [27-29] 28 [27-29] .057
Risk factors 
Hypertension (%) 334 (72%) 34 (89%) .021
Diabetes (%) 61 (13%) 3 (8%) .454
Hypercholesterolemia (%) 219 (47%) 17 (45%) .867
Smoking ever (%) 328 (71%) 25 (66%) .580
BMI (kg/m2), median [IQR] 26.7 [24.2-29.8] 26.0 [24.0-30.4] .617
SVD imaging markers 
WMH volume (mL), median [IQR] 3.2 [1.2-10.2] 15.2 [6.9-24.2] < .001
Lacunes presence (%) 109 (23%) 23 (61%) < .001
Microbleed presence (%) 63 (14%) 20 (53%) < .001
Data are presented as mean (SD), median [IQR], or N (%). DWI+ = diffusion-weighted imaging- 
positive; DWI- = diffusion-weighted imaging-negative; SD = standard deviation; MMSE = 
Mini-Mental State Examination; IQR = interquartile range; BMI = body mass index; SVD = cerebral 
small vessel disease; WMH = white matter hyperintensities. Groups represent participants with 
at least one DWI+ lesion at any MRI time point (DWI+) or no DWI+ lesion (DWI-).
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Evolution of DWI+ lesions
Follow-up imaging for assessment of lesion evolution was available for 23 out 
of 50 DWI+ lesions. On first and (if available) second follow-up MRI, 22 (out of 
the 23 DWI+ lesions) converted to MRI markers of SVD at the exact location of 
the former DWI+ lesion (Table 4.2). One lesion was no longer visible on the 
second MRI five years later. These 22 markers of SVD on follow-up, appeared as 
a WMH in 14, whereas eight lesions were visible as a cavity (Figure 4.2; Panel A 
and B). Of the eight cavitated lesions, two were smaller than the standard size 
for a lacune of presumed vascular origin (3-15 mm) as described in the STRIVE 
criteria, whereas the remaining six lesions did meet these criteria.4 One DWI+ 
lesion that evolved into a cavity smaller than a lacune, was located next to a 
hypointensity on T2*-weighted MRI, which remained visible on follow-up 
MRI, suggesting mixed (hemorrhagic and ischemic) pathology (Figure 4.2; 
Panel C).
DWI+ lesions and SVD progression
Participants with DWI+ lesions at either the first or second MRI (n = 16) had 
a higher annual WMH progression (β = 0.173, 95% CI [0.072 – 0.274], p <.001), 
and a higher yearly increase in the number of lacunes (β = 0.229, 95% CI [0.130 
– 0.328], p <.001) and a higher yearly increase in the number of microbleeds 
(β = 0.275, 95% CI [0.176 – 0.375], p <.001) compared with individuals without 
DWI+ lesions (model 1; Table 4.3). These associations remained statistically 
significant after adjusting for age at the time of the DWI+ lesion (model 2; Table 4.3). 
Table 4.2 |  Evolution of diffusion-weighted imaging-positive lesions  
by location
Evolution into SVD markers
Location of DWI+ lesion N (pt) FU 
available
WMH Cavity Disappearance
Cortex 3 (3) 0 NA NA NA
Supratentorial WM 38 (28) 20 (13) 13 (9) 6 (6) 1 (1)
Overlapping (cortex and WM) 3 (3) 1 (1) 1 (1) 0 0
Deep GM 4 (4) 1 (1) 0 1 (1) 0
Cerebellum 2 (2) 1 (1) 0 1 (1) 0
Data are presented as N (pt), where N represents the number of DWI+ lesions and pt the number 
of participants. DWI+ = diffusion-weighted imaging-positive; SVD = cerebral small vessel disease; 




The associations between the presence of DWI+ lesions and WMH progression 
or progression of lacunes were no longer significant after correction for 
pre-existing WMH volume, or pre-existing lacunes. In contrast, the association 
between the presence of DWI+ lesions with the yearly increase in the number 
of microbleeds remained statistically significant after adjusting for the number 
of pre-existing microbleeds (model 3; Table 4.3).
Figure 4.2 | Evolution of DWI+ lesions into a spectrum of SVD MRI markers
Baseline DWI+ lesions are shown on diffusion-weighted images, whereas lesion 
evolution is illustrated on FLAIR images. The insets display T1 (Panel A and B) or 
T2*images (Panel C). A. Evolution of a DWI+ lesion into a WMH at 5 and 9 years of FU. 
B. Evolution of a DWI+ lesion into a lacune at 5 and 9-years of FU. Note that at the time 
of the DWI+ lesion cavitation is already visible. C. A DWI+ lesion evolving into a cavity 
after 5 years of FU with a hemorrhagic component that was already visible at the time of 
the DWI+ lesion. DWI+ = diffusion-weighted imaging-positive; FLAIR = fluid-attenuated 
inversion recovery; SVD = cerebral small vessel disease; WMH = white matter hyper-
intensities; FU = follow-up.
Baseline 5-year FU 9-year FUDWI+ lesion
A.    Evolution into a WMH
B.    Evolution into a lacune
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Discussion
This study shows that DWI+ lesions occur in over 3% of individuals with SVD 
and evolve into a WMH in around two-thirds and into a cavity in the remaining 
one-third of individuals. DWI+ lesions are strongly related to the presence and 
annual progression of SVD markers on MRI.
The prevalence of DWI+ lesions of 3.4% is low when compared to a previous 
study that found six DWI+ lesions in 8% of patients with hypertensive SVD.191 
This discrepancy may be explained by the fact that in that study participants 
had more severe SVD than in our study. We found that individuals with DWI+ 
lesions had a greater SVD burden at baseline (WMH volume, lacunes, micro - 
bleeds) than those without. Prevalence of DWI+ lesions indeed seems to vary 
according to disease severity as it ranges from virtually zero in healthy 
individuals194 up to 38% in individuals with severe manifestations of SVD such 
as acute ICH.201,202 In our study, we had indeed expected DWI+ lesions to be 
a rare phenomenon, as individuals had predominantly mild to moderate SVD.
Table 4.3 |  Associations between DWI+ lesions and annual progression 
of SVD in individuals with DWI+ lesions at either the first or 
second MRI (n=16)











(0.072 – 0.274) 
< .001 0.229 
(0.130 – 0.328) 
< .001 0.275 






(0.058 – 0.248) 
.002 0.221 
(0.122 – 0.320) 
< .001 0.258 






(-0.087 – 0.076) 
.892 0.053 
(-0.035 – 0.142) 
.237 0.127 
(0.027 – 0.226) 
.013 
DWI+ = diffusion-weighted imaging-positive; MRI = magnetic resonance imaging; SVD = 
cerebral small vessel disease; WMH = white matter hyperintensities; β = standardized beta; CI = 
confidence interval. Model 1 is univariable; Model 2 is adjusted for age; Model 3 is adjusted for age 
and pre-existing SVD (WMH volume, number of lacunes or number of microbleeds) at the time 
of the DWI+ lesion.
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Preliminary evidence suggests that acute ischemia, as reflected by DWI+ lesions, 
plays a role in the origin of SVD markers (WMH, lacunes, microbleeds).8,9,13 
This is in line with our findings demonstrating that DWI+ lesions evolve into a 
WMH or a lacune over a follow-up period of 9 years. We did not find a DWI+ 
lesion evolving into a microbleed, but this may be because of small numbers. 
Almost all DWI+ lesions (> 95%) converted into markers of SVD on follow-up, 
whereas in a previous small study approximately half of DWI+ lesions became 
radiologically inapparent after almost seven months.66 However, this study was 
small and performed in individuals with CAA. It is as yet unclear what causes a 
DWI+ lesion to disappear, to cavitate or to evolve into a WMH on follow-up. 
Recently the severity of the ischemia corresponding to the DWI+ lesion, defined 
as more pronounced DWI abnormalities (lower lesional apparent diffusion 
coefficient [ADC] values) and higher neurofilament light chain protein (NfL) 
serum levels (a marker of neuroaxonal damage), were found to be associated 
with subsequent cavitation.13
Although DWI+ lesions seem to play a role in the origin of SVD MRI markers, 
they may not account for the entire progression of SVD markers on MRI. In fact, 
the etiology of SVD might be more heterogeneous than previously thought.2 
For instance, almost all DWI+ lesions converted into a focal, isolated WMH 
rather than that they were expansions of pre-existing WMH, suggesting that 
the progression of pre-existing WMH might be due to another pathological 
process than that of the development of isolated, focal WMH, such as chronic 
hypoperfusion.203 Similarly, recent studies showed a heterogeneous origin of 
microbleeds, where the majority reflected primary hemorrhages whereas some 
microbleeds were secondary to a microinfarct.9,58 Despite the fact that we 
could not capture the conversion of a DWI+ lesion into a microbleed in this 
study, we did show that DWI+ lesions were associated with annual progression 
of microbleeds even after adjusting for the previous number of microbleeds. 
Future studies should further specify the origin of MRI-defined SVD markers.
One of the strengths of this study includes the large cohort of SVD participants 
with high external validity for SVD patients from a general neurology outpatient 
clinic. Moreover, MRI assessment at three different time points allowed us to 
investigate the MRI signature of DWI+ lesions at multiple moments in time. 
Furthermore, we used a long-term follow-up period of nine years to investigate 
the role of DWI+ lesions in the origin of SVD MRI markers.
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Our study also has limitations. Because we were not able to make use of high 
field strength and high-spatial resolution MRI, we may have missed DWI+ 
lesions < 2 mm typically located in cortical regions.90 In addition, we used 
inter-scan intervals of several years, which may have resulted in underestima-
tion of the role of DWI+ lesions in the progression of SVD as DWI+ lesions are 
only visible for several weeks.198,204 Finally, there was a selective loss to 
follow-up. Participants lost to follow-up were older, had a higher burden of SVD, 
and had more vascular risk factors compared to individuals who remained in 
the study, probably leading to an underestimation of DWI+ lesion occurrence 
and SVD progression. The generalizability of our findings to the general 
population might be limited as we selected participants with presence of SVD 
on neuroimaging.
In conclusion, our study shows that over 3% of individuals with SVD have DWI+ 
lesions at a random MRI not related to clinical symptoms. Although DWI+ 
lesions play a role in SVD progression, they probably do not explain all 
progression of SVD markers on MRI, suggesting that other factors than acute 
ischemia are at play. Future high-frequency imaging studies with such short 
MRI intervals that they are able to capture all occurring DWI+ lesions are needed 
to determine to what extent DWI+ lesions can explain SVD progression, and 
whether they represent a promising target for future clinical trials or treatments 
aimed at slowing SVD progression.
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Objective: To determine the contribution of acute infarcts, evidenced by diffu-
sion-weighted imaging-positive (DWI+) lesions to progression of white matter 
hyperintensities (WMH) and other cerebral small vessel disease (SVD) markers.
Methods: We performed monthly 3 T MRI for 10 consecutive months in 54 
elderly individuals with SVD. MRI included high-resolution multi-shell DWI, 
and 3D FLAIR, T1 and SWI. We determined DWI+ lesion evolution, WMH 
progression rate (mL/month), and number of incident lacunes and microbleeds, 
and calculated for each marker the proportion of progression explained by 
DWI+ lesions.
Results: We identified 39 DWI+ lesions on 21/472 DWI scans in 9/54 subjects. 
Of the 36 DWI+ lesions with follow-up MRI, two evolved into WMH, four into a 
lacune (three of which with cavity < 3 mm), three into a microbleed, and 27 
were not detectable on follow-up. WMH volume increased at a median rate of 
0.027 (0.005-0.073) mL/month, but was not significantly higher in subjects 
with DWI+ lesions compared to those without (p = .195). Of the two DWI+ lesions 
evolving into WMH on follow-up, one explained 23% of the total WMH volume 
increase in one subject, whereas WMH regressed in the other subject. DWI+ 
lesions preceded 4/5 incident lacunes, and 3/10 incident microbleeds.
Interpretation: DWI+ lesions explain only a small proportion of the total WMH 
progression. Hence, WMH progression seems to be mostly driven by factors 
other than acute infarcts. DWI+ lesions explain the majority of incident lacunes 
and small cavities, and almost a third of incident microbleeds, confirming that 
WMH, lacunes, and microbleeds, although heterogeneous on MRI, can have a 
common initial appearance on MRI.
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Introduction
Cerebral small vessel disease (SVD) constitutes the main vascular cause of 
cognitive impairment and dementia, and accounts for about a fifth of all 
strokes.4,36 SVD is further associated with gait impairment, mood disturbances, 
and late-life disability.3 Conventional magnetic resonance imaging (MRI) 
markers of SVD include white matter hyperintensities (WMH), lacunes, and 
cerebral microbleeds, with WMH being the most widely studied.4 Traditionally, 
WMH have been attributed to chronic cerebral hypoperfusion. However, 
evidence for this hypothesis remains inconclusive.62,189
The limited understanding of the pathogenesis of SVD has several reasons. 
First, since SVD is rarely a cause of death, histopathology studies generally 
reflect advanced disease stages,156 such studies are by definition cross-sec-
tional, limiting any causal inference. Finally, in vivo longitudinal studies are 
mostly conducted with follow-up intervals of several years,189 impeding 
detailed mechanistic insights into SVD progression. Thus, novel in vivo study 
designs with highly frequent follow-ups are needed to gain further insight into 
SVD progression.
Only recently, a weekly MRI study, applied over 16 weeks, among five individuals 
with SVD reported on an acute rather than chronic ischemic origin of WMH, 
as demonstrated by small acute diffusion-weighted imaging-positive (DWI+) 
lesions that evolved into WMH on follow-up.8 Because DWI+ lesions are 
frequently clinically silent, and only detectable within approximately the first 
four weeks,10 they usually go unnoticed. It is estimated that the detection of a 
single DWI+ lesion at a random moment in time is indicative of hundreds of 
new cerebral microinfarcts per year.90
Recent studies show that DWI+ lesions may not only transform into WMH, 
but may also become a lacune or microbleed, or they may become invisible on 
follow-up scans.4,9,12,13,58 Importantly, it is currently unknown what proportion 
of SVD progression can be explained by DWI+ lesions.
We hypothesized that DWI+ lesions drive progression of SVD markers, in 
particular WMH. Therefore, we conducted a prospective monthly MRI study, 
the RUN DMC – InTENse study (Radboud University Nijmegen Diffusion tensor 
and Magnetic resonance imaging Cohort – Investigating The origin and 
EvolutioN of cerebral small vessel disease),204 and investigated the proportion 
of WMH progression explained by DWI+ lesions. In addition, we assessed 
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the number of incident lacunes and incident microbleeds preceded by a 
DWI+ lesion.
Methods
Study Design and Subjects
The prospective RUN DMC – InTENse cohort study was performed at the 
Radboud University Medical Center and the Donders Institute for Brain, Cognition 
and Behavior (Nijmegen, the Netherlands) between March 11, 2016 and 
November 3, 2017. Details of the study protocol have previously been published.204 
To summarize, this study comprised 12 visits to our research center, including 
a pre-visit, ten consecutive monthly MRI visits, and a follow-up visit one year 
after the start of the study.
Subjects were selected from the previous prospective RUN DMC study, 
comprising MRI and clinical data collection in 2006, 2011 and 2015 among 503 
patients with sporadic SVD referred to our Neurology department.164 Selection 
criteria for the RUN DMC – InTENse study were aimed at including 50 
individuals with a high likelihood of progression of SVD imaging markers, 
while meticulously excluding those individuals with presumed causes of 
cerebral ischemia other than SVD. Therefore, inclusion criteria comprised 
participation in at least the RUN DMC 2006 and 2015 waves, WMH progression 
between 2006-2015 (those with largest WMH progression were invited first), 
and being able to visit our clinic monthly. The main exclusion criteria comprised 
a carotid artery stenosis > 50% (either in the medical history or on ultrasound 
made during the pre-visit), a cardioembolic source (e.g. atrial fibrillation; in the 
medical history or detected on ECG during the pre-visit), use of oral anti-
coagulants, radiological or clinical evidence of a cortical ischemic stroke or 
transient ischemic attack, or vasculitis. Patients with any intracranial hemorrhage 
other than a microbleed on MRI or another pre-existing structural brain lesion 
preventing MRI analysis, dementia, Parkinson’s disease, 3 T MRI contraindication, 
or a disease with life expectancy < 1 year, were excluded. The RUN DMC – 
InTENse study was approved by the medical ethics committee region Arn-
hem-Nijmegen, and all subjects gave written informed consent prior to the 
start of the study.
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MRI Acquisition
Subjects were scanned using a single 3 T MRI scanner (MAGNETOM Prisma, 
Siemens Healthineers, Erlangen, Germany) and 32-channel head coil, including 
the following sequences (see also Supplemental Table 5.1 for further details):
-	multi-shell DWI, with 99 diffusion-weighted directions (3 × b = 200, 6 × b = 
500, 30 × b = 1000, and 60 × b = 3000 s/mm2) covered uniformly within and 
across shells, 10 × b = 0 images (University of Minnesota, Center for Magnetic 
Resonance Research sequence), multi-band acceleration factor 3,204 and 1.7 
mm isotropic voxels;
-	one b = 0 image with opposite phase-encoding direction but acquisition 
parameters otherwise equal to the previous DWI sequence, to correct for 
 susceptibility-induced distortions in DWI;
-	 -3D fluid-attenuated inversion recovery (FLAIR) with 0.85 mm isotropic 
voxels;
-	 -3D T1-weighted using a Magnetisation Prepared 2 Rapid Acquisition 
Gradient Echoes (MP2RAGE) with 0.85 mm isotropic voxels;
-	 -3D multi-echo fast low angle shot (FLASH) providing magnitude and phase 
images (6 echoes) to create susceptibility-weighted images with 0.8 × 0.8 × 
2.0 mm voxels.
Automated checks of sequence parameters of all acquired images and standardized 
visual image quality control ensured high data quality.
Image Processing
Diffusion data were pre-processed for denoising and removal of Gibbs artefacts 
using tools from MRtrix (version 3.0, http://www.mrtrix.org).205,206 Using 
eddy and topup within the Functional Magnetic Resonance Imaging of the 
Brain (FMRIB) Software Library (FSL; v5.0), raw diffusion data were corrected 
for susceptibility-induced distortions, motion, and eddy currents. Intensity 
bias correction was performed with the N4 bias correction as implemented in 
the Advanced Normalization Tools, version 2.1.0.167 Diffusion-weighted trace 
images were generated for the b=1000 and b=3000 images based on the 
arithmetic mean across diffusion directions. Using dtifit in FSL, we calculated 
the mean diffusivity map utilizing the b=1000 shell. The mean diffusivity map 
is equivalent to the apparent diffusion coefficient, but derived from a diffusion 
tensor model.72
FLAIR images were bias corrected using the N4 bias correction procedure.
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MP2RAGE data were processed to obtain robust T1-weighted images, which 
constitute the best compromise between image intensity bias and increased 
noise levels in the image background and cavities of the skull. This was done 
according to a previously described procedure,207 using custom written scripts 
in MATLAB (R2016b, The MathWorks, Natick, Massachusetts, USA).
To generate susceptibility-weighted images, for each of the six echo times we 
multiplied high-pass filtered (filter size = 12 pixels) phase images with their 
corresponding magnitude images, which were subsequently averaged into a 
single susceptibility-weighted imaging (SWI) scan.
To facilitate the systematic detection of incident lesions, difference images 
were generated for the DWI (both b=1000 and b=3000 trace images), FLAIR, and 
T1 image modalities. For this purpose, we first skull stripped the images using 
the Brain Extraction Tool (BET) in FSL and normalized the image intensity to 
the 95th percentile. Next, we registered (within each modality) the images of all 
different MRI visits to a subject-specific template, generated using FreeSurfer’s 
mri_robust_template.208 Difference images were then created by subtracting 
registered and intensity-normalized images from consecutive MRI visits, 
thereby highlighting incident SVD lesions as an easily discoverable hyperintense 
or hypointense voxel cluster on a uniform background (Figure 5.1).180 
Assessment of MRI Markers of SVD and Lesion Evolution
SVD lesions were assessed blinded to clinical characteristics according to the 
previously published STandards for ReportIng Vascular changes on nEuro - 
imaging (STRIVE).4
To detect DWI+ lesions, one rater (AtT) manually screened all available difference 
images. The mean diffusivity map was assessed to verify a hypointense or 
isointense signal at the corresponding lesion location. A second rater (KW) 
screened all positive scans, together with a random set of 50 negative scans 
(~10%). Cohen’s kappa was 0.78 (95% CI 0.62 to 0.95) and Dice similarity 
coefficient (DSC) was 0.86, indicating good inter-rater agreement. After final 
consensus was reached, both raters manually segmented all DWI+ lesions on 
the b=3000 native trace image to calculate lesion volume. Median DSC (IQR) on 
the entire set of DWI+ lesions was 1.0 (0.8-1.0) indicating high spatial overlap 
between the segmentations of the two raters.
WMH were segmented using an automatic algorithm based on deep fully 
convolutional network and ensemble models.209 Input images were the native 
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space FLAIR images together with the registered T1-weighted images. This 
algorithm was chosen, because it was ranked first in the WMH Segmentation 
Challenge at MICCAI 2017. WMH volumes were extracted from the resulting 
binary WMH masks. To address variability present in the WMH segmentation 
Figure 5.1 | Incident lesion detection using difference imaging
DWI difference images were created by subtracting registered diffusion-weighted 
imaging (DWI) trace images (shown here b=3000) from consecutive MRI visits to detect 
incident DWI+ lesions (A). Incident lacunes were detected on T1 and FLAIR difference 
images created by subtracting registered baseline T1 and FLAIR scans from the last 
available follow-up scan (B).
DWI
DierenceWeek 0
A. DWI dierence imaging
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results, we calculated predicted individual WMH volume (at each time point) 
and rate of WMH change (mL/month), using all time points and a simple linear 
regression model on WMH volumes over time (Figure 5.2), and report here the 
WMH volumes as volumes predicted by this linear model. To account for 
atrophy, WMH volumes were also expressed as percentage of total white matter 
volume, estimated at each time point from robust T1-weighted images using 
the Statistical Parametric Mapping (SPM) toolbox tissue segmentation algorithm 
(v12; Wellcome Department of Cognitive Neurology, London, UK; http://www.
fil.ion.ucl.ac.uk/spm). Given that WMH are often misclassified by SPM as 
cerebrospinal fluid or gray matter, the white matter mask was corrected using 
the WMH mask.
To detect lacunes, we followed a consensus rating strategy, as inter-rater 
agreement of lacune detection is known to be low.210 Two raters (AtT, JJdK) 
performed a sensitive rating of all baseline FLAIR and T1-weighted images to 
identify possible baseline lacunes, and subsequently, all difference FLAIR and 
T1-weighted images representing the change from baseline to last available 
follow-up to identify possible incident lacunes. Final decisions were made in 
consensus involving more raters (MDu, FEdL).
To detect microbleeds, one rater (KW) visually screened possible microbleeds 
(including lesions with axial diameter < 2 mm) detected by a semi-automatic 
method based on the radial symmetry transform, including minimum intensity 
projection, which improves sensitivity and reduces the number of possible 
locations.211 True microbleeds were selected by the human rater. A second rater 
(JJdK) screened all positive cases plus a random set of 25 negative cases (~5%). 
Cohen’s kappa was 0.70 (95% CI 0.46 to 0.86) and the DSC was 0.67 indicating 
good inter-rater agreement. Final consensus was reached involving a third 
rater (FHBMS).
The evolution of DWI+ lesions was determined by consensus (AtT, KW, MDu, 
FEdL) using the last available FLAIR, T1-weighted and SWI scans, and included 
the following categories: WMH, lacune or small incident cavity (to include 
incident cavities with axial diameter < 3 mm, which are currently not covered 
by STRIVE), microbleed, and disappearance or almost vanished (i.e. very subtle 
tissue alteration, which can only be seen with prior knowledge of the DWI+ 
lesion). To assess lesion evolution, images of the different modalities (DWI, 
FLAIR and SWI) were affine registered to the T1-weighted image of the same 
visit. Next, T1-weighted images of the monthly follow-up visits were affine 
registered to the T1-weighted image of the first MRI visit. The estimated trans-
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formations were applied to the co-registered images of the other modalities 
and lesion masks. All transformations were done using Advanced Normalization 
Tools (ANTs, version 2.1.0).207
Clinical Characteristics
Cardiovascular risk factors were assessed during the pre-visit (unless otherwise 
specified) and defined as follows: hypertension as a mean systolic blood 
pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mmHg and/or use 
of an antihypertensive drug; diabetes as a random glucose ≥ 11.1 mmol/L, or an 
overnight fasting glucose ≥ 7.0 mmol/L measured at least one month later, and/or 
use of an antidiabetic drug; hypercholesterolemia as fasting total cholesterol 
levels ≥ 6.5 mmol/L measured in parallel with the third MRI scan, and/or use 
of a lipid-lowering drug; smoking status as ever or never smoked; body 
mass index as weight over height squared. In addition, we assessed use of 
Figure 5.2 | Predicted change of white matter hyperintensity volume
On the basis of white matter hyperintensity (WMH) volumes measured at each time 
point (black) and a simple linear regression model on WMH volumes over time (grey), 
rate of WMH change was calculated per subject (i.e. the slope of the regression model). 
To address variability present in the WMH segmentation results, we reported the WMH 
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antithrombotic agents, educational level using a 7-point Dutch rating scale, and 
the Mini-Mental State Examination score during the pre-visit.
Statistical Analysis 
All statistical analyses were performed in R (versions 3.4.3-4; https://www. 
R-project.org). We determined the cumulative incidence of DWI+ lesions, as 
well as their median monthly incidence on the basis of the DWI+ lesion 
incidence per MRI visit. Demographic, clinical and baseline MRI characteris-
tics were compared between subjects with vs. without any DWI+ lesion during 
the study period, using non-parametric tests. WMH progression rate, and 
incidence of lacunes (and small cavities) and microbleeds were also compared 
between these groups. We determined the proportion of the total WMH 
progression that could be attributed to a DWI+ lesion per individual as follows: 
DWI lesion volume/total predicted WMH increase. The two-tailed significance 
level α was set at 0.05. To take into account that we could have missed a DWI+ 
lesion due to missing data, individuals with an incident lesion without DWI one 
month prior to the event were excluded from the analysis where appropriate.
Results 
Characteristics of Cohort
The RUN DMC – InTENse cohort comprised 54 subjects with sporadic SVD 
(Figure 5.3, upper panel). Median baseline age was 69 years (IQR 66-74) and 63% 
was male. Of the 54 subjects, 39 had ten complete MRI datasets, whereas two 
subjects never had follow-up MRI (Figure 5.3, lower panel). In total, 472 DWI 
scans were collected. The median duration of follow-up was 39.5 weeks (IQR 
37.8-40.3) with a median MRI interval of 31.2 (IQR 30.0-32.3) days.
Incidence of DWI+ lesions
In total, 39 DWI+ lesions were observed in 9/54 (16.7%) subjects (21/472 scans), 
resulting in a median monthly incidence of DWI+ lesions of 4.4% (95% CI 3.9 to 
5.8). Four subjects had a single DWI+ lesion. Two subjects had two DWI+ lesions 
on a single MRI, and three subjects had multiple DWI+ lesions (n = 7, 8, and 16) 
on multiple MRI scans (n = 6, 6, and 3, respectively). The median volume of 
DWI+ lesions was 0.010 mL (IQR 0.010-0.032). All DWI+ lesions were silent in 
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Figure 5.3 | Flow diagram of the RUN DMC – InTENse cohort and number of DWI 
scans collected
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DWI+ lesions were distributed throughout the brain, with 32 (82%) being 
supratentorial (Figure 5.4; Supplemental video 1: https://onlinelibrary.wiley.
com/doi/full/10.1002/ana.25556). These were located in the white matter (n = 5), 
subcortical gray matter (n = 3), cortex (n = 22), and the cortical gray-white matter 
junction (n = 2). All seven (18%) infratentorial DWI+ lesions were located in the 
cerebellar cortex.
Compared to subjects without DWI+ lesions, subjects with a DWI+ lesion were 
older (p = .004). Median WMH volume was > 2-fold higher in subjects with 
DWI+ lesions compared to those without (9.0 vs. 3.8 mL), although this 
difference did not reach statistical significance (p = .214), possibly due to the 
small sample size. Similarly, no other statistical differences with respect to 
demographic, clinical, and MRI characteristics were observed between the two 
groups (Table 5.1).
Figure 5.4 | Distribution of DWI+ lesions
The distribution of DWI+ lesions is depicted in MNI-152 standard space. The image was 
created using BrainNet Viewer, http://www.nitrc.org/projects/bnv/ 
cerebellum
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Evolution of DWI+ lesions
Follow-up scans were available for 36 (92%) DWI+ lesions. Two DWI+ lesions 
evolved into a WMH, one into a lacune ≥ 3 mm and three into a small cavity < 3 
mm. Three DWI+ lesions evolved into a microbleed, with two lesions further 
being hyperintense on T2 in the acute phase and on follow-up. 25 DWI+ lesions 
disappeared or almost vanished on follow-up FLAIR and T1, despite having 
shown a FLAIR and/or T1 signal change in the acute phase. The majority of 
lesions that disappeared were located in the cortex. Two DWI+ lesions never 
became visible on FLAIR and T1, neither in the acute phase or on follow-up 
(Table 5.2; Figure 5.5; Supplemental video 2: https://onlinelibrary.wiley.com/
doi/full/10.1002/ana.25556).







Age (years) 68 (65-72) 76 (69-82) .004
Men 27 (60%) 7 (78%) .458
Level of education 5 (5-6) 5 (5-6) .883
Clinical characteristics 
MMSE 29 (28-30) 28 (28-30) .363
Antithrombotic agents 21 (47%) 5 (56%) .724
Hypertension 37 (82%) 8 (89%) 1.000
Diabetes 3 (7%) 3 (33%) .051
Hypercholesterolemia 22 (49%) 5 (56%) 1.000
BMI (kg/m2) 25 (24-28) 26 (25-28) .634
Smoking (ever) 32 (71%) 6 (67%) 1.000
MRI characteristics 
WMH volume (mL) 3.8 (2.2–10.2) 9.0 (5.1–10.5) .214
WMH volume (% of WM 
volume) 
1.0 (0.5-2.3) 2.1 (1.5-3.2) .181
Lacunes, prevalence 9 (20%) 3 (33%) .399
Microbleeds, prevalence 19 (42%) 6 (67%) .275
WM volume (mL) 426 (395-462) 400 (379-446) .493
Data are median (IQR), or number (%). Level of education was determined using a 7-point Dutch 
rating scale ranging from primary school not completed (1) to academic degree (7). MMSE = 
Mini-Mental State Examination. BMI = body mass index. DWI+ = diffusion-weighted imag-
ing-positive. WMH = white matter hyperintensity. WM = white matter.
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Contribution of DWI+ lesions to total SVD progression
The volume of WMH increased at a median rate of 0.027 (IQR 0.005-0.073) mL/
month. However, WMH progression rate was not higher in subjects with one 
or more incident DWI+ lesions compared to those without (p = .195; Table 5.3), 
also after correction for white matter atrophy (p = 0.282, data not shown). 
Of the two cases with evolution of a DWI+ lesion into a WMH, the DWI+ lesion 
contributed to 23% of the total increase in WMH in one case, whereas in the 
other case there was a regression of WMH volume.
Figure 5.5 | Differential evolution of DWI+ lesions
Each panel shows b=3000 diffusion-weighted imaging (DWI) trace images, prelesional 
scans (left) and last available follow-up scans (right).
Week
A. Evolution into a white matter hyperintensity
D. DisappearanceC. Evolution into a microbleed





















Contribution of acute infarcts to SVD progression
Analyzing FLAIR and T1 difference images, we found six incident lacunes 
or small incident cavities in 3/52 (5.8%) subjects over the entire study period. 
One subject had an incident lacune without DWI one month prior to the event, 
and was therefore excluded from the subsequent statistical analysis. The incidence 
of lacunes and small incident cavities was significantly higher in subjects with 
a DWI+ lesion (p = 0.028; Table 5.3) compared to those without. DWI+ lesions 
preceded 4/5 (80%) incident lacunes or small incident cavities at the 
corresponding location.
Analyzing the SWI scans, we found ten incident microbleeds in 6/52 (12%) 
subjects over the entire study period. These incident microbleeds occurred in 
3/9 subjects with a DWI+ lesion, and 3/43 without DWI+ lesions (p = .057; Table 5.3). 
DWI+ lesions preceded 3/10 (30%) incident microbleeds at the corresponding 
location.
Table 5.2 | Evolution of DWI+ lesions according to lesion location
Evolution
Location  























































































White matter 1 3 0 0 0 0 1 
Subcor-tical gray matter 0 1 0 1 1 0 0 
Cortex 0 0 0 0 20 1* 1 
Cortical gray-white junction 1 0 0 0 0 1* 0 
Cerebellum 
Cortex 0 0 1 1 4 0 1 
The evolution of DWI+ lesions was determined using the last available FLAIR, T1-weighted and 
SWI scans. Shown are the locations of the DWI+ lesions in rows, and the evolution in columns. 
*Both lesions were never visible on FLAIR and T1-weighted imaging. DWI+ = diffusion-weighted 




In this monthly MRI study of individuals with sporadic SVD, we found clinically 
silent DWI+ lesions in almost one-fifth of subjects, resulting in a monthly 
incidence of 4.4%. However, DWI+ lesions explained only a small proportion of 
the total WMH volume increase. In addition to WMH, DWI+ lesions preceded 
80% of incident lacunes or small cavities, and 30% of incident microbleeds. 
Cortical DWI+ lesions mostly disappeared on follow-up MRI.
The observed incidence of DWI+ lesions is in line with previous cross-sectional 
studies.90 However, the cumulative incidence of DWI+ lesions of 17% during the 
course of our study is much lower compared to a small longitudinal case series 
in which 3/5 (60%) individuals with SVD developed DWI+ lesions within the 
white matter during a 16-week period.8 This discrepancy is most likely related to 
the difference in SVD burden. While all cases from the previous case series had 
moderate to severe SVD (Fazekas ≥ 2), our study included participants with an 
on average lower but wider range of SVD burden, with approximately 50% of 
the cohort having a Fazekas score ≥ 2.
In the present study, we demonstrated a differential evolution of DWI+ lesions, 
corroborating recent findings.4,9,12,13,58 Although factors determining lesion 
evolution remain largely unclear, our data show that markers of SVD which are 
heterogeneous on MRI, can have a common initial appearance on MRI.
Table 5.3 |  Progression of SVD MRI markers and proportion explained by 
DWI+ lesions




p Incident MRI 
markers of SVD 









Lacunes, incidence 0 (0%) 2 (22%) .028* 4/5 (80%)
Microbleeds, 
incidence 
3 (7%) 3 (33%) .057 3/10 (30%)
Data are median (IQR), or number of subjects with an incident lesion (%). WMH = white matter 
hyperintensity. *One subject with an incident lacune but without DWI one month prior to the 
event was excluded from this analysis. DWI+ = diffusion-weighted imaging-positive.
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The contribution of DWI+ lesions to WMH progression was, however, minor. 
Thus, we could not confirm the hypothesis that DWI+ lesions are the major 
cause of WMH. Two factors could potentially have led to an underestimation of 
the role of DWI+ lesions in WMH progression. First, despite the rather high 
resolution and high quality of the DWI scans, small DWI+ lesions, below the 1.7 
mm voxel size, might have gone undetected and consequently their conversion 
into incident WMH might have been missed, because the DWI resolution was 
lower than the FLAIR resolution.90,212 Second, as a result of our monthly MRI 
frequency, DWI+ lesions could have gone unnoticed for which the DWI signal 
was increased only shortly. It seems, however, more likely that WMH are mostly 
driven by other factors than acute ischemia, including blood-brain barrier 
disruption, demyelination, and inflammation.62,156,213 Future work is required 
to unravel how these different pathological mechanisms are related in time. In 
contrast, we revealed that DWI+ lesions are the major cause of incident lacunes 
and small incident cavities.
This study highlights two further interesting findings, which require future 
investigations. First, in contrast to most previous studies, many DWI+ lesions 
were located in the cortex, with the majority of these lesions meeting the size 
criteria of acute cortical microinfarcts (< 5 mm).90 Previous studies may simply 
have been unable to detect these microinfarcts due to limited resolution of the 
DWI scans.
Second, the vast majority of cortical lesions disappeared on follow-up MRI. In 
line with our findings, one recent study among patients with transient ischemic 
attack demonstrated DWI+ lesion disappearance, with cortical topography and 
small lesion size being important predictors for lesion disappearance.214 Based 
on animal studies, we hypothesize, however, that lesion disappearance does 
not imply full recovery.215 More likely, these small acute infarcts cause 
microscopic tissue injury below the T1 and FLAIR detection limit. Nonetheless, 
when accumulating over time, these microscopic lesions may contribute to 
cortical atrophy and cognitive decline.2
SVD is now recognized as the most important vascular contributor to dementia, 
but a causal treatment directed at preventing the development or slowing the 
progression of SVD does not yet exist. Our findings indicate DWI+ lesions as a 
marker of SVD, and therapeutic strategies aimed at the prevention of acute 
ischemic DWI+ lesions could contribute to halting part of the progression of 
SVD. Among patients with vascular cognitive impairment, the presence of 
acute microinfarcts was associated with a two-year poor clinical outcome, 
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suggesting their value as an imaging target in future trials.216 However, due to 
the limited detection window of DWI+ lesions, high-frequent imaging is 
required, which might be a critical limitation for clinical trials.
The prospective study design and the acquisition of ten monthly serial MRIs 
make this study powerful and unique. A major strength of the study is the high 
quality of the MRI protocol. We acquired high-resolution isotropic multi-shell 
DWI, including a b=3000 shell, which is superior over b=1000 for the detection 
of small hyperacute DWI+ lesions,217 in combination with high-resolution 3D 
FLAIR, 3D T1, and 3D SWI scans. As a result, we were able to detect incident 
lesions with axial dimensions below the defined STRIVE criteria,4,90 and 
characterize DWI+ lesion evolution in more detail, including small cavities 
without fluid suppression on FLAIR and hemorrhagic transformation. In fact, 
the three small incident cavities and two microbleeds with T2 hyperintensity 
would be considered WMH on follow-up when evaluating FLAIR images only. 
In addition, we assessed imaging markers of SVD in a reliable and sensitive 
way, and calculated progression of WMH on the basis of all available time points 
utilizing a state-of-the-art deep learning-based segmentation algorithm. 
Finally, we carefully selected individuals with sporadic SVD, and excluded those 
with other or additional causes of acute ischemic stroke on the basis of data 
collected within the ongoing longitudinal RUN DMC study, and the additional 
carotid artery ultrasound and ECG made during the pre-visit of the current 
study.204
Some limitations should also be addressed. First, although we optimized our 
study protocol to detect DWI+ lesions, both in terms of spatial resolution of the 
DWI scan and frequency of scanning, we cannot rule out that we have missed 
(smaller) DWI+ lesions. However, whilst the general consensus is that the DWI 
signal is highest within the first fourteen days after ictus, the signal evolution 
varies largely between individuals and may be elevated at least four weeks.10 
Increasing the MRI frequency would have increased the likelihood of detecting 
more DWI+ lesions. However, we felt that this frequency would have seriously 
increased the attrition rate. Because only one small incident cavity could not be 
attributed to a DWI+ lesion on DWI one month prior to the event, we feel that 
this limitation has influenced our results only to a minor extent, although has 
potentially led to a slight underestimation of the contribution of DWI+ lesions 
to total SVD progression. Second, whereas recruitment of subjects from the 
nine-year follow-up RUN DMC study represents a major strength, this, together 
with the relatively small sample size (although the largest in its field), might limit 
the external validity of the observed incidence rate of DWI+ lesions within our 
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study. In addition, despite applying stringent in- and exclusion criteria to rule 
out large artery disease and/or a cardioembolic source, we cannot completely 
rule out embolic sources as the possible cause of DWI+ lesions. Finally, although 
DWI+ lesions are highly suggestive of small acute infarcts,218 the acute ischemic 
nature of (clinically silent) DWI+ lesions in the context of SVD has not yet been 
confirmed. Diffusion restriction may also result from other conditions, 
including hypoglycemia, acute demyelination, or seizures, although these 
conditions are usually associated with a distinct topographical pattern on MRI 
and clinical presentation.219,220 In addition, the cause of (micro)infarcts 
remains to be established, but an ischemic nature seems plausible as previous 
studies suggest a role for hypoperfusion and microemboli.90 Combined 
MRI-histopathology studies, as well as high-field quantitative imaging are 
required to shed new light on the nature and causes of DWI+ lesions.
In conclusion, DWI+ lesions are a marker of SVD, but their contribution to 
progression of SVD, in particular WMH, is minor. Our data imply that WMH 
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Assessing cortical cerebral 
microinfarcts on iron-sensitive MRI 





Recent studies suggest that a subset of cortical microinfarcts may be identifiable 
on T2* but invisible on T1 and T2 follow-up images. We aimed to investigate 
whether cortical microinfarcts are associated with iron accumulation after the 
acute stage. The RUN DMC – InTENse study is a serial MRI study including 
individuals with cerebral small vessel disease (SVD). 54 Participants underwent 
10 monthly 3T MRIs, including diffusion-weighted imaging, quantitative R1 
(=1/T1), R2 (=1/T2), and R2* (=1/T2*) mapping, from which MRI parameters 
within areas corresponding to microinfarcts and control region of interests 
(ROIs) were retrieved within 16 participants. Finally, we compared pre- and 
post-lesional values with repeated measures ANOVA and post-hoc paired 
t-tests using the mean difference between lesion and control ROI values. We 
observed 21 acute cortical microinfarcts in 7 of the 54 participants (median age 
69 years [IQR 66-74], 63% male). R2* maps demonstrated an increase in R2* 
values at the moment of the last available follow-up MRI relative to prelesional 
values (p=.08), indicative of iron accumulation. Our data suggest that cortical 
microinfarcts are associated with increased R2* values, indicative of iron 
accumulation, possibly due to microhemorrhages, neuroinflammation or neuro- 
 degeneration, awaiting histopathological verification. 
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Cortical microinfarcts and R2* imaging
Introduction
Cortical microinfarcts are frequently encountered on neuropathological 
examination of brains of elderly individuals, especially in those with cerebro-
vascular disease or dementia.223,224 Nonetheless, only a small proportion (< 1%) 
of the total microinfarct burden can be detected with MRI, clearly limiting our 
understanding of the causes and consequences of microinfarcts.90
In the RUN DMC – InTENse study, a monthly serial imaging study, we detected 
acute cortical microinfarcts (A-CMI) in 13% of the participants.29,206 However, 
none of the A-CMI turned into a chronically visible lesion on follow-up MRI.14,29 
This mismatch between detection of A-CMI and chronic microinfarcts (C-CMI) 
may be explained by the fact that C-CMI have currently been defined to be 
isointense on iron-sensitive MRI sequences.90 A recent in vivo 3T MRI study, 
demonstrated that 56% of the detected A-CMI demonstrated visible signal 
alterations on susceptibility-weighted imaging (SWI) after 1 to 3 years, whereas 
signal alterations on follow-up T2-weighted imaging were found in only 29% of 
the A-CMI.15
 
However, SWI dichotomizes tissue into abnormal and normal tissue and tends to 
extend regions of high susceptibility (blooming artefact), which appear as dark 
voids that are not reliable for quantification of the degree of iron accumulation.223 
This limitation is overcome by using quantitative R2* mapping, which is a 
quantitative relaxometry metric whose changes can be linearly related to 
changes in local brain concentration (an increase in R2* is associated with a 
given increase in concentration of iron), thereby providing a detailed evaluation 
of the underlying tissue alterations at the voxel level.223,224 Therefore, the aim 
of this study was to investigate whether initial acute cortical microinfarcts 
are associated with signal alterations on R2* mapping indicative of iron 
accumulation after the acute stage. 
Materials and methods
Study design and subjects
Participants were included from the RUN DMC – InTENse (Radboud University 
Nijmegen Diffusion tensor and Magnetic resonance imaging Cohort – Investigating 
The origin and EvolutioN of cerebral small vessel disease) study.204 Details of 
the study protocol and MRI processing have been described previously.29,204 
Briefly, we selected 54 participants with progressive sporadic SVD (median 
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[IQR] 69 years [66-74], 63% male) from the ongoing RUN DMC study. Because 
previous WMH progression is the most important determinant of future WMH 
progression, individuals were invited by volume of WMH progression on MRI scans 
between 2006 and 2015,164 while meticulously excluding those individuals with 
other causes of cerebral ischemia.225 Participants with intracranial hemorrhage 
on MRI (except microbleeds), dementia, Parkinson’s diseases, life expectancy 
<1 year, or 3 T MRI contraindication were also excluded. Participants underwent 
a pre-screening visit to assess study eligibility, cardiovascular risk factors and 
cognition and 10 monthly MRI scans.204 Cardiovascular risk factors were 
defined as previously described.29,204 Data were collected between March 2016 
and November 2017. 
Standard protocol approvals, registrations, 
and patient consents
The study was approved by the medical ethics committee region Arnhem- 
Nijmegen. All participants provided written informed consent. The guidelines 
according to the Declaration of Helsinki were followed.
MRI protocol and processing 
Participants underwent monthly MRI scanning in a 3T scanner (MAGNETOM 
Prisma, Siemens Healthineers, Erlangen, Germany) with a 32-channel head 
coil. The MRI protocol was specified in detail previously,204 and included the 
following sequences relevant to the current study: 3D T1 mapping (MP2RAGE) 
for R1 mapping (=1/T1) with 0.85 mm isotropic voxels;226 multiple spin echo 
T2-weighted imaging for R2 mapping (=1/T2) and reconstructed voxel size 
0.36 × 0.36 × 3.3 mm;227 3D fluid-attenuated inversion recovery (FLAIR) with 
0.85 mm isotropic voxels; multi-shell DWI including 90 diffusion-weighted 
directions (30xb=1000, and 60xb=3000 s/mm2) and 10 non-diffusion-weighted 
scans (b=0) with 1.7 mm isotropic voxels and multi-band acceleration factor 3,205 
and one b=0 image with imaging parameters equal to the previous DWI but 
with reversed phase-encoding direction for susceptibility-induced distortion 
correction.288 Diffusion data were processed as described previously.29 
Diffusion- weighted trace images were generated based on the arithmetic 
mean across all diffusion directions within one shell, and mean diffusivity 
(MD) and fractional anisotropy (FA) maps were calculated on the inner shell 
using dtifit in FSL;72 3D multiecho gradient echo sequence (GRE) providing 
magnitude and phase images (6 echoes; ΔTE=4.92 ms) for susceptibility 
weighted images and R2* mapping (=1/T2*) with 0.8 x 0.8 x 2.0 mm voxels. 
To create the SWI images, phase images were high-pass filtered using a 2D 
hamming filter with a 12x12 kernel across all image slices and all echoes. The 
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high-pass filtered phase images were subsequently self-multiplied four times 
(i.e., m=4), before combining to the magnitude data as described previously.252 
The magnitude SWI images were then subsequently averaged across all echoes 
to produce the final SWI image.29 R2* maps were derived from the multi-echo 
magnitude GRE data, using the closed-form solution based on the trapezoidal 
rule to approximate the integration of the magnitude decay, as described 
previously,229 implemented in a custom-written tool (https://github.com/
kschan0214/r2starmapping) in Matlab. 
Acute cortical microinfarcts
A-CMI were defined as <5 mm hyperintense lesions on DWI restricted to the 
cerebral cortex, with a corresponding hypo- or isointense signal on the mean 
diffusivity (MD) map.14,29 All monthly DWI scans were assessed for A-CMI and 
manually segmented,29 with high spatial overlap between segmentations of 
the two raters (IQR = 0.8–1.0). Afterwards, the A-CMI were visually inspected on 
T1/FLAIR scans of the same visit as A-CMI onset and the last follow-up visit as 
described previously,14 and on SWI/R2* scans of the same visits. 
Chronic cortical microinfarcts 
C-CMI were defined as lesions <5 mm in diameter restricted to the cerebral 
cortex, according to previously published criteria.14,230 Two trained raters 
screened all baseline and last follow-up scans, masked to clinical information.14 
Final consensus was reached involving more raters (M.D.; S.J. van Veluw, PhD, 
Massachusetts General Hospital), after which true C-CMI were visually 
inspected on SWI/R2* scans of the first visit.14 
Other MRI markers of SVD
As described previously,29 conventional MRI markers of SVD, including white 
matter hyperintensities (WMH), lacunes, and cerebral microbleeds (CMB) were 
assessed according to the universally standardized STandards for ReportIng 
Vascular changes on nEuroimaging (STRIVE) criteria.4 WMH volumes were 
reported as the proportion of total white matter volume.
Imaging analysis
To assess lesion evolution, skull-stripped images of different modalities (T1, T2, 
GRE, DWI) were registered to the DWI image of the first visit using the FMRIB 
Software Library (FSL) Linear Image Registration Tool (FLIRT).167 First, images 
were registered to the MP2RAGE image of the same visit. This included registration 
between MP2RAGE and GRE images, and between MP2RAGE and DWI images. 
Second, registration between the different visits was performed by registering 
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all MP2RAGE images to the one acquired in the first visit. All transformation 
matrices derived from the first and second steps were concatenated and applied 
to coregister images of the other modalities and lesion masks to the DWI image 
of the first visit. To minimize the effect of interscan variability, we created a 
control region of interest (ROI) outside the lesion by dilating the A-CMI mask 
one voxel in all directions followed by subtraction of the original lesion ROI. 
As R2* maps were subject to motion artifacts affecting different locations in 
the brain, which were not systematic across time points, a control ROI in the 
contralateral hemisphere would introduce biases in our measurements. 
Nevertheless, when using a control ROI in a proximal region both lesion and 
control ROIs should have similar biases, which could be eliminated when 
computing the mean difference between the two ROIs. 
Statistical analysis
Statistical analyses were performed in R (version 3.6.2; https://www.R-project.
org) and α was set at .05, two-tailed. Demographics, cardiovascular risk factors 
and baseline SVD characteristics of participants with any (chronic or acute) 
CMIs were compared to those without using the Mann-Whitney U test for 
continuous and chi-square test for categorical independent variables (or 
Fisher’s exact test where appropriate). 
We calculated the mean of the different MRI parameters (DWI trace, MD, FA, R1, 
R2, and R2* values) within the lesion and control ROI at each time point. To 
mitigate partial volume effects from cerebrospinal fluid (CSF) and white matter, 
only voxels with R2* values ranging from 5 s-1 to 30 s-1 were accepted in the 
final analyses to avoid inclusion of voxels dominated by CSF (very low R2* 
values) and white matter (typically ~30s-1),231 while the typical grey matter R2* 
is around 15 s-1 and the mean R2* of A-CMI was 19 s-1 across all MRI sessions in 
this study.353 The difference between the mean signal in the lesion and control 
ROI was used in the analysis, followed by the subtraction of the mean difference 
of all timepoints before lesion onset to ensure any differences between control 
and lesion ROIs due to residual partial volume was further minimized. To be 
able to study the dynamic evolution of the extracted parameters, they were 
temporally realigned in respect to the onset time, the visit in which the A-CMI 
initially appeared on the MRI (designated as “MRI 0”). We classified MRI 
parameters as follows: (1) MRI before the onset of a new lesion (“pre-lesional”); 
(2) MRI at which a new lesion is first identified (“lesional”); (3) last available 
follow-up MRI (“post-lesional”). We used a one-way repeated measures ANOVA 
and post-hoc 2-tailed paired-samples t tests to compare lesion values from the 
three time points (pre-lesional, lesional, post-lesional).  
103
6
Cortical microinfarcts and R2* imaging
Data availability
Data requests can be sent to the corresponding author (FrankErik.deLeeuw@
radboudumc.nl).
Results
Of the 54 included subjects (median age 69 years [IQR 66-74], 63% male) 
52 underwent follow-up MRI (median total follow-up duration 40 weeks [IQR 
38-40]). In total, 22 of the 54 individuals had (acute or chronic) CMIs during the 
study period. Individuals with any CMIs were significantly older compared to 
those without (median [IQR] 73 [67-80] vs 68 [65-70] years, p = .014, Table 6.1). 
Other baseline characteristics were similar (all p > .05).
Between March 2016 and November 2017, we observed 21 A-CMI in 7 of the 54 
participants (13% [0.06-0.24]).14 Of these, 20 (95%) were visible on FLAIR and T1 
images at the moment of appearance, nine (43%) were hypointense on R2* 
maps in the acute stage (Figure 6.1). Of these 9 A-CMI, two were hyperintense 
and seven were isointense on SWI images. The remaining 12 A-CMI (57%) were








Age (years) 68 (65 ‒ 70) 73 (67 ‒ 80) .014
Men 17 (53%) 17 (77%) .071
Level of education 5 (5 ‒ 6) 5 (5 ‒ 6) .628
Cardiovascular risk factors
Hypertension 24 (75%) 21 (96%) .067
Diabetes 4 (13%) 2 (9%) 1.00
Hypercholesterolemia 16 (50%) 11 (50%) 1.00
BMI (kg/m2) 26 (4) 26 (4) .881
Smoking (ever) 22 (69%) 16 (73%) .753
Baseline MRI characteristics
WMH volume* 0.80% (0.51 – 1.99) 1.54% (0.86 – 3.05) .138
Lacunes, presence 5 (16%) 7 (32%) .194
Microbleeds, presence 14 (44%) 11 (50%) .651































































































































































































































































































































































































































Cortical microinfarcts and R2* imaging
isointense on both R2* and SWI.  For 20 of the 21 A-CMI (95%), one or more 
follow-up MRI scans were available. Whereas none of the A-CMI was visible on 
the FLAIR and T1 images of the last available follow-up MRI, 4/20 (20%) A-CMI 
demonstrated a hyperintense signal on R2* maps and a hypointense signal on 
SWI images, indicative of iron accumulation (Figure 6.1). These 4 A-CMI all 
demonstrated a hypointense R2* signal at the moment of appearance. None of 
the other 16 A-CMI were visible on follow-up MRI (R2* or SWI images).  
For, 15 of the 21 (71%) A-CMI time series data analysis could be performed. We 
excluded four A-CMI because they appeared on the first or last available 
follow-up MRI and therefore either pre- or post-lesional values were unavailable, 
and two because they were located too close to the pial surface to exclude 
partial volume effects. There was a statistically significant main effect of time 
on DWI trace values (p < 0.001). At the moment of occurrence, DWI trace values 
were significantly increased compared to pre-lesional values five weeks earlier 
(median [IQR], 5 [4-5]) and post-lesional values five weeks later (median [IQR], 
5 [5–14], both p < 0.001, Figure 6.2). However, post-lesional values were similar 
to pre-lesional values. Moreover, we found a significant effect of time on MD 
values (p < 0.001). Specifically, MD was significantly lower compared to its 
pre-lesional value at the time of lesion appearance (p=.002). Post-lesional MD 
values were significantly higher than lesional values (p < 0.001), whereas values 
of the last available follow-up MRI were not statistically different from 
pre-lesional values. There were no significant changes in FA values over time at 
the location of the lesion. However, there was a statistically significant main 
effect of time on R1 values (p < 0.001). At the time of the lesion detection, 
R1 values were significantly lower than pre-lesional values (p < 0.001), 
or post-lesional values (p = 0.002). At the last available follow-up MRI, values 
returned to pre-lesional R1 values.  R2 values demonstrated a significant change 
over time (p = 0.036). At the time of lesion detection, R2 demonstrated a 
significant decrease compared to pre-lesional values (p=.019), whereas lesional 
values were similar to values of the last available follow-up MRI. Moreover, 
post-lesional values did not differ significantly from pre-lesional values. Lastly, 
R2* values demonstrated a significant change over time (p = 0.017). A negative 
trend was observed for R2* values, with R2* values decreasing from pre-lesional 
levels at the moment of A-CMI appearance (p = 0.066). Compared to lesion 
values, R2* values significantly increased at the moment of post-lesional 
follow-up MRI (p = 0.015). Thereafter, R2* values showed a non-significant 
increase to higher than pre-lesional levels at the moment of the post-lesional 
follow-up MRI (p=.077). Furthermore, these observations were unchanged 

























































































































































































































































































































































































































































































































































































































































































































































































































Cortical microinfarcts and R2* imaging
To investigate the prevalence of iron-positive microinfarcts in the chronic 
stage, we assessed the R2* signal change in the 81 C-CMI detected previously 
in 19 of the 53 participants (35% [95% CI 0.24-0.49]) of the RUN DMC – InTENse 
study population.14 Of these, 17 (21%) were hyperintense on R2* maps and 
hypointense on SWI images on the baseline MRI (Figure 6.3), consistent with 
the accumulation of iron. Whereas, 38 of the 81 (47%) C-CMI were hypointense 
on baseline R2* maps demonstrating CSF-like properties (35 showed cavitation 
on FLAIR images). These 38 C-CMI were all isointense on SWI baseline images. 
The remaining 26 C-CMI were isointense on both R2* maps and SWI images of 
the first visit. 
Figure 6.3 | Example of R2* signal change at the location of a chronic cortical micro -
infarct 
Example of a chronic cortical microinfarct demonstrating iron accumulation, characterized 
by a hypointense signal on T1, a hyperintense signal on T2, a hypointense signal on 






We found an increase in R2* at the location of A-CMI, suggestive of iron 
accumulation, whereas the changes found in diffusion, R1 and R2 parameters 
at the moment of appearance of A-CMI disappeared from follow-up MRI. These 
results suggest that we should reconsider the formerly established criteria for 
the rating of microinfarcts,90 as C-CMI have currently been defined to be 
isointense on iron-sensitive MRI scans. 
Traditionally, MR lesions visible on GRE are believed to represent accumulation 
of iron consistent with hemosiderin-laden macrophages in perivascular tissue, 
corresponding to vascular leakage of blood cells.60,232-234 Inherently, this 
suggests that the observed iron accumulation as picked up by R2* at the site of 
A-CMI could be the result of hemorrhagic transformation. This is in line with 
recent in vivo studies that described hemorrhagic transformation of subcortical 
DWI+ lesions into a MRI-detectable microbleed,9,29 and with the small number 
of post-mortem MRI studies that have demonstrated a shared underlying 
histopathology of cerebral microbleeds and microinfarcts.58,235 Furthermore, a 
previous neuropathological study demonstrated different types of C-CMI using 7 T 
post-mortem MRI, including C-CMI with or without cavitation, and C-CMI 
with or without hemorrhagic components.236 
However, the more subtle changes in iron (as picked up by the quantitative R2*) 
could have more potential underlying causes. A combined in vivo histopathol-
ogy-MRI study found several pathological changes at the core of C-CMI, 
including extracellular accumulation of lipofuscin and depletion of neurons, 
and activated macrophages and astroglia with a varying degree of iron 
accumulation.237 These changes were not found at the location of A-CMI. First, 
the extracellular accumulation of lipofuscin could be one possible source of 
iron. Lipofuscin aggregates as a result of neuronal cell death, and could therefore 
signify the beginning of tissue necrosis, a process which could ultimately result 
in C-CMI with cavitation.237,238 Another explanation could be the activation of 
macrophages associated with neuroinflammation,239 characterized by the 
presence of microglial cells which have been described to have a high content 
of ferritin. 
The changes found in R1 and R2 parameters at the moment of A-CMI 
appearance showed normalization already on the subsequent follow-up MRI, 
consistent with our previous findings.14 However, because we were not able to 
investigate the disappearing A-CMI on brain pathology, it remains unclear 
whether this indicates tissue salvation or whether tissue damage persists that is 
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not visible on in vivo 3T MRI. Prior research on subcortical DWI lesions has 
demonstrated that of the DWI+ lesions that cavitated on follow-up MRI, in 
general only a small part of the initial DWI+ lesion showed cavitation, whereas 
the largest part of the DWI+ lesion had no signal abnormality on follow-up 
MRI.240 As CMI are typically very small in size (between 0.05 and 5 mm in 
diameter), the proportion of the tissue that remains visible on follow-up MRI 
might be too small to be detected with in vivo 3T MRI. Although we are unsure 
whether these findings on subcortical DWI+ lesions can be translated to the 
cortex, several MRI studies demonstrated that especially small cortical infarcts 
seem to disappear during follow-up.29,88,214
Our findings accentuate the notion that cortical microinfarcts affect brain 
structure beyond the acute period. Due to the poor spatial and temporal 
resolution of in vivo MRI, a single A-CMI large enough to be detected on DWI 
scans, although having a limited effect by itself, may be indicative of a yearly 
incidence of hundreds of new microinfarcts,11 which all  together may have a 
substantial effect on the brain. Furthermore, it has recently been suggested that 
microinfarcts could be associated with focal cortical atrophy,87,88,90 in which 
accumulation of iron could be a key mechanism. Future in vivo combined his-
topathology-MRI studies should investigate the causes and consequences of 
iron accumulation in the evolution of A-CMI into C-CMI, and its effect on the 
surrounding brain structure. 
This study has several strengths and limitations. This is, to the best of our 
knowledge the first prospective in vivo study which investigated the R2*-based 
quantification of iron deposition, in the evolution of A-CMI to C-CMI. Major 
strengths include its monthly imaging and the use of quantitative high-resolu-
tion MRI data. Furthermore, our participants represent a well-defined SVD 
sample. However, due to the low sample size and small number of A-CMI, this 
study might have been underpowered to find associations with small or 
medium effect sizes. Therefore, a future study with a larger sample size could 
be beneficial to investigate lesion development using quantitative MRI. Second, 
we cannot exclude errors due to registration processes or partial volume effects, 
as microinfarcts are by definition located on the cortical surface of the brain, 
thus very close to tissue boundaries. However, we assume these errors to be 
small as all images were thoroughly checked using visual inspection. Third, the 
spatial resolution of R2* data might have limited our analysis. Especially, small 
DWI+ lesions, significantly below the 2.0mm slice thickness, might have gone 
undetected because of partial volume effects, and consequently R2* changes at 
visual assessment might have been missed. Future studies, should acquire R2* 
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data with higher through-slice resolution to limit the intra-voxel partial volume 
effect and with longer echo times to ensure higher SNR of the R2* maps. 
Fourth, we were not able to pathologically confirm that the observed increases 
in R2* indeed represent iron accumulation. While previous studies using a 
combined MRI-histopathology approach demonstrated a high correlation 
between R2* values and iron concentration in grey matter,231, 241 other local 
background sources confound the measurement of tissue iron content as they 
also relate to the R2* signal, such as cell density or other trace elements.224 
Furthermore, the observed changes in magnetic susceptibility could be due to 
other causes than iron depositions. For instance, deoxygenated hemoglobin 
trapped in small blood clots or in venous blood could also result in fast R2* 
changes. Nevertheless, the presence of blood clots in blood vessels of otherwise 
healthy and asymptomatic individuals seems rather unlikely. Moreover, both 
an increase in myelination and an increase of iron concentration could result 
in an increased R2* signal. As a result, if iron deposition occurs concurrently to 
demyelination, R2* changes would be smaller than expected and underestimate 
the increase of iron deposition. However, since we focussed on cortical grey 
matter regions in this study, a region of low myelin concentration (when 
compared to the white matter), the contribution of myelin to the R2* signal is 
less significant.
These findings indicate that some cortical microinfarcts detected in vivo 
are characterized by iron accumulation, possibly due to microhemorrhages, 
neuroinflammation, or neurodegeneration, awaiting further histopathological 
verification. This may call for inclusion of iron-sensitive MRI scans in the MRI 
requirements for the detection of CMI. Future in vivo combined-histopathology- 
MRI studies should further investigate the causes and consequences of iron 
accumulation in the evolution of A-CMI into C-CMI. 
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Objective: To conduct a systematic review and meta-analysis of studies reporting 
on risk factors according to the location of the intracerebral hemorrhage. 
Methods: We searched PubMed and Embase for cohort and case-control 
studies reporting on ≥100 patients with spontaneous intracerebral hemorrhage, 
that specified the location of the hematoma and reported associations with risk 
factors published until June 27th, 2019. Two authors independently extracted 
data on risk factors. Estimates were pooled with the generic variance-based 
random effects method.
Results: After screening 10 013 articles, we included 42 studies totaling 26 174 
patients with intracerebral hemorrhage (9 141 lobar and 17 033 non-lobar). Risk 
factors for non-lobar intracerebral hemorrhage were hypertension (risk ratio 
4.25, 95% confidence interval 3.05-5.91, I2=92%), diabetes (RR 1.35, 1.11-1.64, 
I2=37% ), male sex (RR 1.63, 1.25-2.14, I2=61%), alcohol overuse (RR 1.48, 1.21-1.81, 
I2=19%), underweight (RR 2.12, 1.12-4.01, I2=31%), and being black (RR 2.19, 
1.21-3.96, I2=96%) or Hispanic (RR 2.95,1.69-5.14, I2=71%) in comparison with 
being white. Hypertension, but not any of the other risk factors, was also a risk 
factor for lobar intracerebral hemorrhage (RR 1.83, 1.39-2.42, I2=76%). Smoking, 
hypercholesterolemia and obesity were associated with neither non-lobar nor 
lobar intracerebral hemorrhage.
Conclusions: Hypertension is a risk factor for both non-lobar and lobar intra -
cerebral hemorrhage, although with double the effect for non-lobar intracerebral 
hemorrhage. Diabetes, male sex, alcohol overuse, underweight, and being black 
or Hispanic are risk factors for non-lobar intracerebral hemorrhage only. Hence, 
the term “hypertensive intracerebral hemorrhage” for non-lobar intracerebral 
hemorrhage is not appropriate.
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Introduction
Intracerebral hemorrhage (ICH) is still the deadliest subtype of stroke.160,161,242 
One-month case fatality is approximately 40% and the reported proportion of 
patients with poor outcome at 12-50 months varies between 61 and 88%.16 
Although the overall incidence of ICH has remained stable over the last decades, 
there are important differences in time trends according to age and ICH loca-
tion.243,244,e1 ICH incidence remains stable243 or increases among people ≥75 
years due to increase in lobar ICH and rise in use of antithrombotic medication.
e1 In contrast, in younger patients ICH incidence decreases243,244,e1 as a result 
of a decrease in non-lobar ICH, probably because of an improved control of 
hypertension.e1
In a previous review and meta-analysis of risk factors for spontaneous ICH, 
we identified hypertension and high alcohol intake as important modifiable 
risk factors besides the nonmodifiable factors male sex and higher age.245 
Subsequent systematic reviews have suggested additional risk factors, including 
ApoE genotype and diabetes.246-253 However, these reviews did not assess risk 
factors for ICH according to its location. Pathogenesis of spontaneous ICH 
varies according to location, as cerebral amyloid angiopathy (CAA) plays a role 
in a significant proportion of lobar ICH but not in non-lobar ICH. Some studies 
have suggested that risk factor profiles vary according to location,254,255 which 
may have implications for secondary prevention. The aim of this systematic 
review and meta-analysis was to estimate associations of risk factors and ICH 
according to location.
Methods
Search strategy and selection criteria
We registered our protocol in PROSPERO (CRD42019117543). We searched 
PubMed and Embase for cohort, case-crossover, and case-control studies on 
risk factors for ICH published until June 27th 2019 according to the PRISMA 
statement methodology.256 We used different combinations of the keywords 
intracerebral hemorrhage and synonyms; cohort, case-control, case-crossover 
or longitudinal study; and potential risk factors and synonyms (data available 
from Dryad; see e-1 for detailed search strategy). For this review we did not 
assess use of (antithrombotic) medication as a risk factor nor did we study 
genetic risk factors. We used the studies selected in our previous systematic 
review and meta-analysis for studies published before 2001. We checked 
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reference lists of all included publications and the citation list of our previous 
systematic review and meta-analysis for additional articles,245 and repeated 
this until no further studies were found. We applied no language restrictions.
Titles and abstracts and subsequently full-text versions were screened 
independently by two investigators (WMTJ and KW) using the following 
inclusion criteria: 1) Included patients were 18 years or older; 2) ICH had to be 
confirmed by CT, MRI, or autopsy in 100% of cases, not only based on 
International Classification of Diseases (ICD) codes; 3) ICH location had to be 
specified; 4) A cohort, case-crossover or case-control design; 5) ICH had to 
be analyzed as a separate entity, not in combination with subarachnoid 
hemorrhage; 6) Reporting on at least 100 patients with ICH. If studies included 
patients with ICH caused by a vascular malformation, tumor, coagulation 
disorder (use of antithrombotic medication was allowed), or hemorrhagic 
transformation of infarction, data extraction needed to allow exclusion of these 
patients; if not the study was excluded. Conflicts regarding inclusion were 
resolved by consensus with a third reviewer (CJMK). We used Covidence 
(www.covidence.org) for standardized screening of articles.
Data extraction
Data were extracted independently by two reviewers (WMTJ and KW) using a 
prespecified and piloted extraction form (data available from Dryad; e-2). 
Discrepancies in extracted data were resolved by discussion, and if necessary, 
a third reviewer (CJMK) was consulted. In case of multiple publications on 
overlapping cohorts, we included the study that best matched our inclusion 
criteria and with the largest amount of data relevant to the review. We extracted 
data on study period, study design, country of study, in- and exclusion criteria, 
number of cases and controls, mean or median age, proportion of males, and 
risk factors. Risk factors were assessed according to lobar and non-lobar 
(deep and infratentorial) ICH location and if possible, for deep (basal ganglia, 
thalamus and intraventricular) and for infratentorial hemorrhages (brainstem 
and cerebellum) separately. We assessed methodological quality, including risk 
of bias, of the included studies according to the Newcastle-Ottawa Scale (NOS) 
for cohort and case-control studies.257
Statistical analysis
Estimates of cohort and case-control studies were first analyzed separately and 
then combined if 95% confidence intervals (CIs) of the pooled estimates from 
cohort studies overlapped with those of case-control studies. We also combined 
maximally adjusted estimates, when available, with unadjusted estimates, if 95% 
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CIs of the pooled unadjusted estimates overlapped with pooled adjusted 
estimates. If studies used different definitions for risk factors, we standardized 
risk factors across studies whenever possible or otherwise we accepted the 
criteria used in the studies. Risk factors reported in at least three studies were 
combined in meta-analyses; for the different subgroups of a risk factor we 
accepted two studies for meta-analyses. For the included studies odds ratios 
(ORs), relative risks (RRs) and hazard ratios (HRs) with corresponding 95% CIs, 
whichever were available, were obtained for the various risk factors and pooled 
with the generic variance-based method, weighing individual study results by 
the inverse of their variance. 
Heterogeneity was assessed using I2 statistics.258 We used a random-effects 
model because of the heterogeneous study characteristics. Because ORs 
accurately estimate RRs when risks of disease are small, we combined ORs with 
RRs and HRs from the longitudinal studies.259,260 We performed a sensitivity 
analysis for studies with a high-quality, defined as studies with >5 points 
(arbitrarily chosen) on the NOS. Meta-analyses were performed in R 
(R programming, version 1.1.456), using the meta package (version 4.9-4).261
Data availability
Data used in this study are available to qualified investigators on request to the 
corresponding and senior authors.
Results 
We identified 42 studies (references indicated with e- are available from 
Dryad),e1-e42 of which 24 were cohort studies,e1-e4, e8-e11, e13, e14, e17-e21, e24, e25, 
e28, e30, e31, e33, e37, e38, e41 17 case-control studies,e5-7, e12, e15,e16, e22, e23, e26, e27, e29, 
e32, e34-e36, e39, e42 and one had a case-crossover designe40 (Figure 7.1).
Study characteristics are summarized in the data supplement available from 
Dryad (Table e-3). The 42 studies included 26 174 patients (mean age 68.2 years, 
standard deviation 14.1 and 57% men) with ICH, of which 9 141 had lobar ICH 
(35%) and 17 033 non-lobar ICH (65%). Twenty-three studies further stratified 
non-lobar ICH into 7 758 patients with deep ICH (82%), of whom 78 had intra-
ventricular hemorrhage (1%), and 1 649 infratentorial ICH (17%). Eighteen studies 
were population-based (43%) and 24 were hospital-based (57%). Eleven of the 
17 (65%) case-controls studies adjusted for potential confounders. Of the 42 
included studies, 29 (69%) fulfilled the criteria for high quality studies (NOS >5). 
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Definitions of the risk factors in the included studies, adjustment factors for 
maximally adjusted estimates, and all separate analyses of cohort and 
case-control studies with unadjusted and adjusted estimates are available from 
Dryad (Tables e-4 - e27). To investigate the possible influence of publication 
bias we made funnel plots for the risk factor with the most studies (hypertension), 
which showed that publication bias has not played an important role in our 
meta-analyses (data not shown).
We report pooled RRs combining unadjusted and maximally adjusted estimates 
and estimates from cohort and case-control studies, since the pooled estimates 
had overlapping 95% CIs. For all risk factors, 95% CIs of the pooled estimates of 
the sensitivity analyses of high quality studies overlapped with those including 
all studies (data available from Dryad; Tables e-5, e-7, e-10, e-12, e-14, e-15, e-17, 
e-19, e-20, e23 – e-25 and e-27).
Figure 7.1 | Flowchart of literature search
12 491 articles identified from 
PubMed and Embase searches 
(until June 27th 2019)
10 013 articles eligible for 
title/abstract screening
17 additional articles identified 
from bibliographies
693 articles eligible for 
full-text screening  




 498: estimates not available by location ICH
 86: not journal papers
 23: describing genetic risk factors
 12: describing anticoagulant medication 
  related ICH
 11: duplicates
 6: wrong study design 
  (systematic review and meta-analyses)
 7: <100 ICH patients
 4: overlapping cohorts
 2: risk factors not selected 
  (cerebral microbleeds)
 1: including secondary ICH and not possible 
  to extract separate numbers
 1: article not available 
2 495 duplicates 
removed
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In Table 7.1 we summarized the main results. Twenty-five studiese1, e3, e6, e8, e13, 
e15, e16, e18, e20, e22-e31, e33-e35, e39, e41, e42 provided data on hypertension (Figure 
7.2), resulting in a pooled RR for lobar ICH versus controls without ICH of 1.83 
(95% CI 1.39-2.42, I2=76%, 11 studies) and for non-lobar ICH versus controls 
without ICH of 4.25 (95% CI 3.05-5.91, I2=92%, 13 studies). The pooled RR for 
non-lobar ICH versus lobar ICH was 1.96 (95% CI 1.59-2.41, I2=79%, 20 studies). 
Within the group of non-lobar ICH, we found no difference between deep and 
infratentorial ICH.
Nineteen studiese1, e3, e6, e12, e13, e15, e17, e18, e21, e22, e24, e26, e2, e29, e30, e36, e39, e41, e42 
provided data on diabetes mellitus (Figure 7.3), resulting in a pooled RR for lobar 
ICH versus controls without ICH of 1.13 (95% CI 0.94-1.36, I2=0%, nine studies) 
and for non-lobar ICH versus controls without ICH of 1.35 (95% CI 1.11-1.64, 
I2=37%, 12 studies). The pooled RR for non-lobar ICH versus lobar ICH was 
1.28 (95% CI 1.06-1.55, I2=32%, 16 studies) and for deep versus infratentorial ICH 
1.85 (95% CI 0.95-3.59, I2=0%, four studies).
Fourteen studiese3, e6, e9, e13, e15, e20, e24, e26, e27, e30, e31, e39, e41, e42 provided data on 
male sex (data available from Dryad; e-9), resulting in a pooled RR for lobar ICH 
versus controls without ICH of 0.98 (95% CI 0.82-1.16, I2=26%, six studies) 
and for non-lobar ICH versus controls without ICH of 1.63 (95% CI 1.25-2.14, 
I2=61%, five studies). The pooled RR for non-lobar versus lobar ICH was 1.32 
(95% CI 1.02-1.71, I2=72%, ten studies). 
Thirteen studiese3, e6, e13, e15, e22, e23, e26, e27, e30, e31, e39, e41,e42 provided data on 
(current or ever) smoking (Figure 7.4), resulting in a pooled RR for lobar ICH 
versus controls without ICH of 1.04 (95% CI 0.76-1.41, I2 =57%, seven studies) 
and for non-lobar ICH versus controls without ICH of 1.09 (95% CI 0.92-1.31, 
I2=39%, nine studies). The pooled RR for non-lobar ICH versus lobar ICH was 
1.24 (95% CI 0.98-1.58, I2=46%, eight studies).
Thirteen studiese2, e4-e6, e15, e20, e23, e27, e30, e31, e33, e39, e41 provided data on alcohol 
(Figure 7.5). Alcohol overuse was not a risk factor for lobar ICH (versus controls 
without ICH; RR 1.01, 95% CI 0.78-1.29, I2=16%, four studies), whereas it increased 
the risk of non-lobar ICH (versus controls without ICH; RR 1.48, 95% CI 1.21-1.81, 
I2=19%, five studies). The pooled RR for non-lobar ICH versus lobar ICH was 
1.50 (95% CI 1.31-1.72, I2=0%, eight studies) and for deep versus infratentorial 
ICH 1.08 (95% CI 0.78-1.49, I2=0%, two studies). Alcohol consumption was not 




Nine studiese1, e15, e22, e23, e27, e30, e39, e41, e42 provided data on cholesterol (Figure 
7.6), resulting in a pooled RR of hypercholesterolemia for lobar ICH versus 
controls without ICH of 0.82 (95% CI 0.66-1.01, I2=18%, four studies) and for 
non-lobar ICH versus controls without ICH of 0.78 (95% CI 0.46-1.32, I2=90%, 
four studies). When we excluded the one study performed in an Asian 
population,e15 hypercholesterolemia was a protective factor for both lobar ICH 
(versus controls without ICH; pooled RR 0.81, 95% CI 0.68-0.97, I2=0%, three 
studies) and for non-lobar ICH (versus controls without ICH; pooled RR 0.59, 
95% CI 0.42-0.82, I2=72%, three studies). The pooled RR for non-lobar ICH 
versus lobar ICH was 0.99 (95% CI 0.79-1.23, I2=42%, seven studies).
Nine studiese3, e6, e7, e14, e22, e30, e39, e41, e42 provided data on weight (data available 
from Dryad e-21), of which six used obesity as risk factor and three used 
underweight. The pooled RR of obesity with lobar ICH versus controls without 
Table 7.1 | Pooled risk ratios of risk factors for ICH according to location














Abbreviations: CI = confidence interval; ICH = intracerebral hemorrhage; RR = risk ratio.  










































































































































































Location specific risk factors for ICH
ICH was 1.66 (95% CI 0.66-4.17, I2=89%, two studies) and for non-lobar ICH 
versus controls without ICH 1.39 (95% CI 0.85-2.26, I2=77%, three studies). 
The pooled RR for non-lobar ICH versus lobar ICH was 1.43 (95% CI 0.87-2.34, 
I2=74%, five studies). For the association of underweight with lobar ICH we did not 
have enough data to pool, the pooled RR for non-lobar ICH versus controls 
without ICH was 2.12 (95% CI 1.12-4.01, I2=31%, two studies). The pooled RR for 
non-lobar ICH versus lobar ICH was 0.34 (95% CI 0.09-1.23, I2=81%, two studies).
Six studiese9, e10, e19, e20, e35, e38 provided data on ethnicity (data available from 
Dryad; e-26), of which five studies reported on blacks, three studies on 
Hispanics and two studies on Asians. With whites as a reference group, the 
pooled RR of blacks with lobar ICH versus controls without ICH was 1.93 (95% CI 
0.98-3.78, I2=84%, two studies) and for non-lobar ICH versus controls without 
ICH 2.83 (95% CI 1.02-7.84, I2=96%, two studies). The pooled RR for non-lobar 
Table 7.1 | Pooled risk ratios of risk factors for ICH according to location














Abbreviations: CI = confidence interval; ICH = intracerebral hemorrhage; RR = risk ratio.  










































































































































































Figure 7.2 | Forest plot of risk ratios of hypertension for ICH according to location
Association between hypertension and the occurrence of ICH by location. Size of 
rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; 
TE=treatment effect; SE=standard error; CI=confidence interval; IV=inverse variance. 
# Controls without ICH.
Study
Lobar        Controls# Lobar    
Non-Lobar Controls# Non-Lobar
TE SE Weight     Risk Ratio 95% CI
Risk Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 20
Total (95% CI)














































1.83 [1.39;  2.42]
0.79 [0.30;  2.08]
2.66 [1.34;  5.29]
2.29 [1.18;  4.47]
4.26 [1.26; 14.37]
2.53 [1.41;  4.56]
1.88 [1.13;  3.13]
1.04 [0.75;  1.45]
6.69 [1.29; 34.69]
1.23 [1.03;  1.47]
2.23 [1.87;  2.65]
1.92 [1.13;  3.25]
Total (95% CI)






















































4.25 [3.05;  5.91]
3.90 [2.21;  6.88]
1.95 [1.27;  3.01]
5.21 [3.13;  8.67]




4.01 [2.41;  6.68]
2.86 [2.13;  3.83]
1.86 [1.59;  2.17]
3.94 [3.43;  4.51]
1.82 [1.03;  3.22]
5.10 [2.89;  9.01]
Size of rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance.  #Controls without ICH. 
125
7
Location specific risk factors for ICH
Figure 7.2 | Continued
Study
Non-Lobar versus Lobar        Lobar     Non-Lobar
Deep versus Infratentorial Infratentorial Deep
TE SE Weight     Risk Ratio 95% CI
Risk Ratio
IV, Random, 95% CI
0.1 0.2 0.5 1 2 5 20
Total (95% CI)


















































































1.96 [1.59;  2.41]
1.88 [0.79;  4.45]
4.90 [1.84; 13.07]
3.39 [2.38;  4.82]
1.23 [0.79;  1.94]
1.28 [0.83;  1.98]
1.51 [0.96;  2.37]
2.36 [1.10;  5.08]
0.94 [0.70;  1.26]
2.27 [1.19;  4.34]
1.77 [0.87;  3.58]
3.74 [1.71;  8.20]
3.35 [1.50;  7.49]
4.48 [2.86;  7.03]
2.83 [1.73;  4.62]
2.41 [1.69;  3.43]
2.29 [1.38;  3.82]
1.48 [0.98;  2.23]
1.04 [0.57;  1.91]
1.23 [1.05;  1.44]
1.77 [1.45;  2.15]
Total (95% CI)
















































Size of rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance. 
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Figure 7.3 | Forest plots of risk ratios of diabetes mellitus for ICH according to location
Association between diabetes mellitus and the occurrence of ICH by location. Size of 
rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; 
TE=treatment effect; SE=standard error; CI=confidence interval; IV=inverse variance. 
# Controls without ICH.
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Figure 3· Forest plots of risk ratios (RRs) of diabetes mellitus for ICH according to location
Size of rectangle is proportional to the weight of the study; ICH=intracerebral haemorrhage; TE=treatment eect; 
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Figure 7.3 | Continued
Study
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2.12 [0.47;  9.58]
1.57 [0.51;  4.79]
Size of rectangle is proportional to the weight of the study; ICH=intracerebral haemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance
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Figure 7.4 | Forest plots of risk ratios of smoking for ICH according to location
Association between smoking and the occurrence of ICH by location. Size of rectangle is 
proportional to the weight of the study; ICH=intracerebral hemorrhage; TE=treatment effect; 
SE=standard error; CI=confidence interval; IV=inverse variance. # Controls without ICH.
Study
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TE SE Weight     Risk Ratio 95% CI
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Figure 4. Forest plots of risk ratios (RRs) of smoking for ICH according to location
Size of rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance. #Controls without ICH. 
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versus lobar ICH was 1.72 (95% CI 0.99-2.96, I2=52%, four studies) and for deep 
versus infratentorial ICH 1.08 (95% CI 0.80-1.44, I2=0%, two studies). For the 
association of Asians with lobar or non-lobar ICH we did not have enough data 
to pool. The pooled RR for non-lobar versus lobar ICH was 3.86 (95% 
CI 1.65-9.04, I2=0%, two studies). For the association of Hispanics with lobar ICH 
we did not have enough data to pool and the pooled RR for non-lobar ICH 
versus controls without ICH was 2.95 (95% CI 1.69-5.14, I2=71%, two studies). 
The pooled RR for non-lobar ICH versus lobar ICH was 2.01 (95% CI 1.68-2.41, 
I2=0%, three studies) and for deep versus infratentorial ICH 0.93 (95% 
CI 0.55-1.56, I2=43%, two studies).
A total of thirteen risk factors were reported in only one or two studies and for 
three risk factors (age, history of cardiac disease and history of cerebrovascular 
disease) definitions were too divergent to allow pooling of data (data available 
from Dryad; e-27). Of these risk factors, school education less than high school 
showed an association with lobar ICH.e23 School education less than high 
school,e23 a first degree relative with ICH,e23 a lower intake of dietary saturated 
fatty acids,e37 tumor necrosis factor receptor 1 and 2,e32 and air pollution (fine 
particulate matter ≤2.5 μm)e40 were associated with non-lobar ICH (versus 
controls without ICH). In the direct comparison of non-lobar versus lobar ICH 
atherosclerotic peripheral arterial disease,e27 a family history of stroke,e30 
atmospheric pressure, and air temperaturee11 were associated with non- 




Figure 7.5 | Forest plot of risk ratios of alcohol consumption and overuse for ICH 
according to location
Association between alcohol overuse and consumption and the occurrence of ICH by 
location. Size of rectangle is proportional to the weight of the study; ICH=intracerebral 
hemorrhage; TE=treatment effect; SE=standard error; CI=confidence interval; IV=inverse 
variance. # Controls without ICH.
Study
Lobar        Controls#      Lobar    
Non-Lobar versus Lobar Lobar Non-Lobar
Deep versus Infratentorial Infratentorial Deep
TE SE Weight     Risk Ratio 95% CI
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IV, Random, 95% CI
Total (95% CI)




















































Size of rectangle is proportional to the weight of the study; ICH=intracerebral haemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance. #Controls without ICH. 
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Figure 7.5 | Continued
Study
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B) Alcohol abuse 
Size of rectangle s proportional to the weight of the study; ICH=intracerebral haemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance. #Controls without ICH. 
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Figure 7.6 | Forest plot of risk ratios of hypercholesterolemia for ICH according to 
location
Association between hypercholesterolemia and the occurrence of ICH by location. Size 
of rectangle is proportional to the weight of the study; ICH=intracerebral hemorrhage; 
TE=treatment effect; SE=standard error; CI=confidence interval; IV=inverse variance. 
# Controls without ICH.
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Non-Lobar Controls Non-Lobar
Non-Lobar versus Lobar Lobar Non-Lobar 
TE SE Weight     Risk Ratio 95% CI
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Total (95% CI)
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Size of rectangle is proportional to the weight of the study; ICH=intracerebral haemorrhage; TE=treatment eect; 
SE=standard error; CI=confidence interval; IV=inverse variance. #Controls without ICH. 
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Discussion
Our data indicate that hypertension is a risk factor for both non-lobar and lobar 
ICH, whereas diabetes, male sex, alcohol overuse, underweight, and being 
black or Hispanic compared with being white are risk factors for non-lobar ICH 
only. Smoking, hypercholesterolemia and obesity were not a risk factor for 
either lobar or non-lobar ICH. We found no differences in risk factors between 
deep and infratentorial ICH.
In a previous review that compared patients with lobar and deep ICH,262 
prevalence of hypertension was higher in patients with deep ICH, which 
supports our finding that hypertension is a stronger risk factor for non-lobar 
than for lobar ICH. The exact mechanism through which hypertension causes 
ICH in both lobar and non-lobar location is unclear. Hypertension is thought 
to cause arteriolosclerosis with lipohyalinosis, microatheromas, and micro-
aneurysms in the small, deep, perforating intracranial arteries,3 which increases 
the probability of vessel rupture in deep and infratentorial locations.263 
In pathology studies similar hypertension-related changes have been described in 
leptomeningeal and cortical vessels, which suggest that similar mechanisms play 
a role in lobar ICH.264-266 These changes in leptomeningeal and cortical vessels 
can be found both in patients with and without CAA. A recent study found that 
42% of participants with lobar ICH had moderate or severe arteriolosclerosis in 
addition to moderate or severe CAA on pathological examination.183 Moreover, 
39% of participants with lobar ICH had moderate or severe arteriolosclerosis 
alone.183 Leptomeningeal and cortical vessels might simply be less affected by 
hypertension than deep perforating arteries, but this needs further investigation.
In addition to hypertension, other vascular risk factors, including diabetes and 
hypercholesterolemia, affect the small, deep, perforating intracranial arteries,267 
resulting in an increased risk of non-lobar ICH.268 Our results show that the 
previously reported increased risk of ICH with diabetes,247 is driven by the 
increased risk of non-lobar ICH. Abnormal glucose metabolism causes 
impaired endothelial function leading to arteriolosclerosis,268 and subsequently 
the likelihood of non-lobar ICH.3 It has been suggested that small (deep or 
leptomeningeal) arteries might be susceptible to hemorrhage because of 
low cholesterol, which is hypothesized to induce necrosis of arterial smooth 
muscle cells, making the endothelium vulnerable to development of 
microaneurysms.248,269-271 However, we found the higher risk of lobar and 
non-lobar ICH only in non-Asians, which may be explained by differences in 
genetic backgrounds and dietary pattern between Asians and non-Asians.272,e15 
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Low serum total cholesterol, might be a result of a low BMI.248 Our finding that 
underweight is associated with ICH has been shown in several other 
studies.273,274 These studies also showed an increased risk of ICH, but did not 
take location of the ICH into account. Furthermore, weight loss might be 
associated with alcohol overuse, which could confound the association with a 
higher risk of ICH.274,e41 Of the three articles describing underweight included 
in our meta-analysis, only one adjusted for alcohol overuse. We showed that 
the previously found increased risk of alcohol overuse for ICH in general,275 
is predominantly caused by its effect on the risk of non-lobar ICH. As alcohol 
overuse is a risk factor for hypertension, it may act as a mediator for the 
relationship between hypertension and non-lobar ICH.276 Three of the five studies 
included in our meta-analysis adjusted for hypertension as a confounder; 
in two of these alcohol remained a risk factor for non-lobar ICH. Moreover, 
alcohol intake may cause impaired platelet function and additional effects on 
hemostasis,277,278,e4 resulting in a higher bleeding propensity. In line with a 
previous systematic review and meta-analysis in ICH not taking into account 
its location,275 we found that light and moderate alcohol consumption was not 
associated with either lobar or non-lobar ICH.
Men have a higher prevalence of hypertension, diabetes and alcohol overuse,279-
281 which may explain our finding that male sex is a risk factor for non-lobar 
ICH but not for lobar ICH. Our finding that blacks, Asians and Hispanics 
compared with whites have an increased risk of non-lobar ICH, but not lobar 
ICH, may also be explained by a higher prevalence of these risk factors in these 
populations.282,e35 This probably also plays a role in the two times higher 
incidence of ICH in general in Asians.16 In the current meta-analysis we did not 
find any studies from Eastern Asia that investigated risk factors for ICH by 
location.
In contrast to our previous review,245 we did not find (current) smoking to be a 
risk factor for either lobar or non-lobar ICH. This may be explained by the 
different categorization of never, previous or current smoker, in the included 
studies in our meta-analysis, and the absence of data on burden of smoking, 
such as numbers of packyears. 
Our results show a similar risk factor profile in patients with deep ICH (basal 
ganglia and thalamus), and those with infratentorial ICH (brainstem or 
cerebellum), suggesting a common underlying small vessel disease. Previous 
pathology studies showed that most cerebellar ICHs are likely caused by 
arterio losclerosis, similar to changes seen in deep perforating vessels, although 
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a small proportion of cerebellar hematomas is related to vascular amyloid 
deposition.19,20
Strengths of our systematic review and meta-analysis include the comprehensive 
literature search without language restrictions, and inclusion of studies based 
on predefined selection criteria. A further strength is our diagnostic accuracy, 
because we did not include studies based solely on ICD codes, and diagnosis 
and location had to be confirmed by imaging. We were able to quantify the 
associations between risk factors and lobar and non-lobar ICH in many studies 
that were not specifically designed to examine these associations, resulting 
in a meta-analysis of a high number of patients. In addition, we checked 
consistency between estimates from cohort and case-control studies, and 
unadjusted and adjusted estimates, before pooling data. Finally, we performed 
sensitivity analyses including high quality studies only, in which we found 
similar results as in our main analyses, which strengthens the validity of our 
results.
Our study also has limitations. First, different sources of bias may have 
influenced the results of the included observational studies. Selection bias in 
case-control studies may influence external validation of the results. Recall and 
misclassification bias because of different and changing definitions for risk 
factors may have resulted in both over- and underestimation of the true effect. 
Investigation bias, because of varying methods and extent to which patients 
were investigated for the presence of risk factors may have been different 
between patients with lobar ICH and non-lobar ICH. For example, patients who 
are younger or had lobar ICH may have been investigated more extensively for 
a secondary cause,283,284 which may have resulted in over- or underestimation 
of a risk factor. However, since macrovascular lesions are the cause in only a 
minority of ICH patients, we do not think this potential bias has influenced 
our results to a large extent. Second, although we included a total of 42 studies, 
the number of studies per risk factor by location was relatively small with a 
maximum of 13 studies. Third, misclassification of hematoma location in 
included studies might have occurred.262 Although some studies defined 
hemorrhages that could not be classified as lobar or non-lobar as mixed ICH 
and excluded these patients from analysis.e7, e22, e27, e42 If investigators were not 
blinded for risk factors such as hypertension, this knowledge may have resulted 
in an incorrect classification of a hematoma as non-lobar and subsequently an 
over- or underestimation of risk factors.262 Fourth, not all included studies 
adjusted for age or other risk factors and there was variation in number and 
type of adjustment factors between studies.
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The differences in risk factor profiles between lobar and non-lobar ICH suggest 
that with regard to secondary prevention spontaneous ICH should not be 
treated as one single disease. In contrast to traditional beliefs, hypertension is 
not the only cause for non-lobar ICH, as also diabetes, alcohol overuse, 
underweight, and being male, black or Hispanic are risk factors for non-lobar 
ICH. For lobar ICH we could only identify the risk factor hypertension. Based on 
our findings, we consider the term “hypertensive ICH” to distinguish deep from 
lobar ICH inappropriate. Since non-lobar ICH shares more risk factors with 
ischemic stroke than lobar ICH, future studies should investigate whether this 
difference in risk factor profiles should lead to distinct secondary prevention 
strategies for lobar and non-lobar ICH. 
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Objective: To determine whether the presence of DWI+ lesions is associated 
with recurrent stroke after ICH. 
Methods: The REstart or STop Antithrombotics Randomized Trial (RESTART) 
assessed the effect of restarting versus avoiding antiplatelet therapy after ICH 
on major vascular events for up to 5 years. We rated DWI sequences of MRI 
done before randomization for DWI+ lesion presence, masked to outcome and 
antiplatelet use. Cox proportional hazards regression models were used for 
statistical analysis. The trial is registered with the ISRCTN registry, number 
ISRCTN71907627.  
Results: Of 537 participants in RESTART, 247 (median [IQR] age 75.7 [69.6-81.1] 
years; 170 men [68.8%]; 120 started vs. 127 avoided antiplatelet therapy) had DWI 
sequences on brain MRI at a median of 57 days (IQR 19-103) after ICH, of whom 
73 (30%) had one or more DWI+ lesion. During a median follow-up of 2.0 years 
(1.0-3.0), 18 participants had recurrent ICH and 21 ischemic stroke. DWI+ lesion 
presence was associated with all stroke, (adjusted hazard ratio [HR] 2.2 [95% CI 
1.1-4.2]) and recurrent ICH (4.8 [1.8-13.2]), but not ischemic stroke (0.9 [0.3-2.5]). 
DWI+ lesion presence (0.5 [0.2-1.3]) versus absence (0.6 [0.3-1.5], P interaction=0.66) 
did not modify the effect of antiplatelet therapy on a composite outcome of 
recurrent stroke.   
Conclusions: DWI+ lesion presence in ICH survivors is associated with 
recurrent ICH, but not with ischemic stroke. We found no evidence of 
modification of effects of antiplatelet therapy on recurrent stroke after ICH by 
DWI+ lesion presence. These findings provide a new perspective on the 
significance of DWI+ lesions, which may be markers of microvascular occlusive 
events that are associated with recurrent ICH. 
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Introduction
Worldwide roughly ~3 million people suffer spontaneous intracerebral 
hemorrhage (ICH) every year.285 In most patients, ICH results from cerebral 
small vessel disease (SVD), affecting the small perforating vessels of the brain. 
Survivors of ICH are at high risk for recurrent stroke (both recurrent ICH and 
ischemic stroke) and other vascular events.21,26
 
Diffusion-weighted imaging-positive (DWI+) lesions are present in 11-41% of 
patients on brain MRI performed days to months after ICH.177,192,201,202,286-291 A 
recent meta-analysis investigating the association between DWI+ lesions and 
various subtypes of ICH showed that the prevalence of DWI+ lesions within 90 
days after ICH averages 20%.27 Furthermore, in all ICH, DWI+ lesions were 
associated with previous ICH and with other SVD biomarkers on brain MRI.27 
Whether DWI+ lesions predict clinical events after ICH is still uncertain. Poor 
functional outcome (assessed by the modified Rankin Scale [mRS] score at 
3 months after ICH) was associated with the presence of DWI+ lesions in some 
studies,30,201,292 but not others.25,288 One study of 97 patients found that the 
presence of DWI+ lesion(s) five days after ICH was associated with a higher risk 
of both ischemic stroke as well as a composite of ischemic stroke, recurrent 
ICH, and vascular death, during a median follow-up period of 3.5 years.25 
However, another study of 466 patients with ICH found that presence of a DWI+ 
lesion was associated with a higher risk of ischemic stroke, but not recurrent 
ICH.26 Therefore, we aimed to investigate whether DWI+ lesion presence in 
 antithrombotic-associated ICH survivors was associated with recurrent stroke, 
in a post-hoc exploratory sub-group analysis of RESTART. 
Methods
Study design and participants
RESTART was a prospective, multicenter, randomized controlled trial in 122 
hospitals in the United Kingdom, which aimed to estimate the effect of 
restarting versus avoiding antiplatelet therapy on the risk of recurrent ICH, 
and whether this risk might exceed the expected decrease in the number of 
vaso-occlusive events by antiplatelet therapy. The procedures and main results 
of the trial have been described in detail previously.24,293,294
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Briefly, we included patients ≥ 18 years old, who were taking antithrombotic 
(antiplatelet or anticoagulant) therapy until ICH for the prevention of 
vaso-occlusive disease and survived at least 24 hours. Antithrombotic therapy 
had to be discontinued at the time of the ICH, and both the participant and 
their physician had to be uncertain about whether to start or avoid antiplatelet 
therapy, meaning that if either one had strong beliefs about avoiding or 
restarting antiplatelet therapy then the participant was not eligible for the trial. 
In addition, spontaneous ICH had to be confirmed on brain imaging (computed 
tomography [CT] or MRI) and made available to the trial-coordinating center. 
Participants were excluded if the ICH was due to trauma, hemorrhagic 
transformation of ischemic stroke, or if it was not located in the brain 
parenchyma. 
Participants were randomized within 24 hours to start or avoid antiplatelet 
therapy by a digital minimization algorithm, which minimized differences 
between participants in the two trial arms based on five variables: (1) age at 
randomization (<70 years vs ≥70 years); (2) ICH location (lobar vs non-lobar); 
(3) time since symptom onset (1-6 days, 7-30 days, >30 days); (4) type of 
antiplatelet therapy if assigned to restart (aspirin vs other); and (5) probability 
of being alive and independent at 6 months (<0.15 vs ≥0.15).295
Standard protocol approvals, registrations,  
and patient consents
RESTART was approved by the Scotland A Research Ethics Committee and 
informed consent was obtained from every participant (or their legal 
representative), including for brain MRI if this had not already been performed. 
The trial is registered with the ISRCTN registry, number ISRCTN71907627. 
MRI acquisition and assessment of brain characteristics
Participants underwent brain MRI at a median of two days before randomization 
compatible with the RESTART standardized protocol (http://www.restarttrial.
org/documents/RESTART_MRI_protocol.pdf), including axial gradient- recalled 
echo (GRE) T2*, fluid-attenuated inversion recovery (FLAIR), diffusion-weighted 
imaging (DWI) including apparent diffusion coefficient (ADC) maps, T2- 
weighted and T1-weighted sequences (Supplemental Table 8.1).294
As described previously, anonymized images were reviewed in DICOM format 
by a panel of neuroradiologists blinded to treatment allocation and clinical 
outcome using the in-house, web-based, Systematic Image Review System 
(SIRS2) tool (https://sirs2.ccbs.ed.ac.uk/sirs2).294 In short, this included the 
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rating of ICH characteristics (side, location) on MRI and volume in mL 
(measured by the ABC/2 method) on CT.296 Additionally, the following MRI 
biomarkers of SVD according to the universally standardized STandards for 
ReportIng Vascular changes on nEuroimaging (STRIVE) criteria,4 were assessed 
using validated scales: white matter hyperintensities (WMH);297 old ischemic 
lesions;4 cerebral microbleeds (CMB);170,298 any cortical superficial siderosis, 
(focal and disseminated),299 and the probability of cerebral amyloid angiopathy 
(CAA) according to the Modified Boston criteria.299
Diffusion-weighted imaging-positive lesions 
We defined DWI+ lesions as hyperintense lesions on diffusion-weighted 
imaging, that were not located within or immediately adjacent to the hematoma. 
Presence, number, and location of DWI+ lesions were assessed in Carestream 
Vue PACS version 11.3.2, Carestream Health, Inc, USA, by one trained rater (KW) 
blinded to clinical outcome and treatment allocation. DWI and ADC signals 
change at different rates in white matter versus grey matter, and prolonged 
DWI-positive signal may indicate ongoing tissue pathological changes instead 
of T2 shine through.300,301 Therefore, acuity of DWI+ lesions was determined 
based on the corresponding intensity of ADC maps at the location of the 
DWI+ lesion, and deemed to be in the acute (hypo- or isointense) or subacute 
(hyperintense) phase. We determined inter-rater reliability of presence or 
absence of definite DWI+ lesions with one member of the panel of neuro-
radiologists (PMW) in a smaller subsample (N=40) which indicated substantial 
agreement (Cohen’s kappa 0.73 (95% confidence interval [CI] = 0.51-0.94). The 
size of a DWI+ lesion was defined as the greatest diameter of the DWI lesion.
Clinical outcomes
We collected follow-up data after randomization until death or November 30, 
2018, as described previously.24 Each participant (or their representative) and 
their primary care practitioner were asked about the occurrence of any serious 
vascular event, hospital admission, vital status, and medication use. In this 
study, we focused on recurrent stroke, including symptomatic ICH as evidenced 
by neuroimaging or pathology,293 and ischemic stroke as clinical outcomes. 
All stroke outcome events were assessed and verified by a neurologist outcome 
adjudicator masked to treatment allocation according to standardized definitions.24
Statistical analysis
KW performed statistical analyses in R (v3.6.2; https://www.R-project.org). 
We compared baseline demographics, ICH characteristics, and MRI biomarkers 
of SVD between participants with and without any DWI+ lesions using 
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nonparametric tests. We used the Mann-Whitney U test for continuous and 
chi-square test for categorical dependent variables (or Fisher’s exact test where 
appropriate). We estimated the survival function of time to first occurrence of 
recurrent stroke, censored at death or final follow-up using Kaplan-Meier 
survival analysis. We quantified annual event rates with 95% CI. After confirming 
the proportional hazards assumption with Schoenfeld residuals, we used 
observational Cox proportional hazards regression models to assess whether 
DWI+ lesion presence was associated with recurrent stroke (recurrent ICH, 
ischemic stroke, or both). As different types of stroke present with different risk 
factors for stroke recurrence, we used three models including different 
covariates. Collinearity of covariates in multivariable regression models was 
analyzed using Belsley collinearity diagnostics (mctest R package).302 The 
model for ICH was adjusted for age at randomization, lobar ICH location, 
probable CAA, and use of antiplatelet therapy (as predictors of recurrent ICH), 
whereas the model for ischemic stroke was adjusted for age at randomization, 
use of antiplatelet therapy, and atrial fibrillation (as predictors of ischemic 
stroke). The model for all stroke was adjusted for all variables included in the 
other two models. In additional Cox regression models presented in our online 
data supplement, we replaced probable CAA with the presence of cortical 
superficial siderosis, since this is a well-known risk factor for ICH recurrence,303, 304 
and investigated the association between DWI+ lesion presence and recurrent 
stroke stratified according to the qualifying ICH location (lobar vs. non-lobar). 
Furthermore, we performed two sensitivity analyses. First, we constructed Cox 
regression models using the sub-distribution hazard method of Fine and Gray 
to assess the effect of the competing risk of death.305 Second, we reanalyzed 
these Cox regression models after excluding participants with presence of one 
or more DWI+ lesion that had no ADC sequence available or who exclusively 
had subacute DWI+ lesion(s). 
We included an interaction term between presence of any DWI+ lesions and 
treatment group to investigate whether DWI+ lesion presence modified the 
effect of antiplatelet therapy on recurrent stroke (recurrent ICH alone, ischemic 
stroke alone, or any stroke). Cox proportional hazards interaction models were 
adjusted for the five covariates in the minimization algorithm. Additionally, we 
repeated these interaction models after excluding individuals without ADC 
sequences or exclusively subacute DWI+ lesion(s). 
Results are presented as hazard ratios (HRs) with 95% confidence intervals (CI). 
The two-tailed significance level α was set at 0.05. 
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Data availability
An anonymized version of the RESTART dataset will be available from 22 May 
2020 (one year after publication of the primary findings), upon request to the 
members of the RESTART trial steering committee by using the online data 
request form (https://datashare.ed.ac.uk/handle/10283/3632).  
Results
537 participants were included in RESTART between May 22, 2013 and May 31, 
2018,24 of whom we excluded 12 from these analyses because they did not have 
ICH (Figure 8.1). Of the remaining 525 participants, 254 participants had brain 
MRI performed according to the RESTART imaging protocol and were included 
in the brain MRI sub-study.294 Of the 525 participants, 507 had undergone 
brain CT; we did not find any differences in demographics, ICH characteristics, 
and brain CT biomarkers of SVD between the 240 participants who underwent 
brain MRI and 267 participants without brain MRI (see Supplemental Table 8.2). 
Of all 254 participants who had brain MRI, we excluded seven participants with 
inadequate DWI sequence quality from our analyses. This resulted in a final 
sample size of 247 participants (median [IQR] age 75.7 [69.6-81.1] years; 170 men 
[68.8%]) with a median interval between the qualifying ICH and brain MRI of 
57 days (IQR 19-103), of whom 120 were assigned to restart antiplatelet therapy, 
127 were assigned to avoid antiplatelet therapy, and none withdrew from 
follow-up.  
Among the 247 participants, 73 (30%) had at least one DWI+ lesion. We found a 
total of 150 DWI+ lesions, with a median diameter of 4 mm (IQR 3-6). DWI+ 
lesions were located in the cerebral white matter (n=70), cerebral cortex (n=52), 
cortical grey-white matter junction (n=12), subcortical grey matter (n=7) and 
cerebellum (n=9). Seventy-seven DWI+ lesions were in the hemisphere 
contralateral to the ICH (51%) and 73 in the ipsilateral hemisphere (49%). 
Sixty-four of the 73 participants with DWI+ lesions also had ADC maps available. 
These 64 individuals had 138 DWI+ lesions, of which 115 (83%) were deemed 
to be in the acute phase and 23 (17%) were deemed to be in the subacute phase. 
The baseline demographic and ICH characteristics of participants with and 
without any DWI+ lesions did not differ (Table 8.1). Participants with one or 
more DWI+ lesion had more severe WMH (Fazekas score 3-6: 77% vs. 63%, 
P=.039), and higher frequencies of any cortical superficial siderosis (33% vs. 
21%, P=.042), compared with individuals without any lesions. There was no 
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difference in the number of participants with two or more CMB (49% vs. 35%, 
P=.058), more than one old ischemic lesion 32% vs. 23%, P=.202), or the number 
of participants with probable CAA (29% vs. 18%, P=.070) according to the 
modified Boston criteria. 
The median follow-up of all 247 participants was 2.0 years (IQR 1.0-3.0). During 
this period, 18 participants had recurrent ICH and 21 had ischemic stroke. 
There was no evidence of a violation of the proportional hazards assumptions 
of analyses involving recurrent stroke at follow-up or collinearity among 
covariates in any of the regression analyses. We found a higher risk of all stroke 
for DWI+ lesion presence versus absence (adjusted HR 2.15 [95% CI 1.10-4.18], 
P=.025; Table 8.2; Figure 8.2; Supplemental Table 8.3). Participants with at least 
one DWI+ lesion had a higher risk of recurrent ICH (adjusted HR 4.83 [95% CI 
Figure 8.1 | Flowchart of patients with suitable brain MRI studies in RESTART
Abbreviations: ICH, intracerebral hemorrhage; MRI, magnetic resonance imaging; DWI, 
diffusion-weighted imaging.
12 no intracerebral hemorrhage 
   5 hemorrhagic transformation of ischemic stroke 
   3 subarachnoid hemorrhage alone 
   3 intraventricular hemorrhage alone 
   1 meningioma 
254 included in brain MRI substudy 
247 MRI available for rating 
537 participants randomly assigned 
525 eligible participants with ICH 
278 not eligible for MRI substudy 
   244 no MRI performed 
   3 unable to tolerate MRI 
   
4 DWI quality not adequate for rating 
2 no DWI performed
1 DWI made after randomization
1 MRI not readable
 
   23 MRI not performed according to imaging protocol  
   
7 no high quality DWI available  
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Table 8.1 | Group characteristics 
No DWI+ lesions 
(n=174)




Age (years) 75 (68 - 81) 77 (72 - 82) .121
Men 116 (67%) 54 (74%) .258
Time between ICH and MRI (days) 56 (19 - 102) 63 (20 - 103) .753
Characteristics of the largest ICH
Side .104
        Left 84 (48%) 27 (37%)
        Right 90 (52%) 46 (63%)
Location of the ICH .553
        Lobar 71 (41%) 35 (48%)
        Deep 84 (48%) 30 (41%)
        Infratentorial 19 (11%) 8 (11%)
ICH volume (mL) † 5.4 (1.6-13.9) 3.2 (0.9-12.4) .235
MRI markers of SVD 
Fazekas score .039
        0-2 64 (37%) 17 (23%)
        3-6 110 (63%) 56 (77%)
Old ischemic lesions .202
        None 107 (61%) 36 (49%)
        One 27 (16%) 14 (19%)
        More than one 40 (23%) 23 (32%)
Cerebral microbleeds .058
        0-1 105 (65%) 35 (51%)
        2 or more 57 (35%) 33 (49%)
Cortical superficial siderosis .042
        Focal or
        disseminated
36 (21%) 24 (33%)
        None 138 (79%) 49 (67%)
Modified Boston Criteria of CAA299 .070
        Probable CAA 32 (18%) 21 (29%)
        Other 142 (82%) 52 (71%)
Note: Demographics, ICH characteristics, and biomarkers of SVD of participants with any DWI+ 
lesions compared to those without were assessed using the Mann-Whitney U test for continuous 
and chi-square test for categorical dependent variables (or Fisher’s exact test where appropriate). 
Data represent median (IQR) or No. (%). Abbreviations: ICH, intracerebral hemorrhage; SVD, small 
vessel disease; CAA, cerebral amyloid angiopathy. † measured by the ABC/2 method on CT.
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Table 8.2 |  Risk of recurrent stroke during follow-up according to diffusion- 
weighted imaging-positive lesion presence
Events/ 
participant (%)





HR (95% CI) P value HR (95% CI) P value
All stroke 17 (23%) 22 (13%) 2.28 (1.21-4.30) .011 2.15 (1.10-4.18) .025
Intracerebral 
hemorrhage
12 (16%) 6 (3%) 5.36 (2.01-14.28) <.001 4.83 (1.77-13.17) .002
Ischemic stroke 5 (7%) 16 (9%) 0.90 (0.33-2.50) .858 0.89 (0.32-2.50) .824
Note: The adjusted model for all stroke includes age, lobar ICH location, probable CAA, antiplatelet 
use, and atrial fibrillation; the model for intracerebral hemorrhage includes age, lobar ICH 
location, probable CAA, and antiplatelet use; and the model for ischemic stroke includes age, 
antiplatelet use, and atrial fibrillation. Abbreviations: DWI+, at least one diffusion-weighted 
imaging lesion; HR, hazard ratio, CAA, cerebral amyloid angiopathy.
Figure 8.2 | Cumulative proportion of RESTART participants with a first recurrent stroke 
during follow-up stratified by DWI+ lesion presence vs. absence before randomisation
Numbers at risk include survivors under follow-up at the start of each year according to 
presence or absence of diffusion-weighted imaging lesions. Number of cumulative events 
show the participants under follow-up with a first stroke event. Abbreviations: DWI+, at least 
one diffusion-weighted imaging lesion; DWI-, no diffusion-weighted imaging lesion.
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Figure 8.2 | Continued
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1.77-13.17], P=.002, even when including the presence of cortical superficial 
siderosis as a confounder (Supplemental Table 8.4). However, DWI+ lesion 
presence was not significantly associated with future ischemic stroke (adjusted 
HR 0.89 [95% CI 0.32-2.50], P=0.824). The association between DWI+ lesion 
presence and recurrent stroke remained similar when stratifying analysis 
according to the location of the qualifying ICH (Supplemental Table 8.5), except 
for the association with all stroke after non-lobar ICH. Results were similar 
using the sub-distribution hazard method of Fine and Gray to assess the effect 
of the competing risk of death (Supplemental Table 8.6). Results were unchanged 
in sensitivity analyses excluding individuals with one or more DWI+ lesion and 
no ADC map or exclusively subacute DWI+ lesion(s) (n=15; see Supplemental 
Tables 8.7 and 8.8). 
There was no evidence of heterogeneity of the effects of antiplatelet therapy by 
DWI+ lesion presence versus absence on the risk of any recurrent stroke 
(adjusted HR 0.45 [95% CI 0.16–1.26] vs 0.61 [0.26–1.47]; P interaction=.661; 
Supplemental Tables 8.9 and 8.10; Supplemental Figure 8.1), recurrent ICH 
(adjusted HR 0.57 [95% CI 0.17–1.87] vs 0.24 [0.03–2.10]; P interaction=.499), 
or ischemic stroke (adjusted HR 0.26 [95% CI 0.03–2.36] vs 0.82 [0.30–2.21]; 
P interaction=.356). Results were unchanged in sensitivity analyses excluding 
individuals with one or more DWI+ lesion and no ADC map, or exclusively 
subacute DWI+ lesion(s) (Supplemental Tables 8.11 and 8.12). 
Discussion
We found that DWI+ lesions occurred in 30% of ICH survivors who had been 
taking an antithrombotic drug before ICH. The presence of one or more DWI+ 
lesion was associated with recurrent ICH, but not ischemic stroke. 
We found DWI+ lesions in almost one third of our participants; this prevalence 
is higher than found in a recent systematic review,27 possibly because of the 
burden of SVD or prevalence of vascular risk factors in the RESTART population. 
In the acute phase, ICH might trigger changes in cerebral hemodynamics, 
blood-brain barrier permeability, induce inflammatory responses, or a decrease 
in blood pressure, contributing to development of DWI+ lesions. Conversely, 
acute ICH may reflect an active ongoing process in the small vessels that likely 
predates the ICH, which could result in the occurrence of DWI+ lesions outside 
this acute time window. The high prevalence of DWI+ lesions after ICH, the 
higher burden of MRI biomarkers of SVD in patients with any DWI+ lesions, 
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together with the association of DWI+ lesion presence with recurrent ICH but 
not ischemic stroke, suggests that the DWI+ lesions are markers of microvascular 
occlusive events predisposing to rupture of microvessels. Future research 
needs to determine whether DWI+ lesions in ICH survivors are a consequence 
or marker of the underlying SVD, or mechanisms induced by the rupture of 
whole blood into the brain parenchyma, or both. 
The appearance of DWI+ lesions in individuals with acute ICH has been 
associated with a high risk of either ischemic stroke or a composite of ischemic 
stroke, recurrent ICH, or vascular death in a small study,25 and with an increased 
risk of ischemic stroke, but not recurrent ICH, in a recent pooled individual 
patient data analysis including 466 patients from the ATTACH-2 and the 
MISTIE-III trials.26 In the RESTART MRI sub-study, presence of any DWI+ 
lesion was not associated with ischemic stroke; in the small study,25 four of the 
five ischemic strokes were due to SVD, but we did not investigate the likely 
cause of the ischemic strokes we observed during follow-up. Furthermore, the 
majority of the patients in previous studies had non-lobar ICH associated with 
hypertension, and very few patients had cortical superficial siderosis, an 
independent predictor of recurrent ICH. In RESTART, the association between 
DWI+ lesion presence and recurrent ICH might have been confounded by a 
slight, non-significant excess of CAA-related ICH in participants with one or 
more DWI+ lesion (Table 8.1) even though we adjusted for modified Boston 
criteria for probable CAA and the association between one or more DWI + 
lesion and recurrent ICH remained (Table 8.2). The association between DWI+ 
lesion presence and recurrent ICH did not differ according to ICH location (see 
Supplemental Table 8.5), however cortical DWI+ lesion location might be a 
marker of  CAA-related ICH, so larger studies could investigate whether a 
cortical DWI+ lesion distribution is associated with an increased risk of lobar 
ICH.  
We did not find any evidence that DWI+ lesion presence modifies the risk of 
recurrent stroke with antiplatelet therapy. Although the direction of effects in all 
subgroups was consistent with the main finding of RESTART – that starting 
antiplatelet therapy may reduce the risk of recurrent ICH when compared with 
avoiding antiplatelet therapy24 – the number of outcomes was too small to 
detect any significant differences between subgroups, and thus needs to be 
interpreted with caution. Nonetheless, these findings can be informative for 
sub-group analyses in MRI sub-studies in definitive main phase RCTs and 
meta-analyses of antiplatelet and anticoagulant RCTs after ICH (see 
Supplemental Table 8.13 for a list of the many trials’ NCT entries).
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The main strengths and limitations of RESTART and the MRI sub-study are 
described elsewhere.24,294 Our findings provide a new perspective on the 
clinical significance of DWI+ lesions, which may be markers of SVD activity 
rather than just ischemia. Other strengths include the multi-center prospective 
study design, standardized imaging protocol, blinded expert review of MRI 
imaging according to widely established criteria, and outcome assessment 
using standardised definitions.
However, this study has some limitations. First, our findings might not be 
generalizable to a broader population of individuals with ICH. RESTART 
participants were already taking antithrombotic agents for the prevention of 
vaso-occlusive disease before ICH, which tended to be smaller in (median 4.6 
mL) compared with ICH volumes reported in the majority of previous 
MRI-based studies,192,286,289 or population-based cohorts.306 More severe ICHs 
are often fatal, and therefore less likely to be investigated by MRI, which may 
have resulted in an underestimation of the true prevalence of DWI+ lesions. 
However, we did not find evidence of any selection biases when comparing 
participants included or not included in the MRI sub-study (see Supplemental 
Table 8.2). Second, the prevalence of DWI+ lesions might have been further 
underestimated due to the broad interval between the qualifying ICH and brain 
MRI, since prior reports suggest that the early post-ICH period is a high risk 
time for DWI+ lesion occurrence.177 Third, the higher prevalences of superficial 
siderosis in participants with DWI+ lesion presence may suggest an overrep-
resentation of CAA-related ICH, which could have confounded the association 
between DWI+ lesions and recurrent ICH,299 but this association was 
independent of probable CAA in a multivariable analysis. Fourth, although we 
made use of a standardized imaging protocol, field strength and parameters of 
the DWI sequence varied between participants, by which prevalence of DWI+ 
lesions is likely to be influenced. Fifth, we did not systematically perform brain 
MRI at a set interval after ICH, which may have influenced the number of 
observed DWI+ lesions.201,202,286 Finally, the modest sample size of RESTART 
resulted in a small number of clinical outcomes, which limited the statistical 
power to detect any significant effects. 
In conclusion, we found that DWI+ lesion presence in survivors of ICH enrolled 
in the RESTART trial was associated with recurrent ICH, but not with ischemic 
stroke. These findings provide a new perspective on the significance of DWI+ 
lesions, which may be markers of microvascular occlusive events that are 
associated with recurrent ICH.
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Supplemental Table 8.2 | Characteristics of participants with and without 
MRI, who also had brain CT available, in the main RESTART trial






Age (years) 77 (69 - 83) 76 (70 - 82) .647
Men 172 (64%) 167 (70%) .217
Time between ICH and MRI (days) 0 (0 - 1) 0 (0 - 1) .488
Characteristics of the largest ICH
Side .270
        Left 131 (49%) 106 (44%)
        Right 136 (51%) 134 (56%)
Location of the ICH .292
        Lobar 98 (37%) 104 (43%)
        Deep 135 (51%) 111 (46%)
        Infratentorial 34 (13%) 25 (10%)
ICH volume (mL) 3.6 (1.0-10.4) 4.5 (1.3-12.6) .168
CT markers of SVD 
Periventricular lucencies score† .673
        0-2 162 (61%) 150 (63%)
        3-4 105 (39%) 90 (38%)
Previous vascular lesions .305
        No 95 (36%) 96 (40%)
        Yes 172 (64%) 144 (60%)
Edinburgh CT-only criteria for CAA299 .251
        Lobar ICH with
        high probability of 
        CAA
12 (5%) 17 (7%)
        Lobar ICH with
        low probability of 
        CAA
83 (31%) 82 (35%)
        Non-Lobar ICH 169 (64%) 136 (58%)
Note: Demographics, ICH characteristics and biomarkers of SVD assessed on computed tomography 
(CT) imaging of participants included in the MRI sub-study compared to those not included 
were assessed using the Mann-Whitney test for continuous and chi-square test for categorical 
dependent variables (or Fisher’s exact test where appropriate). Data represent median (IQR) or No. (%). 
† Periventricular lucencies score combines both anterior and posterior white matter scores 
(0=no lucency; 1=lucency restricted to region adjoining ventricles; 2=lucency covering entire region 
from lateral ventricle to cortex). Abbreviations: ICH, intracerebral hemorrhage; SVD, small vessel 
disease; CT, computed topography; CAA, cerebral amyloid angiopathy.
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Supplemental Table 8.4 | Risk of recurrent stroke during follow-up 











HR (95% CI) P value HR (95% CI) P value



















Note: The adjusted model for all stroke includes age, lobar ICH location, presence of superficial 
cortical siderosis, antiplatelet use, and atrial fibrillation; the model for intracerebral hemorrhage 
includes age, lobar ICH location, presence of superficial cortical siderosis, and antiplatelet use; 
and the model for ischemic stroke includes age, antiplatelet use, and atrial fibrillation. 




























































































































































































































































































































































































































































































































































































































































































































































































































































Supplemental Table 8.6 | Risk of recurrent stroke during follow-up 
according to diffusion-weighted imaging- positive lesion presence 











HR (95% CI) P value HR (95% CI) P value
All stroke 17 (23%) 22 (13%) 2.15 (1.14-4.03) .017 2.06 (1.04-4.09) .039
Intracerebral 
hemorrhage







5 (7%) 16 (9%) 0.85 (0.31-2.30) .740 0.82 (0.29-
2.34)
.710
Note: Fine and Gray method for competing risk of death. The adjusted model for all stroke includes 
age, lobar ICH location, probable CAA, antiplatelet use, and atrial fibrillation; the model for 
intracerebral hemorrhage includes age, lobar ICH location, probable CAA, and antiplatelet use; 
and the model for ischemic stroke includes age, antiplatelet use, and atrial fibrillation. 
Abbreviations: DWI+, at least one diffusion-weighted imaging lesion; HR, hazard ratio, CAA, 
cerebral amyloid angiopathy.
Supplemental Table 8.7 | Risk of recurrent stroke during follow-up 
according to diffusion-weighted imaging- positive lesion presence 
(sensitivity analysis according to ADC intensity)
Events/participant 
(%)





HR (95% CI) P value HR (95% CI) P value
All stroke 15 (26%) 22 (13%) 2.66 (1.38-5.15) .004 2.37 (1.17-4.80) .016
Intracerebral 
hemorrhage





3 (5%) 16 (9%) 0.71 (0.21-2.44) .585 0.63 (0.18-2.23) .471
Note: This analysis excludes participants with DWI+ lesions and no accompanying ADC scan 
available, and participants with one or multiple DWI+ lesions that have a hyperintense signal at 
the corresponding location on their ADC scan (if they have multiple DWI+ lesions of which only 
one is hyperintense on ADC they remain in the analysis). The adjusted model for all stroke 
includes age, lobar ICH location, probable CAA, antiplatelet use, and atrial fibrillation; the model 
for intracerebral hemorrhage includes age, lobar ICH location, probable CAA, and antiplatelet use; 
and the model for ischemic stroke includes age, antiplatelet use, and atrial fibrillation. 
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Supplemental Table 8.8 | Cumulative annual event rates of recurrent stroke 
during follow-up according to diffusion-weighted imaging-positive lesion 
presence (sensitivity analysis according to ADC intensity) by year
Year 1 Year 2 Year 3 Year 4
Event 
rate 
95% CI Event 
rate 
95% CI Event 
rate 




    DWI+ 18 7-27 29 14-41 35 16-49 35 16-49
    DWI- 7 3-11 12 6-17 14 8-20 22 11-31
Intracerebral hemorrhage
    DWI+ 14 5-23 26 11-38 26 11-38 26 11-38
    DWI- 2 0-5 4 1-7 4 1-7 4 1-7
Ischemic stroke
    DWI+ 4 0-8 4 0-8 9 0-20 9 0-20
    DWI- 4 1-8 8 3-12 10 5-16 18 8-26
Annual event rates (%) based on Kaplan-Meier estimates. Abbreviations: DWI+, at least one diffusion- 
weighted imaging lesion; HR, hazard ratio.
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Supplemental Table 8.9 | Cumulative annual event rates of recurrent stroke 
during follow-up according to diffusion-weighted imaging-positive lesion 
presence and antiplatelet therapy by year
Year 1  Year 2 Year 3 Year 4
Event 
rate
95% CI Event 
rate
95% CI Event 
rate





     Start 12 0-22 20 4-34 20 4-34 20 4-34
     Avoid 22 7-34 30 12-45 37 14-54 37 14-54
  DWI-
     Start 5 0-10 10 3-17 10 3-17 16 2-27 
     Avoid 8 2-14 13 5-21 18 8-27 27 11-40
Intracerebral hemorrhage
DWI+   
     Start 9 0-18 18 2-31 18 2-31 18 2-31
     Avoid 14 2-24 22 6-35 22 6-35 22 6-35
DWI-   
     Start NA NA 2 0-5 2 0-5 2 0-5
     Avoid 5 0-9 6 1-12 6 1-12 6 1-12
Ischemic stroke
DWI+    
     Start 3 0-8 3 0-8 3 0-8 3 0-8
     Avoid 8 0-17 8 0-17 16 0-31 16 0-31
DWI-    
     Start 5 0-10 9 2-15 9 2-15 14 1-25
     Avoid 4 0-8 7 1-13 12 3-20 20 5-33
Annual event rates (%) based on Kaplan-Meier estimates. Abbreviations: DWI+, at least one diffusion- 
weighted imaging lesion; HR, hazard ratio.
161
8





























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DWI+ lesions and risk of recurrent stroke
Supplemental Table 8.11 | Cumulative annual event rates of recurrent 
stroke during follow-up according to diffusion-weighted imaging-positive 
lesion presence and antiplatelet therapy (sensitivity analysis according to 
ADC intensity) by year
Year 1  Year 2 Year 3 Year 4
Event 
rate
95% CI Event 
rate
95% CI Event 
rate




   DWI+
      Start 16 0-30 30 5-48 30 5-48 30 5-48
      Avoid 19 4-31 29 9-45 38 3-17 38 3-17
   DWI-
      Start 5 0-10 10 3-17 10 3-17 16 2-27
      Avoid 8 2-14 13 5-21 18 8-27 27 11-40
Intracerebral hemorrhage
DWI+   
     Start 13 0-25 27 2-45 27 2-45 27 2-45
     Avoid 16 2-27 26 6-41 26 6-41 26 6-41
DWI-
     Start NA NA 2 0-5 2 0-5 2 0-5
     Avoid 5 0-9 6 1-12 6 1-12 6 1-12
Ischemic stroke
DWI+
     Start 4 0-11 4 0-11 4 0-11 4 0-11
     Avoid 3 0-10 3 0-10 13 0-30 13 0-30
DWI-
     Start 5 0-10 9 2-15 9 2-15 14 1-25
     Avoid 4 0-8 7 1-13 12 3-20 20 5-33
Annual event rates (%) based on Kaplan-Meier estimates. Abbreviations: DWI+, at least one diffusion- 


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DWI+ lesions and risk of recurrent stroke
Supplemental Table 8.13 | Overview of NCT entries of antiplatelet and 
anticoagulant RCTs after ICH
Trial name NCT entry
Antiplatelet RCTs
· RESTART (ISRCTN71907627)
· RESTART in France (NCT02966119)
· STATICH-antiplatelets (NCT03186729)
· ASPIRING (NCT04522102)







· ENRICH-AF (NCT03950076) 
· PRESTIGE-AF (NCT03996772)
† Direct factor Xa inhibitors, direct thrombin inhibitors, or vitamin K antagonists. Abbreviations: 
NCT, national clinical trial; RCT, randomized clinical trial; ICH, intracerebral hemorrhage.

Submitted as
Wiegertjes K, Voigt S, Jolink WMT, Koemans EA, Schreuder FHBM, van Walderveen 
MAA, Wermer MJH, Meijer FJA, Duering M, de Leeuw FE, Klijn CJM.
Etiology of diffusion-weighted imaging lesions after intracerebral hemorrhage
Etiology of diffusion-weighted 






Background and purpose: We aimed to investigate whether diffusion-weight-
ed imaging-positive (DWI+) lesions after acute intracerebral hemorrhage (ICH) 
are associated with the underlying small vessel disease (SVD) or are linked to 
the acute ICH. 
Methods: We included patients ≥18 years with spontaneous ICH confirmed on 
neuroimaging and performed 3T MRI after a median of 11 days (interquartile 
range [IQR] 6-43). DWI+ lesions were assessed in relation to the hematoma 
(perihematomal vs. distant, and ipsilateral vs. contralateral). Differences in 
clinical characteristics, ICH characteristics and MRI markers of SVD between 
participants with any DWI+ lesions and those without were investigated using 
non-parametric tests. 
Results: In 138 participants (median age [IQR] 65 [55-73] years; 71% male, 59 
lobar ICH) with available DWI, 54 DWI+ lesions were observed in 30 (22%) 
patients up to 86 days after the ICH. We found DWI+ lesions both ipsilateral 
(54%) and contralateral (46%), and 5 (9%) DWI+ lesions were located in the 
immediate perihematomal region. DWI+ lesion presence was associated with 
probable CAA diagnosis (38% vs 15%, p = .01) and larger ICH volumes (37 [8–47] 
vs 12 [6-24] mL, p=.01), but not with imaging features of SVD.
Conclusions: Our findings suggest that DWI+ lesions after ICH are a feature of 
both the underlying SVD and ICH-related mechanisms. 
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Introduction
In patients with acute intracerebral hemorrhage (ICH) due to small vessel 
disease (SVD) diffusion-weighted imaging-positive (DWI+) lesions occur on 
average in 20% on MRI performed within 90 days.27 These DWI+ lesions have 
been associated with worse outcome.30 Although DWI+ lesions are less frequent 
in patients with SVD without ICH (<5%),28 it remains uncertain whether this 
high frequency of DWI+ lesions is secondary to the acute ICH or the result of 
the underlying SVD. 
Recent individual patient data meta-analyses demonstrated the association 
between DWI+ lesions after ICH with both magnetic resonance (MRI) markers 
of cerebral small vessel disease (SVD) and ICH characteristics, but data on the 
timing and location of DWI+ lesions in relation to the ICH were not available.27,30 
Therefore, we aimed to investigate the prevalence, timing and location of DWI+ 
lesions in survivors of SVD related ICH. 
Materials and Methods
Detailed methods are available in the data supplement.
Study design and population
Data requests can be sent to the corresponding author (karin.klijn@radboudumc.
nl). We included 138 patients with available MRI DWI images from the 
multi-center prospective cohort Finding the ETiology in spontaneous Cerebral 
Hemorrhage (FETCH) study.165 There were some minor differences between 
the patients with and without 3T MRI (Supplemental Table 9.1). 
Neuroimaging markers
Participants underwent 3T MRI within 3 months of ICH onset using a 
standardized MRI protocol (Supplemental Table 9.2). DWI+ lesions were assessed 
on DWI by two trained raters (S.V. and E.A.K.). The location of DWI+ lesions in 
relation to the ICH was assessed as follows: (1) perihematomal (<10 mm of 
the hematoma); (2) ipsilateral or contralateral. The location and volume of the 
ICH, and the perihematomal edema extension distance were calculated.307 
SVD markers were rated according to universally standardized criteria.4 Patients 
with probable cerebral amyloid angiopathy (CAA) were identified using the 




Statistical analyses were performed in R (R Foundation). Comparisons of the 
prevalence of DWI+ lesions on acute (≤ 7 days) versus non-acute (> 7 days) MRI 
scans and differences between DWI+ and DWI- cases were performed using 
Mann-Whitney U tests and χ2 tests (or Fisher exact tests when appropriate). 
A 2-tailed α was set at .05. 
Results
Of the 138 patients 98 were men (71%), and their median age was 65 years 
(interquartile range [IQR] 55-73). In 59 of 138 patients, the ICH was lobar (43%), 
and in 79 (57%) non-lobar (56 deep and 23 infratentorial). Twenty-four of the 
59 patients (41%) with lobar ICH fulfilled the modified Boston criteria for 
probable CAA. 
We identified 54 DWI+ lesions in 30 of the 138 patients (22%), of which 5 (9%) 
were located in perihematomal regions. DWI+ lesions were equally distributed 
in both hemispheres (ipsilateral 54% and contralateral 46%; Figure 9.1). There 
was a higher number of patients with probable CAA in the DWI+ group 
compared to the DWI- group (38%, vs 15%, p = .01). Individuals with probable 
Figure 9.1 | Topographical distribution of DWI+ lesions
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CAA more often had strictly cortical DWI+ lesions than individuals with 
no-CAA ICH (78% vs 17%, p<.01). 
We observed DWI+ lesions on MRIs up to 86 days after the ICH (Figure 9.2). 
The frequency of DWI+ lesions appeared similar on acute and non-acute MRI 
scans (23% vs. 20%, p=.90). Although we found larger ICH volumes in patients 
with DWI+ lesions relative to those without (37 [8-47] vs 12 [6-24] mL, p=.01), 
clinical characteristics and SVD imaging features were similar between groups 
(Table 9.3). 
Discussion
Our results demonstrate a widespread distribution of DWI+ lesions after 
spontaneous ICH, unrelated to the anatomical location of the hematoma nor 
to the time after ICH onset. Furthermore, DWI+ lesion presence was associated 
with ICH volume, and a diagnosis of probable CAA, but not with imaging 
features of SVD. 
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Table 9.3 | Characteristics of participants with and without DWI+ lesions
No DWI+ lesion 
(n =108)




Age, y 64 [53-72] 68 [61-75] .24
Men, n (%) 75 (69%) 23 (77%) .44
Hypertension 58 (54%) 21 (70%) .11
Diabetes 14 (13%) 5 (17%) .56
Hypercholesterolemia 35 (32%) 12 (40%) .44
BMI, kg/m2 26 [24-29] 25 [23-29] .62
Smoking, ever 59 (57%) 18 (67%) .35
Antithrombotic agents 45 (42%) 11 (37%) .62
ICH characteristics
Side .12
        Left 56 (52%) 11 (37%)
        Right 50 (46%) 19 (63%)
Location of the ICH .19
        Lobar 43 (40%) 16 (53%)
        Non-lobar 65 (60%) 14 (47%)
ICH volume, mL 12 [6-24] 37 [8-47] .01
EED, cm 0.44 [0.22-0.61] 0.48 [0.29-0.60] .47
MRI markers of SVD 
WMH volume, % of ICV 
volume
0.33 [0.14-0.87] 0.61 [0.23-1.29] .05
Lacunes, prevalence 19 (18%) 5 (17%) .90
Microbleeds, prevalence 54 (55%) 19 (68%) .21
Cortical superficial siderosis, 
prevalence
14 (13%) 7 (26%) .15
MD, 10-4 mm2/s .07
        Siemens 7.91 [7.62-8.16] 8.41 [7.99-8.80]
        Phillips 7.78 [7.46-8.07] 7.76 [7.59-7.98]
Modified Boston Criteria .01
        Probable CAA 14 (15%) 10 (38%)
        Other 81 (85%) 16 (62%)
Data are median (interquartile range) or number (%). DWI+, indicates patients with diffusion-weighted 
imaging-positive lesions; DWI-, patients without DWI+ lesions; ICH, intracerebral hemorrhage; ICV, 
intracranial volume; EED, edema extension distance; MRI, magnetic resonance imaging; BMI, body 
mass index; WMH, white matter hyperintensities; CAA, cerebral amyloid angiopathy; MD, mean 
diffusivity. Information on history of smoking was missing in 8 (7%), presence of lacunes in 5 (5%), 
presence of microbleeds in 11 (8%), presence of cortical superficial siderosis in 10 (9%), and CAA 
diagnosis in 17 (16%) patients, due to incomplete information or poor image quality.
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The similar distribution of ipsilateral and contralateral DWI+ lesions, and their 
high frequency outside the acute post-ICH period, suggests that these lesions 
are reflections of the underlying SVD. The absence of a statistically significant 
association between DWI+ lesions and SVD markers could be due to the small 
sample size. The finding that DWI+ lesions were more frequent in cases 
diagnosed with probable CAA, especially in cortical regions, may indicate that 
the accumulation of amyloid β in the vessel walls of cortical and leptomeningeal 
vessels could be related to the formation of abnormal blood clots resistant to 
degradation, as demonstrated in recent in vitro and in vivo studies.308 
Global mechanisms secondary to the ICH, such as immune-mediated 
mechanisms or blood-brain barrier breakdown could also be involved in the 
origin of ICH-related DWI+ lesions,309 since patients with DWI+ lesions had 
considerably larger ICH volumes. Alternatively, some hemorrhages might be 
caused by hemorrhagic transformation of DWI+ lesions.9,29 
Whereas CAA is a major risk factor for recurrent ICH, these results suggest that 
CAA also predisposes to a higher DWI+ lesion frequency. This poses a clinical 
dilemma regarding the risk of future hemorrhagic or ischemic events when 
treating patients with acute ICH, including the use or avoidance of antithrombotic 
therapy or aggressive blood pressure lowering,24,177 which should be addressed 
in future randomized controlled clinical trials. 
The main strength of our study includes the unique cohort of ICH patients who 
underwent MRI during the acute or subacute phase of ICH. However, not all 
patients underwent MRI, in particular those who were in poor clinical condition, 
causing selection bias. Limitations of our study are the relatively small sample 
size and use of different scanners, although with aligned protocols.
These findings suggest that ICH-related DWI+ lesions are an ongoing process 
associated with the underlying SVD and are possibly promoted by the acute 





204 patients presenting to the University Medical Centers of Nijmegen, Utrecht, 
or Leiden, with a symptomatic spontaneous ICH confirmed on computed 
tomography (CT), were included between October 2013 and December 2018, of 
whom 155 underwent 3T MRI.165 There were minor differences in patient 
demographics and ICH characteristics on brain CT between the 155 participants 
who underwent 3T MRI and 49 participants without MRI (Table 9.3). Of all 
participants who had 3T MRI, 17 participants were excluded due to inadequate 
DWI image quality. This resulted in a final sample size of 138 participants 
(median [IQR] age 65 [55-73] years; 98 men [71%]) with a median interval 
between the qualifying ICH and MRI of 11 days (IQR 6-43). In total, 112 patients 
underwent MRI in the acute phase (<7 days) and 26 in the nonacute phase 
(≥ 7 days). This study was approved by the Medical Ethics Review Committee of the 
University Medical Center Utrecht. Patients provided written informed consent.
MRI rating and processing
Detailed MRI acquisition parameters are presented in Supplemental Table 9.1. 
We classified the location of the ICH as lobar (cerebral lobes) or non-lobar 
(thalamus, basal ganglia, brainstem, or cerebellum). We assessed ICH volume 
and perihematomal edema volume on FLAIR with manual segmentation using 
ITK-SNAP 3.8 (http://www.itksnap.org/). Subsequently, we calculated the edema 
extension distance (EED), as this measure is relatively independent of ICH 
volume.307 SVD markers were rated according to the STandards for ReportIng 
Vascular changEs on neuroimaging (STRIVE) criteria, as described previously.4,310 
DWI+ lesions were defined as hyperintense lesions on diffusion-weighted imaging 
and a hypointense or isointense signal on apparent diffusion coefficient maps 
at the corresponding location and assessed by one trained rater (S.V.). A second 
rater (E.A.K.) assessed DWI+ lesion presence in a random subsample indicating 
perfect agreement (n=10%, Cohen’s kappa 1.00 (95% confidence interval [CI] = 
1.00-1.00). DWI images and corresponding lesion masks were registered to 
the native T1-weighted images, and subsequently normalized into MNI-152 
standard space. Lesion coordinates were extracted from the co-registered 
lesion masks, and visualized using BrainNet Viewer (http://www.nitrc.org/
projects/nmv/), to investigate whether ipsilateral and contralateral DWI+ lesions 
have a similar distribution throughout the brain, which would be indicative of 
a more widespread cause than the acute ICH alone. 
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We pre-processed diffusion-weighted data sets to correct for eddy current- 
induced distortions and head motion, using tools from Mrtrix3 (httpp://www.
mrtrix.org/, dwidenoise, mrdegibbs) and the Functional Magnetic Resonance 
Imaging of the Brain (FMRIB) Software Library (FSL; version 6.0.1, eddy).167 
After pre-processing, trace images were calculated based on the geometric 
mean of all DWI volumes, using MATLAB (version R2019a, The MathWorks, 
Inc). Diffusion tensors were estimated using linear least squares implemented 
in Matlab. DTI measures, such as mean diffusivity were calculated from the 
tensors for each voxel using fslmaths, part of FSL. A white matter skeleton was 
obtained using Tract-Based Spatial Statistics from FSL, using a FA threshold of 
> 0.2 and a custom-made mask,84 excluding areas susceptible to contamination 
by cerebrospinal fluid. The mean of all voxels of the hemisphere contralateral 
to the ICH located in the masked skeleton was used for further analysis. Since 
diffusion data collected from different MRI scanners can vary significantly 
even when using a harmonious MRI protocol,311 we stratified our analysis 
according to the type of MRI scanner (see Supplemental Table 9.1).
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Supplemental Table 9.1 | Characteristics of participants with and without 
3T brain MRI
No 3T MRI (n=49) 3T MRI (n=155) P
Clinical characteristics
Age, y 72 [61-80] 65 [56-74] .02
Men 29 (59%) 111 (71%) .14
Hypertension 29 (59%) 86 (55%) .45
Diabetes 3 (6%) 24 (15%) .11
Hypercholesterolemia 16 (33%) 52 (34%) .95
BMI, kg/m2 26 [23-28] 26 [23-29] .80
Smoking, ever 26 (53%) 87 (56%) .88
Antithrombotic agents 23 (47%) 63 (41%) .33
ICH characteristics
Side .08
        Left 29 (59%) 74 (31%)
        Right 17 (35%) 79 (51%)
Location of the ICH <.01
        Lobar 9 (18%) 70 (45%)
        Non-lobar 38 (78%) 85 (55%)
Data are median (interquartile range) or number (%). MRI, magnetic resonance imaging; BMI, 
body mass index; ICH, intracerebral hemorrhage.
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Supplemental Table 9.2 | MRI protocol
Sequence Utrecht Leiden Nijmegen
MRI scanner* Phillips Phillips Siemens
Patients [n] 64 33 41
T1 Slice [mm] 1.00 1.00 1.00
In-plane [mm] 1.00 1.00 1.00
FLAIR Slice [mm] 3.00 3.00 3.00
In-plane [mm] 0.96 0.96 0.96
DWI Slice [mm] 2.50 2.50 2.00




SWI Slice [mm] - 3.00 -
In-plane [mm] - 0.96 -
T2* Slice [mm] 3.00 - 3.00
In-plane [mm] 0.98 - 0.98
MRI, magnetic resonance imaging; FLAIR, fluid-attenuated inversion recovery; DWI, diffusion- 
weighted imaging; SWI, susceptibility-weighted imaging.













Part I | Introduction
SVD constitutes the major vascular contributor to cognitive impairment and 
dementia, and is the cause of a fifth of all strokes worldwide.4 Most often, SVD 
is due to aging and cardiovascular risk factors.3 The term SVD includes all 
pathological changes to the smallest cerebral blood vessels, which can lead to 
both ischemic and hemorrhagic markers of SVD, including WMH, lacunes, and 
microbleeds on conventional MRI (Panel 1). However, the MRI markers of SVD 
are heterogeneous and not completely understood, since animal models that 
are able to accurately capture the pathological changes in human SVD are 
limited.312 Furthermore, the reason why some vessels rupture while others 
occlude leading to (micro)infarction is poorly understood. Therefore, in this 
thesis, we aimed to provide a deeper understanding of the ischemic and 
hemorrhagic MRI markers of SVD.
In chapter 2 we elaborate on the spectrum of SVD manifestations, including 
WMH, lacunes, microbleeds, recent small subcortical infarcts, cortical 
microinfarcts, brain atrophy and enlarged perivascular spaces. First, we discuss 
that while SVD lesions seem to have an identical appearance on MRI, their 
underlying histopathology and effect on perilesional and remote brain regions 
is heterogenous. Furthermore, SVD markers visible on conventional MRI only 
reveals “the tip of the iceberg”. For example, conventional imaging techniques 
often coarsely dichotomize into normal and abnormal tissue, whereas more 
advanced quantitative imaging techniques such as diffusion tensor imaging 
appear to explain more clinical variation than conventional MRI markers of 
SVD.  This may be because they are able to capture tissue alterations extending 
into the “normal appearing” areas on conventional MRI surrounding WMH. 
Second, because MRI markers of SVD may disrupt structural and functional 
brain networks, even a small subcortical lesion can exert a widespread effect 
throughout the brain. Consequently, the clinical framework of SVD being a 
focal subcortical disease should be revised. From these investigations, we 
conclude that conventional MRI only reveals “the tip of the iceberg” when it 
comes to changes associated with SVD. This may increase our understanding 
of the heterogeneity in clinical symptoms between individuals with a seemingly 
similar burden of SVD markers on conventional MRI. 
In chapter 3 we investigated differences in the most common MRI markers of 
SVD, including WMH, lacunes, and cerebral microbleeds, between patients 
from two prospective cohort studies with either an ischemic or hemorrhagic 
184
Chapter 10
manifestation of SVD, i.e. either a lacunar stroke or a non-lobar ICH. WMH 
volume and its distribution was not different between the 82 patients with a 
lacunar stroke and the 54 patients with a non-lobar ICH. Lacunes were two and 
a half times more frequent in patients with a lacunar stroke compared to 
patients with a non-lobar ICH and demonstrated a large similarity in distribution 
in both patients with a lacunar stroke or a non-lobar ICH suggesting a common 
pathophysiological mechanism. Microbleeds were three times more frequent 
in patients with a non-lobar ICH, and more often located in non–lobar regions 
compared to microbleeds in lacunar stroke. In conclusion, SVD in patients with 
lacunar stroke and non–lobar ICH cannot be differentiated by WMH burden or 
distribution. However, lacunes were more frequent in the ischemic phenotype 
of lacunar stroke, whereas microbleeds were more prevalent in patients 
presenting with the hemorrhagic phenotype of non-lobar ICH. 
Part II |  Acute ischemia in cerebral small vessel disease
Traditionally, acute ischemia due to the occlusion of very small vessels was 
thought to be the most important cause of lacunar infarcts.6,7 Recent studies 
suggested that acute ischemia, as demonstrated by small acute diffu-
sion-weighted imaging-positive (DWI+) lesions, might also be the cause of 
other MRI markers of SVD. For example, small longitudinal studies demonstrated 
the evolution of multiple small DWI+ lesions into a WMH or a microbleed.8,9 
However, it is unknown to what extent incident WMH, lacunes, and microbleeds 
are preceded by DWI+ lesions.
In chapter 4 we investigated the prevalence of DWI+ lesions in 503 elderly 
individuals with sporadic SVD included in the RUN DMC study, on three MRI 
time points during a 9-year period. Furthermore, we established the evolution 
of these DWI+ lesions and examined their relation with progression of MRI 
markers of SVD within this time period. We found 50 DWI+ lesions in 39 
individuals on 1 152 DWI scans (prevalence = 3.4%) within the complete 9-year 
follow-up period. However, follow-up MRI scans to determine DWI+ lesion 
evolution were only available for 23/50 DWI+ lesions. Of these 23 DWI+ lesions, 
14 evolved into a WMH, 8 demonstrated cavitation, and 1 was no longer visible 
on follow-up MRI. Interestingly, one DWI+ lesions that evolved into a cavity 
occurred adjacent to a small hemorrhage, suggesting a mixed pathology 
including both ischemic and hemorrhagic mechanisms. The presence of 
DWI+ lesions was significantly associated with annual progression of WMH 
volume, and annual incidence of lacunes and microbleeds. To conclude, our 
study demonstrated a role for DWI+ lesions in the progression of SVD markers 




from DWI+ lesion onset, serial imaging studies with highly frequent MRI are 
needed, that are able to capture all DWI+ lesions and can demonstrate to what 
extent DWI+ lesions account for SVD progression. 
In chapter 5 we determined the contribution of DWI+ lesions to the progression 
of MRI markers of SVD in the RUN DMC – InTENse study. This study included 
54 non-demented individuals with SVD and no other presumed causes of 
cerebral ischemia. We identified 39 DWI+ lesions on 21/472 DWI scans in 9/54 
participants (median monthly incidence 4.4%), of which 5 were located in the 
cerebral white matter, 3 in the subcortical grey matter, 2 on the cortical 
grey-matter junction, and 29 in the cerebral cortex. Follow-up imaging was 
available for 36/39 DWI+ lesions. WMH volume progressed at a median rate of 
0.027 mL/month. However, only 2 DWI+ lesions evolved into a WMH, and the 
WMH progression rate was not higher in participants with DWI+ lesions 
compared to those without. In total, we detected 5 incident lacunes during the 
study period, which were preceded by DWI+ lesions in 4/5 cases (80%). 
Furthermore, 3 out of 10 incident microbleeds detected during the study period 
either co-occurred or were preceded by a DWI+ lesion, suggesting hemorrhagic 
transformation of the initial DWI+ lesion. In total, 25 DWI+ lesions disappeared 
or almost vanished on follow-up MRI, even though they were visible on FLAIR 
and/or T1 scans during the acute stage, and two DWI+ lesions were never visible 
on FLAIR and/or T1 scans. Interestingly, the majority of the DWI+ lesions that 
disappeared were located in the cerebral cortex. In conclusion, the contribution 
of DWI+ lesions to WMH progression is minor, whereas DWI+ lesions explain 
most incident lacunes and one-third of incident microbleeds. Our results 
suggest that other mechanisms are likely to be involved in the natural history 
of WMH. 
Although all acute cortical microinfarcts observed in the RUN DMC InTENse 
study caused visible signal alterations on FLAIR and/or T1 at the moment of 
occurrence, none were visible on follow-up FLAIR and/or T1 scans. Recent MRI 
studies, however, suggest that part of the cortical microinfarcts may lead to 
visible signal alteration on T2* while remaining invisible on T1 and T2 follow-up 
MRI. Therefore, in chapter 6 we addressed the evolution of 21 acute cortical 
microinfarcts observed on DWI (n=472) in 7 of the 54 participants from the 
RUN DMC InTENse study on quantitative MRI sensitive to iron accumulation 
(R2* imaging). Follow-up imaging was available for 20/21 acute cortical 
microinfarcts. In total, 4 of the 20 cortical microinfarcts were associated with a 
visible signal change on R2* maps of the last available follow-up MRI, indicative 
of iron accumulation. Furthermore, whereas the changes found on MRI 
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sequences sensitive to T1 and T2 relaxation at the location of acute cortical 
microinfarcts in the acute phase disappeared on follow-up MRI, we 
demonstrated an increase in R2* values on follow-up MRI. Our data suggest 
that some of the acute cortical microinfarcts are characterized by iron 
accumulation after the acute stage, possibly due to microhemorrhages, neuro-
inflammation, or neurodegeneration, awaiting further histopathological 
verification. These results may call for the inclusion of iron-sensitive MRI 
sequences in the formerly established MRI criteria for the rating of cortical 
microinfarcts.90
Part III |  Risk factors and MRI markers of cerebral small 
vessel disease in hemorrhagic stroke
In addition to lacunar infarcts, SVD is also the predominant cause of spontaneous 
intracerebral hemorrhage (ICH), which affects more than 3 million people 
worldwide each year.285,313 Identifying risk factors might further improve our 
understanding of the etiology of SVD related ICH. Because the pathogenesis of 
ICH might vary according to the anatomical location of the ICH, risk factor 
profiles may vary according to location as well. Furthermore, the detection of 
small DWI+ lesions after SVD related ICH has been associated with high risk of 
future cerebrovascular events.25,26 If we are able to identify patients at high risk 
for these future events, this could lead to improved personalized secondary 
prevention. Finally, it remains undetermined whether DWI+ lesions after acute 
ICH are secondary to the acute ICH or the result of the underlying SVD.30 
Therefore, the interpretation of DWI+ lesions after SVD related ICH remains 
limited. 
In chapter 7 we present the results of our systematic review and meta-analysis 
including studies described risk factors according to the location of the 
qualifying ICH. In total, 42 studies were selected after screening 10 013 articles, 
including 26 174 patients with spontaneous ICH, of whom 9,141 (35%) had lobar 
ICH and 17 033 (665%) had non-lobar ICH. Our data indicate that hypertension 
is a risk factor for both lobar and non-lobar ICH, although it has double the 
effect-size for non-lobar ICH. Diabetes mellitus, male sex, alcohol overuse, 
underweight, and being a Black or Hispanic person compared with being a 
White person were risk factors for non-lobar ICH only. Therefore, subsequent 
studies should investigate whether this motivates distinct secondary treatment 
decisions for lobar and non-lobar ICH. We consider the term hypertensive ICH 
for non-lobar ICH out-of-date, since hypertension is a risk factor for both lobar 





In chapter 8 we present the results of a post-hoc subgroup analysis of the 
RESTART randomized controlled clinical trial, including 247/537 participants 
with brain MRI at a median of 57 days after ICH. In total, we detected one or 
more DWI+ lesion in 73/247 (30%) participants. Collectively, 18 participants 
suffered from recurrent ICH and 21 from ischemic stroke during a median 
follow-up period of 2.0 years. The presence of one or more DWI+ lesion on 
brain MRI performed days to months after ICH was related to recurrent ICH, but 
not to ischemic stroke. Furthermore, we found no statistically significant 
hazards of antiplatelet use in individuals with or without DWI+ lesions on 
recurrent ICH or ischemic stroke. To conclude, the presence of one or more 
DWI+ lesion in survivors of acute ICH is associated with recurrent ICH, but not 
with ischemic stroke. These findings provide a new perspective on the 
significance of DWI+ lesions, which may be markers of microvascular occlusive 
events that are associated with recurrent ICH.
In chapter 9 we focused on DWI+ lesions after spontaneous ICH in the FETCH 
study, and whether these lesions are associated with the underlying SVD or are 
related to the acute ICH. In total, we observed 54 DWI+ lesions in 30/138 (22%) 
participants with available DWI images up to 86 days after the ICH. Importantly, 
only 5 of these 54 DWI+ lesions were located in perihematomal regions. 
Furthermore, DWI+ lesions were equally distributed in both hemispheres 
(ipsilateral 54% and contralateral 46%). Participants with one or more DWI+ 
lesion more often had probable CAA when compared to participants without a 
DWI+ lesion, and these DWI+ lesions were more often cortical than subcortical. 
Furthermore, we demonstrated that patients with one or more DWI+ lesion had 
larger ICH volumes relative to those without. In conclusion, DWI+ lesions after 
SVD related ICH demonstrate a broad distribution, which is unrelated to the 
anatomical location of the qualifying ICH nor to the time between brain MRI 
and ICH onset. Collectively, our findings suggest that DWI+ lesions after 
spontaneous ICH are a continuous process originating from the underlying 
SVD and are possibly promoted by the acute event of the ICH.
Conclusion 
In this thesis, we show that ischemic and hemorrhagic MRI markers of SVD are 
“two sides of the same coin” by demonstrating they can look heterogeneous on 
MRI, whereas they may partly have a common origin. Future studies should 
further investigate the underlying mechanisms that lead to ischemic and 









The overall aim of this thesis was to investigate the etiology of ischemic and 
hemorrhagic MRI markers of cerebral small vessel disease. First, we characterized 
the evolution of DWI+ lesions (including both acute subcortical as well as cortical 
microinfarcts) on follow-up MRI, and their contribution to the progression of 
imaging markers of SVD. Next, we investigated risk factors for ICH and the 
causes and consequences of DWI+ lesions in patients with spontaneous ICH. 
In this chapter, I provide a general discussion of our findings regarding 
the etiology of ischemic and hemorrhagic imaging markers of SVD, I share 
methodological considerations of the studies performed, and I discuss clinical 
implications and directions for future research.
On the ischemic and hemorrhagic magnetic resonance 
imaging markers of cerebral small vessel disease
Role of acute ischemia in cerebral small vessel disease 
We aimed to investigate the role of acute ischemia in the development of MRI 
markers of SVD, including WMH, lacunes and microbleeds, by determining 
the evolution of DWI+ lesions on follow-up MRI in the RUN DMC study and in 
the RUN DMC InTENse study. 
Evolution of DWI+ lesions. In both studies, we found evidence for a contribution 
of DWI+ lesions to imaging markers of SVD, as shown by their evolution into 
WMH, lacunes, and microbleeds (Chapter 4-5). However, as the proportion of 
WMH volume progression attributable to DWI+ lesions was limited in the RUN 
DMC InTENse study, our data suggest that WMH progression is mostly driven 
by other factors than acute ischemia. Recently, a few alternative mechanisms 
have been suggested.314 One alternative mechanism includes abnormal blood- 
brain barrier permeability,  leading to the extravasation of fluid and plasma 
proteins into the surrounding perivascular tissue, causing inflammation.314,315 
This is supported by studies among patients with mild ischemic lacunar or 
cortical stroke that had impaired blood-brain barrier permeability in WMH 
and in surrounding brain tissue prone to develop into WMH (i.e. normal- 
appearing white matter).316 Other mechanisms underlying WMH could include 
inflammation.314,315 Furthermore, WMH may also reflect demyelination 
since damage to the vascular endothelium has been suggested to affect 
myelin formation and repair.314 Finally, impaired clearance of waste materials, 
such as Aβ, could play a role, which are toxic to vascular endothelial cells 
and pericytes.314,317 These mechanisms are strongly intertwined and should 
therefore not be investigated independent from each other. 
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In the RUN DMC InTENse study 4 of the 5 incident lacunes or small incident 
cavities that we found, were at the location of a DWI+ lesion detected in the 
previous month (Chapter 5). In general, DWI+ lesions are detectable for at least 
4 weeks. However, the DWI signal evolution is highly variable between 
individuals, and is in general highest within the first 14 days.10,198 As the median 
MRI interval was 31 days (IQR = 30-32) we cannot rule out that we have missed 
(smaller) DWI+ lesions, of which one might have preceded the single incident 
cavity that we could not explain by a previous DWI+ lesion. Apart from incident 
cavities, DWI+ lesions explained three out of the ten incident microbleeds in 
our study, which suggests hemorrhagic transformation of the initial DWI+ 
lesions. This is corroborated by evidence from previous studies.9,58,235,318 One 
study found a DWI+ lesion in a patient with probable CAA that evolved into a 
microbleed on follow-up MRI.9 Another study in severe CAA cases, 
demonstrated that 9 of the 15 cortical microbleeds on ex vivo MRI corresponded 
histologically to iron-containing siderophages (suggestive of old hemorrhages) 
in combination with chronic ischemic tissue injury.58 These hemorrhagic 
infarcts have also been found in other studies,235,318 and are indicative of 
primary ischemic tissue injury with hemorrhagic transformation of which the 
remaining siderophages would appear as microbleeds on MRI. 
Interestingly, most cortical DWI+ lesions which met the size criteria for acute 
cortical microinfarcts (<5mm) could no longer be detected on follow-up MRI in 
the RUN DMC InTENse study.90 However, lesion disappearance may not imply 
full recovery, as we detected changes using quantitative MRI beyond the T1 and 
FLAIR detection limit at the location of some cortical microinfarcts, including 
the accumulation of iron (Chapter 6). Although iron accumulation could be 
suggestive of neuroinflammation,236,239 or early neurodegeneration,236,238 
none of the acute cortical microinfarcts evolved into a chronic MRI-detectable 
microinfarct. A recent study demonstrated that on average only one third of 
the voxels initially showing diffusion restriction on baseline MRI undergo 
some degree of cavitation.240 As cortical microinfarcts are by definition very 
small in size, cavitation might only be detectable with very high-resolution 
follow-up MRI (≥7T MRI). Furthermore, several previous studies with follow-up 
MRI up to three years imply that cavitation mostly occurs within the first three 
to six months after DWI+ lesion appearance.13,240,319 The last available follow-up 
MRI of the individuals from the RUN DMC InTENse study with acute cortical 
microinfarcts, was performed a median of 5 weeks (IQR 5-15) after microinfarct 
appearance. Hence, cavitation of cortical microinfarcts after the acute stage 





Factors determining lesion evolution. Even though the precise factors that 
determine the evolution of DWI+ lesions remain to be determined, recent data 
suggest the degree of initial tissue damage as an important 
determinant.13,180,240,322,323 For instance, more severely damaged tissue, 
including amongst others higher levels of markers of neuroaxonal damage 
(serum neurofilament light chain), lower within-lesion apparent diffusion 
coefficient values, and larger DWI+ lesion size, is more likely to undergo 
cavitation, rather than remaining as non-cavitated WMH or to disappear from 
follow-up MRI.13,240 In addition, the tissue surrounding white matter of which 
the integrity is already compromised may be increasingly vulnerable to the 
development of cavities on follow-up MRI.322 For example, DWI+ lesions on the 
edge of pre-existing WMH were more prone to cavitation in previous 
studies,180,322,323 possibly because WMH penumbra is more likely to cavitate 
due to secondary ischemia. In another study, one DWI+ lesion was visible as a 
WMH after 3 months, and demonstrated cavitation on follow-up MRI after 15 
months.13 These observations suggest that different fates of DWI+ lesions may 
reflect shared pathophysiological mechanisms, which are captured on MRI in 
different stages in the evolution of the disease. 
Different stages in the evolution of SVD might be understood in light of the 
degree of vascular endothelial cell dysfunction. At first, an impaired blood-brain 
barrier may result in thickened and stiffened blood vessels due to the build-up 
of extravasated plasma proteins in the vessel walls.314,315 Consequently, these 
vessels show reduced vasoreactivity impairing blood flow and increasing the 
risk of ischemia.317,324 Eventually, increased permeability of the blood-brain 
barrier may compromise clearance of waste materials, such as Aβ.314,317 This 
again may adversely affect the blood-brain barrier, as Aβ is toxic to vascular 
endothelial cells and pericytes, which are the main components of the 
blood-brain barrier.314,317 In case of extensive blood-brain barrier damage, 
including death of brain endothelial cells and/or degradation of tight junctions, 
hemorrhage can occur.325 This hypothesis is substantiated by data from clinical 
studies suggesting that increased blood-brain barrier permeability predicts 
focal hemorrhagic transformation after thrombolysis.326,327 Noteworthy, is a 
case study in which an area of blood-brain barrier leakage transformed into a 
microbleed on follow-up MRI after 10 months.75 A recent combined ex vivo 
MRI – histopathology study also suggests that microbleeds presumably occur 
at a later timepoint in the disease process than microinfarcts, since increased 
Aβ and local stiffening of the vessel wall was observed at the location of 
microinfarcts, whereas microbleeds were associated with remodeling of the 
vessel wall and associated loss of Aβ.328 This suggests that the accumulation of 
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Aβ in the vessel wall alone is not sufficient to cause vessel wall rupture, but that 
in addition, the vessel wall must experience remodeling. 
Risk factors and MRI markers in intracerebral hemorrhage
Vascular risk factors. In our systematic review and meta-analysis, we found 
that hypertension is associated with an increased risk of lobar and non-lobar 
ICH, however, more pronounced for non-lobar than for lobar ICH (Chapter 7). 
This suggests that similar pathophysiological mechanisms may play a role in 
lobar and in non-lobar ICH. Classically, the deep perforating arteries of the 
brain have been believed to be predominantly affected by hypertension, 
inducing pathological changes which can result in vessel rupture, such as 
lipohyalinosis, microatheromas, fibrinoid necrosis and microaneurysms. 
However, recently similar pathological changes have been observed in the 
superficial perforating arteries in cases with and without CAA.265,266,329,330 
Another study found evidence of moderate to severe arteriosclerosis in around 
40% of the participants with lobar ICH and pathologically-proven CAA.183 
Collectively, these results suggest that arteriosclerotic SVD and CAA might 
often co-exist in ICH patients.331-333 
Interestingly, non-lobar ICH shared more risk factors with ischemic stroke than 
with lobar ICH in our systematic review and meta-analysis. A different study 
demonstrated that non-lobar ICH was associated with more of the future 
ischemic than hemorrhagic events, whereas patients with lobar ICH more 
often had recurrent hemorrhagic than ischemic stroke.22 Recently, a 
randomized clinical trial including individuals with antithrombotic-associated 
ICH demonstrated a reduction in recurrent ICH after restarting antiplatelet 
therapy, compared to when avoiding antiplatelet therapy.24 This effect appeared 
more prominent, although the interaction term was not statistically significant, 
in individuals with non-lobar ICH (HR 0.31, 95% 0.10-0.96) versus individuals 
with lobar ICH (HR 0.75, 95% 0.30-1.87). Based on these results I hypothesize 
that ischemia could be the cause of ICH in some, specifically in patients with 
non-lobar ICH. This hypothesis is also supported by the observation that 
microinfarcts may precede microbleeds on in vivo MRI.9 
DWI+ lesions in patients with ICH. Whether DWI+ lesions after ICH are caused 
by similar pathophysiological mechanisms as non-ICH related DWI+ lesions 
remains unclear. Based on the current evidence, we cannot be certain whether 
DWI+ lesions are caused by the acute event of the ICH or are an expression of 
the underlying vasculopathy. There was a substantial interval between the time 




(median 57 days, IQR 19-103), hence, DWI+ lesions were unlikely to be caused 
by the acute event of the ICH (Chapter 8). In chapter 9, we demonstrated a 
statistically significant association between DWI+ lesions and ICH volume in 
ICH survivors after a median of 9 days (IQR 6 – 35). This suggests that DWI+ 
lesions are related to ICH characteristics in the subacute stage. Aside from 
establishing the timelines of ICH-related DWI+ lesions immediately after the 
event, additional clues on potential pathophysiological mechanisms underlying 
DWI+ lesions after ICH may be obtained by investigating the spatial relationship 
with the hemorrhage. The fact that DWI+ lesions were equally ipsilateral and 
contralateral in both the RESTART and FETCH datasets, suggests that the 
underlying SVD is likely to play a role in the origin of these ischemic lesions. 
Furthermore, DWI+ lesions in patients with ICH might be promoted by 
ICH-related mechanisms (e.g. inflammatory response) in the subacute stage.
Methodological considerations
Precision
Precision refers to the degree of random error in a study, which can lead to 
imprecise effect estimates reflected by wide confidence intervals. The precision 
of a study can be increased by using larger sample sizes, and by using validated 
scales to assess outcomes and determinants. 
To increase precision, we made use of larger sample sizes resulting in more 
precise estimates in most studies in this thesis. However, in the RUN DMC – 
InTENse study we were not able to include a larger number of participants, 
since increasing the sample size would have made the study unfeasible. In 
some analyses, we included subgroups with a relatively small number of 
individuals (for example in Chapter 8 we analyzed the effect of antiplatelet 
therapy separately in subgroups of patients included in RESTART with and 
without DWI+ lesions). This resulted in more random error in the estimations as 
reflected by the wider confidence intervals, assuming there was no systematic 
error (bias or confounding).  
To further improve precision, we used standardized scales to assess MRI 
markers of SVD,4 and state-of-the-art automated segmentation methods to 
quantify WMH. Although manual ratings demonstrated high interrater 
agreement, the inter-rater agreement of some MRI features, such as lacunes 
and cortical microinfarcts, is known to be low.211 Furthermore, the quantification 
of WMH is labor-intensive and susceptible to bias due to the need for manual 
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corrections.71 The precision of SVD measurements has been suggested to be 
further improved by the use of automated segmentation. However, whether 
automatic segmentation is superior to manual segmentation is still under 
debate. Even though a large number of automatic and semi-automatic 
segmentation methods have been developed, none of these is currently used in 
clinical practice and only a minority are freely available.334 This is partly 
because of the high risk of misclassification and the imprecision of 
measurements, which might cause instable measurements over time (Figure 
11.1). Another example of misclassification is that most automatic WMH 
segmentation algorithms are unable to differentiate between WMH and stroke 
lesions. However, other fully automated imaging markers might be less subject 
to imprecision. For example, DTI metrics are suggested to outperform 
conventional MRI markers in assessing disease burden in SVD.83,335,336 
However, extensive data postprocessing is still necessary to obtain these DTI 
metrices, hampering a wider application. The peak width of skeletonized mean 
diffusivity (PSMD) includes a computerized and robust imaging marker based 
on high-resolution diffusion tensor imaging,84 for which a toolbox is freely 
available online (www.psmd-marker.com). PSMD has been previously 
associated with microstructural damage as a result of SVD, and is superior to 
other MRI markers of SVD in terms of interscanner reproducibility, and in 
explaining cognitive symptoms.84,151
Internal validity
Internal validity refers to the degree to which the observed changes can be 
ascribed to the exposure instead of alternative factors. The internal validity of a 
study is high when the exposure caused a difference in outcome. However, 
when a difference in outcome was caused by bias (selection bias, information 
bias) or systematic error (confounding), a study may have a low interval validity. 
Selection bias. In randomized controlled clinical trials, randomization results 
in an equal distribution of patient characteristics in both groups. However, in 
some observational studies the study population might not be a random 
selection of the population of interest, causing selection bias. For example, 
individuals who were included in the study may be different in terms of epide-
miological factors or disease severity from those who were not included. These 
factors are likely to influence study participation and might also be associated 





In both the RUN DMC study and the RUN DMC InTENse study selection bias 
might have been present, since non-responders were slightly older than 
included individuals. This has likely resulted in a slight underestimation of the 
contribution of DWI+ lesions to total SVD progression, since the prevalence of 
DWI+ lesions is related to age. Due to the intensive study protocol including 
monthly MRI scans, the participation rate in the RUN DMC InTENse study was 
lower than in the RUN DMC study (71% versus 51%) and consisted of relatively 
healthy individuals. Additionally, attrition bias due to selective dropout might 
have further underestimated the proportion of DWI+ lesions explaining SVD 
progression, since individuals without follow-up were often older and with 
more severe SVD on baseline imaging. 
As in general not every patient with an acute ICH is investigated by MRI, 
selection bias may have also played a role in RESTART and in the FECTH study. 
Individuals with more severe ICH are at higher risk of death and are therefore 
often not included in MRI-based studies. This might have underestimated the 
true prevalence of DWI+ lesions, since the presence of DWI+ lesions on MRI is 
associated with ICH volume.30 Furthermore, since around 30% of the individuals 
in RESTART were unable to participate due to poor health, this may have 
resulted in a reduced risk of recurrent ICH compared to the risk described in 
cohort studies. 
Information bias. Information bias refers to the bias originating from faulty or 
imprecise measurements.337,338 Classically, measurement errors are due to 
imprecision of instrument, measurement procedure, or the investigator.338
Even though we went to great lengths to produce high quality MRI data in all 
studies described in this thesis, information bias could not entirely be 
eliminated. First, one of the key challenges is to minimize the scan-rescan 
variability caused by technological MRI-related or physiological subject-related 
factors, specifically in longitudinal observational studies,151 which can limit the 
detection of SVD imaging markers. In the RUN DMC – InTENse study, we had 
the unique opportunity to assess the reliability of imaging measures using 
multiple timepoints (Chapter 5). Despite using a state-of-the-art automated 
segmentation method, we demonstrated a significant change over time in 
WMH volumes using linear mixed models.339 Example individual time-courses 
for WMH volumes are demonstrated in Figure 11.1.
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Another concern is the low reproducibility of MRI markers of SVD across MRI 
scanners, which causes differences in the detection of SVD markers because of 
variation in image quality.151 The reproducibility of markers is rarely assessed 
systematically but plays an important role in the evaluation of multi-center 
trials with different MRI machines. In the RUN DMC and the RUN DMC InTENse 
study all MRI scans were collected on the same MRI scanner, however, this was 
not the case in the multi-center studies described in this thesis. In the FETCH 
study we used three different MRI machines. To reduce the presence of 
systematic errors in MRI measures we used a similar MRI protocol across 
centers. Furthermore, individuals from RESTART were included from 122 
different medical centers in the UK. Although essential MRI sequences were 
required for study inclusion, such as iron-sensitive MRI sequences, magnetic 
field strength or specific sequence parameters were not specified.
Figure 11.1 | Longitudinal changes of WMH volumes 
The graph shows single subject time-courses of WMH volumes measured in participants 
of the RUN DMC – InTENse study. Four participants are highlight by black lines. Adapted 
from “Multi-Shell Diffusion MRI Models for White Matter Characterization in Cerebral 






















Imprecision in the assessment of MRI markers of SVD could have led to the 
underestimation of effects. In the RUN DMC, RUNDMC – InTENse and FETCH 
datasets, imaging markers of SVD were assessed by an expert rater according to 
widely established criteria.4 Final decisions were made in consensus, including 
an experienced neuroradiologist or stroke neurologist. However, assessors 
were not always blinded to all clinical characteristics. Furthermore, DWI+ 
lesions might have gone unnoticed due to limited resolution of the DWI scans, 
or due to the long in-between MRI intervals because the DWI signal is increased 
for 4 weeks at the most.10 This could have resulted in an underestimation of 
the true prevalence of DWI+ lesions. Furthermore, since patients from the 
FETCH study were scanned in the subacute stage of ICH, image quality was 
compromised in some due to motion artefacts, as it was difficult for these 
patients to be idle during scanning. This might have caused an underestima-
tion of the MRI markers of SVD markers, as the quality of MRI scans largely 
influences the reliability of image assessment.151 In RESTART, imaging markers of 
SVD were assessed by a neuroradiologist, and special care was taken to perform 
rating blinded to clinical outcome and treatment allocation. Furthermore, 
variability in MRI-related factors such as field strength, head coil, gradients, and 
sequence parameters between centers might have added noise to measurements 
of quantitative MRI markers of SVD.151 However, since MRI markers of SVD 
in RESTART were assessed using visual rating scales, the added noise due to 
multicenter variability probably did not affect the association between MRI 
markers of SVD and clinical outcomes. Lastly, ICH location may have been 
misclassified in some studies included in our systematic review and meta- 
analysis. For example, if assessors were not completely blinded to the presence 
of risk factors, such as hypertension, this can lead to misclassification of the ICH 
as non-lobar resulting in an overestimation or underestimation of effects. 
Confounding. A confounding variable is a variable that is associated with both 
the exposure and the outcome variables, resulting in a spurious association 
and invalid conclusions. We were not able to rule out confounding in our 
systematic review and meta-analysis, since not all included studies adjusted for 
age or other risk factors, and the number and nature of covariates varied 
between the included studies. In the other studies described in this thesis, we 
adjusted statistical models for common confounders during data analysis. 
However, the omission or misspecification of important confounders might 
have led to residual confounding. Furthermore, during study design, we 
adhered to strict inclusion and exclusion criteria in order to confine our study 
population mostly to individuals with sporadic SVD. Hence, we excluded all 
individuals with presumed causes of cerebral ischemia other than SVD, and 
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those with an underlying cause of the symptomatic intracerebral hemorrhage, 
such as a tumor, cavernoma, or coagulation disorder. 
External validity
External validity reflects whether study results are generalizable to the larger 
target population. The RUN DMC and the RUN DMC – InTENse study are both 
single-center hospital-based cohort studies, including individuals at baseline 
(2006) between 50 and 85 years old with mild to moderate SVD on MRI, referred 
to the Department of Neurology. Therefore, the observed prevalence of DWI+ 
lesions (<5%) is likely representative of other individuals with SVD seen at a 
Neurology department. However, since these are not population-based studies, 
the generalizability to younger individuals with a lower burden of SVD might 
be limited. This is confirmed by a much lower prevalence of DWI+ lesions 
in population- based studies (≤1.5%).193,194 Also, since the RUN DMC InTENse 
study comprised a smaller, more selective, study sample, who were able to 
undergo MRI every month, results might not be representative of the general 
population. 
Despite the fact that the FETCH study was a multi-center hospital-based cohort 
study, our results might not be representative of all individuals with spontaneous 
ICH. For instance, the 49 participants without MRI were older and more often 
had a non-lobar ICH location than the 155 participants who underwent 3T MRI 
(Chapter 9). Because the prevalence of DWI+ lesions is related to age, this has 
likely resulted in an underestimation of the prevalence of DWI+ lesions. 
Furthermore, the higher frequency of a non-lobar ICH location in individuals 
without MRI may suggest an underrepresentation of CAA-related ICH, which 
could have confounded the prevalence of DWI+ lesions. However, since the 
prevalence of DWI+ lesions was very similar to the pooled prevalence of 20% in 
a recent meta-analysis investigating the association between DWI+ lesions and 
various subtypes of spontaneous ICH,27 we believe that our findings are 
generalizable to a broader population of individuals with spontaneous ICH. 
Most characteristics of individuals included in RESTART were similar to those 
included in other hospital-based studies and population-based cohorts 
describing antiplatelet use after ICH.24,340,341 However, mean ICH volumes 
were smaller compared with those reported in most of the previous MRI-based 
studies,192,286,289 or population-based cohorts.306 Therefore the true prevalence 
of DWI+ lesions might have been underestimated, because individuals with 
more severe ICH are more likely to decease before being investigated by MRI. 




biases when comparing patients with and without MRI in our cohort (Chapter 
8). Another factor limiting the generalizability of the individuals in RESTART, is 
the fact that only adults which were already taking antithrombotic agents for 
the prevention of vaso-occlusive disease before ICH were included. Therefore, 
the generalizability to individuals with ICH and no antiplatelet use is limited. 
This is illustrated by the fact that we found DWI+ lesions in 30% or our 
participants. This prevalence is higher than found in a recent systematic review 
and meta-analysis,27 possibly because of the higher burden of SVD or 
prevalence of vascular risk factors in the RESTART population. 
In our systematic review and meta-analysis, individuals from non-European 
countries, such as Africa, South America and South-East Asia, were underrep-
resented. Therefore, our findings might not be applicable to individuals from 
these countries.282 
Clinical implications
Our findings demonstrate that a proportion of DWI+ lesions contribute to MRI 
markers of SVD, and that DWI+ lesion presence is related to recurrent 
hemorrhagic stroke in patients who survive an ICH. Consequently, the presence 
of a DWI+ lesion on MRI may identify those at high future risk and in need of 
individualized treatments.
We found evidence that DWI+ lesions are able to identify individuals at high-risk 
of SVD progression. The presence of DWI+ lesions was associated with a 2-year 
poor clinical outcome in individuals with vascular cognitive impairment, 
demonstrating their value as an imaging target in future clinical trials.216 
However, DWI+ lesions were found in only 16 of these 783 individuals (2.0%). 
Due to their low prevalence, the presence of a DWI+ lesion on MRI would not be 
an appropriate surrogate endpoint for randomized controlled trials aimed at 
slowing down the progression of SVD, since such studies would be very 
expensive due to the need to recruit a very large sample. Moreover, 
high-frequency MRI is needed due to the limited detection window of DWI+ 
lesions, which might be a critical limitation for clinical trials.  
ICH survivors may represent a specific group of high-risk patients, as DWI+ 
lesions after ICH were associated with recurrent ICH (Chapter 8). Furthermore, 
previous studies demonstrated an increased risk of ischemic stroke and 
vascular death in survivors of ICH with a DWI+ lesion on MRI.25,26 Based on 
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these findings, special care should be taken to reduce the risk of future stroke 
in ICH survivors with DWI+ lesions. However, whether this can be achieved 
by treating individuals with DWI+ lesions in a similar way to those with 
symptomatic stroke remains to be investigated and may pose several challenges. 
One major challenge includes the risk of future hemorrhage associated with 
antiplatelet therapy,342 which must be weighed against the risk of vaso-occlusive 
events. The results of the recently completed RESTART randomized clinical 
trial demonstrated fewer recurrent ICHs in patients that restarted antiplatelet 
therapy compared to patients who avoided antiplatelet therapy.24 These results 
suggest that restarting antiplatelet therapy after ICH might benefit some 
individuals. However, we did not find evidence in RESTART that the presence 
of DWI+ lesions on MRI may identify patients who might specifically benefit 
from antithrombotic therapy (Chapter 8). Although the risk of recurrent stroke 
was more reduced in individuals with antithrombotic therapy and DWI+ lesions 
compared to those with antithrombotic therapy and no DWI+ lesions, these 
differences were not statistically significant. However, the number of outcomes 
may have been too small.
 Aggressive lowering of blood pressure in the acute stage of ICH general appears 
to diminish hematoma expansion and improve outcome.343,344 However, 
blood pressure lowering has also been suggested to trigger cerebral ischemia.201, 
202,286,288 In the Ethnic/Racial Variations of Intracerebral Hemorrhage (ERICH) 
study, DWI+ lesions were associated with acute blood pressure reduction,291 
although this effect could not be replicated using data from the Intracerebral 
Hemorrhage Acutely Decreasing Arterial Pressure Trial (ICH-ADAPT).289 
Future studies with a serial imaging design are needed to confirm whether 
acute blood pressure reduction after ICH causes DWI+ lesions and whether DWI+ 
lesion presence modifies the beneficial effect of blood pressure lowering on 
hematoma expansion and long-term outcomes after ICH.  
Future directions
We have demonstrated that DWI+ lesions contribute to the progression of both 
ischemic and hemorrhagic imaging markers of SVD. However, the contribution 
of DWI+ lesions to WMH progression is only minimal, and therefore future 
investigations are needed to determine which other factors drive the progression 
of WMH. Furthermore, our finding that some DWI+ lesions evolve into micro - 
bleeds on follow-up MRI, warrant future studies to investigate the role of 




As MRI changes due to SVD are present in virtually every individual >60 years, 
most studies have included elderly individuals in which most likely pathological 
processes have commenced years before.5 The MRI markers of SVD in the 
elderly are therefore likely to represent the extreme end of the spectrum of small 
vessel changes, hampering understanding of the natural history of these SVD 
markers from their beginning. Therefore, future studies including individuals 
at young and middle age are necessary. A recent cross-sectional study including 
individuals ≤40 without clinical evidence of cerebrovascular disease demonstrated 
that a healthier cardiovascular risk factor profile was associated with a lower 
WMH lesion count on brain MRI.345 Another study demonstrated that high 
blood pressure from early adulthood into midlife was associated with higher 
WMH volumes measured around the age of 70, whereas no evidence was found 
that blood pressure at a later age affected WMH volumes.346 Collectively, these 
studies demonstrate that valuable information on the natural history of SVD 
can indeed be obtained by studying individuals long before they are typically 
included. 
In this thesis, we have demonstrated the advantages of a serial imaging design 
for insight into the natural history of SVD. Such studies can provide a deeper 
understanding of the exact sequence of events leading to the formation of 
ischemic and hemorrhagic MRI signs of SVD, in contrast to longitudinal studies 
with large interscan intervals. However, as DWI+ lesions are not likely to be the 
primary cause of SVD lesions, new serial imaging studies should investigate 
other factors as possible mechanisms of small vessel dysfunction, such as 
blood-brain barrier impairment. So far, large prospective serial imaging studies 
including MRI sequences evaluating blood-brain barrier permeability in SVD 
are lacking. However, the Mild Stroke Study 3 (MSS-3) is an example of such a 
study, which aims to include up to 150 individuals with a clinical lacunar 
syndrome and 150 control participants with non-lacunar ischemic stroke 
syndromes.347 The aim of the MSS-3 study is to investigate the role of small 
vessel dysfunctions, including blood-brain barrier leakage, cerebrovascular 
reactivity, blood flow, and pulsatility. 
Future studies should also investigate the role of cerebral ischemia in the origin 
of (macro)hemorrhages. DWI+ lesions can be challenging to investigate in 
human brains, because of their unpredictable time of onset. Because this factor 
can be controlled in animal studies, such studies are valuable for our 
understanding of the role of DWI+ lesions in hemorrhage formation. Using a 
variety of technologies and models of cerebrovascular disease, cortical 
microinfarcts resembling those seen in the brains of humans can be induced 
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or can develop spontaneously.348 Longitudinal neuroimaging studies using 
animal models can investigate the structural and functional changes at 
the single-vessel level preceding hemorrhagic transformation of cerebral 
microinfarcts. A recent study demonstrates the feasibility of such an approach.349 
Here in vivo two-photon microscopy used in transgenic mice with mild- 
to-moderate CAA, allowed the longitudinal assessment of the role of vascular 
dysfunction in the formation of microbleeds at the single-vessel level. 
Furthermore, it would be interesting to investigate the role of blood-brain 
barrier damage in hemorrhagic transformation of ischemic stroke. Studies 
using animals that spontaneously develop microinfarcts are needed to 
investigate changes to the neurovascular unit that could result in narrowing or 
weakening of the small vessels of the brain. 
Conclusion
In this thesis, we demonstrate that ischemic and hemorrhagic MRI markers 
of SVD are “two sides of the same coin”, by showing that while they are 
heterogeneous on neuroimaging, they may partially have a common 
pathogenesis. Future studies should be directed towards understanding the 
pathophysiological mechanism that drive the formation of ischemic and 
hemorrhagic lesions in SVD, by means of longitudinal serial imaging studies 












Deel 1 | Introductie
Cerebrale small vessel disease (SVD) is een verzamelnaam voor de schade aan 
de kleinste bloedvaten in de hersenen en wordt gezien als de belangrijkste 
vasculaire oorzaak van dementie en de oorzaak van ongeveer een vijfde 
van alle beroertes wereldwijd.4 In de meeste gevallen wordt SVD veroorzaakt 
door veroudering en risicofactoren voor hart- en vaatziekten.3,155 De schade 
aan de hersenbloedvaten kan leiden tot schade aan het hersenweefsel (laesies) 
als gevolg van een stoornis in de doorbloeding (verstopping, ischemisch) of 
door het barsten van kleine bloedvaten (hemorragisch). In tegenstelling tot de 
kleine bloedvaten zelf, kunnen we de schade aan het hersenweefsel met behulp 
van MRI in beeld brengen (zie Panel 1 Introduction). De typische MRI markers 
van SVD zijn wittestofafwijkingen en lacunes (kleine “holtes” gevuld met vocht) 
welke het gevolg zijn van een doorbloedingsstoornis, en microbloedingen, welke 
het gevolg zijn van een scheur in een bloedvat. Echter is er nog weinig bekend 
over hoe deze MRI markers precies ontstaan. Daarnaast is het onduidelijk waarom 
het ene bloedvat verstopt raakt en een andere scheurt. Het doel van dit proefschrift 
is daarom het ontstaan van deze MRI markers van SVD beter in beeld te brengen. 
In hoofdstuk 2 geven we een overzicht van de verschillende MRI markers van 
SVD, en de redenen dat er veel klinische variatie optreedt tussen personen met 
dezelfde hoeveelheid SVD-gerelateerde schade zichtbaar op de MRI. Wittestof- 
afwijkingen kunnen er bijvoorbeeld vergelijkbaar uitzien op een MRI scan, 
terwijl er diverse oorzaken ten grondslag kunnen liggen aan deze laesies. 
Als gevolg hiervan kan het effect op de nabijgelegen hersenstructuren ook 
verschillen. Daarnaast concluderen we op basis van de literatuur dat SVD 
markers zichtbaar op conventionele MRI scans slechts het topje van de ijsberg 
laten zien van de daadwerkelijke SVD-gerelateerde schade. Een voorbeeld 
hiervan is dat effecten van MRI markers van SVD op de hersenen verder gaan 
dan de op conventionele MRI zichtbare grenzen van de laesies. Met nieuwe 
MRI technieken zijn effecten van de MRI markers van SVD op het hersenweefsel 
ook op afstand van de laesie gemeten. Laesies verstoren namelijk ook de 
structurele en functionele netwerken van de hersenen, waardoor zelfs een 
kleine laesie een groot effect kan uitoefenen op de rest van het brein. Op basis 
van deze observaties concluderen wij dat SVD niet langer gezien moet worden 
als een voornamelijk focale, subcorticale ziekte. Samenvattend, verklaren deze 
bevindingen waarom er heterogeniteit bestaat in klinische symptomen tussen 
individuen met een zichtbaar gelijke hoeveelheid SVD-gerelateerde schade 
op conventionele MRI. 
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In hoofdstuk 3 onderzoeken we of de hoeveelheid wittestofafwijkingen, 
lacunes, en microbloedingen, verschilt tussen deelnemers met een SVD- 
gerelateerd herseninfarct (i.e. een lacunair infarct) of een hersenbloeding. 
Hiervoor selecteerden we deelnemers uit twee prospectieve cohort studies. 
Er werden in totaal 82 deelnemers met een lacunair infarct geselecteerd uit de 
RUN DMC studie. Daarnaast includeerden we 54 patiënten uit de FETCH studie, 
met een hersenbloeding in de niet oppervlakkige structuren van de hersenen 
(“diep”), zoals de basale kernen, thalamus, hersenstam, of de kleine hersenen. 
Het volume en de locatie van de wittestofafwijkingen was niet verschillend 
tussen patiënten met een lacunair infarct en patiënten met een diepe 
hersenbloeding. Daarentegen, kwamen lacunes tweeënhalf keer zo vaak voor 
in patiënten met een lacunair infarct in vergelijking tot patiënten met een 
niet oppervlakkige hersenbloeding. Bovendien vonden we de lacunes op 
vergelijkbare locaties in de hersenen in beiden patiënten groepen wat duidt op 
eenzelfde onderliggend pathofysiologisch mechanisme. Microbloedingen 
kwamen juist drie keer zo vaak voor in patiënten met een niet oppervlakkige 
hersenbloeding en waren vaker gelokaliseerd in niet oppervlakkige hersen-
structuren vergeleken met de microbloedingen in patiënten met een lacunair 
infarct. Op basis van deze gegevens kunnen we SVD in patiënten met een 
lacunair infarct en patiënten met een niet oppervlakkige hersenbloeding niet 
onderscheiden op basis van het volume of de locatie van de wittestofafwijkingen. 
De aanwezigheid van lacunes was echter wel geassocieerd met het ischemische 
fenotype van lacunaire infarcten, terwijl microbloedingen vaker aanwezig 
waren in patiënten met het hemorragische fenotype van een niet oppervlakkige 
hersenbloeding.  
Deel II | Kleine herseninfarcten in cerebrale small vessel disease 
Hoewel SVD in meer of mindere mate aanwezig is bij iedereen die ouder is dan 
zestig jaar, begrijpen we nog erg weinig van de onderliggende pathofysiologie.5 
Op basis van eerder onderzoek weten we dat lacunes het gevolg zijn van 
een herseninfarct oftewel een verstopping van een klein hersenbloedvat.6,7 
Recente MRI studies tonen echter aan dat kleine herseninfarcten mogelijk 
ook een rol kunnen spelen in de oorsprong van de andere MRI markers 
van SVD.8,9 Deze kleine herseninfarcten worden echter vaak niet opgemerkt op 
een MRI scan, aangezien ze slechts tot ongeveer vier weken na hun ontstaan 
zichtbaar zijn op de zogenoemde diffusie-gewogen MRI scan.10 Deze hersen-




Recent MRI onderzoek laat zien dat DWI-positieve laesies na enige tijd zichtbaar 
zijn op een vervolg MRI als een wittestofafwijking, lacune, of micro-
bloeding.4,8,9,12,13 In welke mate kleine DWI-positieve laesies ten grondslag 
liggen aan het ontstaan van de MRI markers van SVD is echter nog onbekend. 
Deze vraag hebben wij om te beginnen onderzocht met gegevens uit de RUN 
DMC studie, een prospectieve cohortstudie waarin 503 ouderen tussen de 
50 en 85 jaar met SVD een MRI scan ondergingen.164 Een deel van deze 
503 deelnemers onderging nog één of twee vervolg MRI scans. Het is echter 
belangrijk om zo frequent mogelijk een MRI scan te maken, omdat de 
DWI-positieve laesies tot slechts ongeveer vier weken na hun ontstaan zichtbaar 
zijn op diffusie-gewogen MRI scans. Zo kan pas echt bepaald worden of deze 
DWI-positieve laesies daadwerkelijk ten grondslag liggen aan de MRI markers 
van SVD. Daarom zijn we gestart met de prospectieve cohort RUN DMC – 
InTENse studie, waarin 54 deelnemers van de RUN DMC studie werden 
geïncludeerd om elke maand gedurende 10 maanden een MRI scan te 
ondergaan. 
In hoofdstuk 4 onderzoeken we hoe vaak DWI-positieve laesies voorkomen in 
deelnemers van de RUN DMC studie. In totaal, vonden we 50 DWI-positieve 
laesies in 39 deelnemers op 1 152 diffusie-gewogen MRI scans (3%) over een 
periode van 9 jaar. Echter was een vervolg MRI scan waarop we de verdere 
ontwikkeling van de DWI-positieve laesies konden bepalen slechts voor 
23/50 DWI-positieve laesies beschikbaar. Van deze 23 DWI-positieve laesies, 
waren er 14 zichtbaar als een wittestofafwijking op de vervolg MRI scan, acht 
DWI-positieve laesies waren zichtbaar als een lacune, en één was niet langer 
zichtbaar op de vervolgscans. Eén DWI-positieve laesie die zich ontwikkelde tot 
een lacune was zichtbaar vlak naast een kleine bloeding, wat suggereert dat 
een combinatie van het barsten van een vaatje en een doorbloedingsstoornis 
de oorzaak was van de lacune. Daarnaast was het waarnemen van een of 
meerdere DWI-positieve laesies op MRI een voorspeller voor de jaarlijkse 
toename in het volume van wittestofafwijkingen, en het aantal lacunes en 
 microbloedingen. Op basis van deze data concludeerden wij dat DWI-positieve 
laesies een belangrijke rol spelen in de toename van MRI markers van SVD. 
Echter is de RUN DMC studie niet goed geschikt om de precieze bijdrage 
van DWI-positieve laesies aan de progressie van SVD te bepalen, aangezien 
DWI-positieve laesies slechts kort zichtbaar zijn en er meerdere jaren zaten 
tussen de verschillende vervolg MRI scans.
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Daarom onderzoeken we in hoofdstuk 5 de bijdrage van DWI-positieve laesies 
aan de progressie van MRI markers van SVD met gegevens van de RUN DMC 
– InTENse studie. We vonden in totaal 39 DWI-positieve laesies in 9 van de 54 
deelnemers op 21/472 diffusie-gewogen MRI scans (gemiddelde maandelijkse 
incidentie 4.4%). Hiervan waren er vijf in de witte stof gelokaliseerd, drie in de 
subcorticale grijze stof, twee op de rand van de grijze en de witte stof, en 29 in 
de hersenschors. Voor 36/39 DWI-positieve laesies was een vervolg MRI 
beschikbaar waarop we het verloop van de laesies konden bepalen. Allereerst 
zagen we een mediane toename in het volume van de wittestofafwijkingen 
van 0.027 mL/maand. Echter ontwikkelden slechts twee DWI-positieve laesies 
zicht tot een wittestofafwijking op de vervolg MRI scans. Ook was de toename 
in het volume van de wittestofafwijkingen niet verschillend tussen deelnemers 
met of zonder DWI-positieve laesies. In totaal, werden vier van de vijf (80%) 
nieuwe lacunes die ontstonden gedurende de studie periode voorafgegaan 
door een DWI-positieve laesie. Bovendien overlapten drie van de 10 (30%) 
nieuwe microbloedingen met DWI-positieve laesies, wat suggereert dat deze 
microbloedingen mogelijk zijn ontstaan als gevolg van een doorbloedings-
stoornis. Opmerkelijk was dat 25 DWI-positieve laesies niet meer zichtbaar 
waren op vervolg MRI scans, ondanks dat ze wel signaal verandering lieten 
zien op de FLAIR en T1 in de acute fase. Daarnaast waren twee DWI-positieve 
laesies nooit zichtbaar op FLAIR en T1 scans. Samenvattend, in dit hoofdstuk 
concludeerden we dat de bijdrage van DWI-positieve laesies aan de progressie 
van wittestofafwijkingen minimaal is. Wel verklaren DWI-positieve laesies 
de meeste nieuwe lacunes en een derde van de nieuwe microbloedingen. 
Onze resultaten suggereren dat andere mechanismen waarschijnlijk ook ten 
grondslag liggen aan de oorsprong van wittestofafwijkingen. 
In hoofdstuk 6 bekijken we acute corticale microinfarcten (DWI-positieve 
laesies < 5 mm in de hersenschors) in de RUN DMC – InTENse studie. Ondanks 
dat alle acute microinfarcten op het moment van voorkomen zichtbaar waren 
op T1-gewogen en/of FLAIR scans, waren ze niet meer detecteerbaar op de 
vervolg MRI scans. Daarom onderzoeken wij in dit hoofdstuk de ontwikkeling 
van de 21 acute corticale microinfarcten geobserveerd op de diffusie-gewogen 
MRI scans (n=472) in 7 van de 54 deelnemers (13%) van de RUN DMC InTENse 
studie. Er zijn studies die suggereren dat hoewel microinfarcten niet meer 
zichtbaar zijn op de T1-gewogen en/of FLAIR scans, een deel van de corticale 
microinfarcten mogelijk in een later stadium zichtbaar gemaakt kunnen 
worden met een speciale MRI scan die sensitief is voor de concentratie van ijzer 
in het brein. Daarom onderzochten we voor de 20 van de 21 acute corticale 




ijzerstapeling op de locatie van de microinfarcten na de acute fase. We zagen 
een verhoogd signaal op de kwantitatieve MRI scan op de locatie van sommige 
acute corticale microinfarcten na de acute fase, wat een aanwijzing is voor een 
verhoogde ijzer concentratie. De veranderingen gevonden op de locatie van de 
corticale microinfarcten op andere kwantitatieve MRI scans, verdwenen op 
vervolg MRI scans. Deze resultaten suggereren dat een deel van de corticale 
microinfarcten gekarakteriseerd wordt door de opstapeling van ijzer. Hoewel de 
oorzaak hiervan nog moet worden bevestigd door histopathologisch onderzoek, 
zouden microbloedingen, neuro-inflammatie of neurodegeneratie mogelijke 
oorzaken kunnen zijn.  
Deel III | Risicofactoren en MRI markers van cerebral small 
vessel disease in mensen met een hersenbloeding
Naast lacunaire infarcten, veroorzaakt SVD ook de meeste hersenbloedingen 
(spontane hersenbloedingen). Per jaar worden meer dan 3 miljoen mensen 
getroffen door een hersenbloeding.285,313 Het identificeren van risicofactoren 
kan ons mogelijk helpen om het ontstaan van SVD-gerelateerde hersenbloe-
dingen beter te begrijpen. Omdat de onderliggende oorzaak van hersenbloe-
dingen kan variëren aan de hand van de locatie van de hersenbloeding, kunnen 
risicofactoren mogelijk ook verschillen aan de hand van de locatie. Ook de 
gevolgen voor toekomstige cerebrovasculaire aandoeningen na het krijgen 
van een hersenbloeding kunnen variëren. De aanwezigheid van een 
DWI-positieve laesie op de MRI scan bij mensen die een SVD-gerelateerde 
hersenbloeding hebben overleefd geeft bijvoorbeeld een hoger risico op het 
krijgen van een hersenbloeding of herseninfarct in de toekomst.25,26 Als we 
patiënten kunnen identificeren die een hoger risico hebben op een toekomstige 
cerebrovasculaire aandoening, zou dit kunnen leiden tot een meer persoonlijke 
aanpak in het voorschrijven van secundaire preventie. Tot slot blijft het 
onduidelijk of DWI-positieve laesies die na een hersenbloeding ontstaan, een 
gevolg zijn van de hersenbloeding zelf of dat ze het resultaat zijn van de 
onderliggende SVD.30 Hierdoor blijft de etiologie van DWI-positieve laesies die 
na een SVD-gerelateerde hersenbloeding ontstaan nog onbekend. 
In hoofdstuk 7 presenteren we de resultaten van een systematisch literatuur-
overzicht en meta-analyse over risicofactoren aan de hand van de locatie van 
de hersenbloeding. Wij hebben in totaal 42 studies geselecteerd waarin 26 174 
patiënten met een hersenbloeding werden geïncludeerd. Hiervan had 65% een 
hersenbloeding in de oppervlakkige structuren van de hersenen (in de buurt 
van de hersenschors van de frontaal, pariëtaal, temporaal of occipitaal kwab). 
De overige 35% had een hersenbloeding in de niet oppervlakkige structuren 
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van de hersenen. Onze data laten zien dat hoewel hypertensie een risicofactor 
is voor hersenbloedingen in de oppervlakkige én niet oppervlakkige structuren, 
het risico dubbel zo groot is voor een hersenbloeding in de niet oppervlakkige 
structuren als het risico op een hersenbloeding in de oppervlakkige structuren. 
Overige risicofactoren, zoals diabetes mellitus, het mannelijke geslacht, 
overmatig alcoholgebruik en ondergewicht gaven alleen een verhoogd risico 
op het krijgen van een hersenbloeding in de niet oppervlakkige structuren. 
Daarnaast observeerden we dat etnische verschillen een rol spelen, gezien 
zwarte mensen en latino’s een hoger risico hadden op een hersenbloeding in 
de niet oppervlakkige structuren dan witte mensen. Aangezien hypertensie 
een risicofactor is voor hersenbloedingen in zowel de niet oppervlakkige als in 
de oppervlakkige structuren, en hypertensie niet de enige oorzaak is voor niet 
oppervlakkige hersenbloedingen, beschouwen we de term hypertensieve 
 hersenbloedingen als achterhaald voor het onderscheid tussen oppervlakkige 
en niet oppervlakkige hersenbloedingen. In de toekomst zullen studies moeten 
uitwijzen of de verschillen in de risicofactoren tot verschillende strategieën in 
secundaire preventie voor oppervlakkige en niet oppervlakkige hersenbloe-
dingen zouden moeten leiden. 
In hoofdstuk 8 hebben we een post-hoc subgroep analyse uitgevoerd met de 
gegevens van RESTART, een gerandomiseerde gecontroleerde klinische studie 
die de gevolgen onderzocht van het stoppen of herstarten van plaatjesaggregatie-
remmers na een hersenbloeding. In deze analyse hebben wij 247 van de 537 
deelnemers geïncludeerd, die een diffusie-gewogen MRI scan zijn ondergaan. 
In totaal vonden we bij 73 (30%) van deze deelnemers een of meerdere 
DWI-positieve laesies op de MRI scan. Over de gehele studieperiode van twee 
jaar hadden 18 deelnemers opnieuw een hersenbloeding en 21 deelnemers een 
herseninfarct. Een DWI-positieve laesie op de MRI scan gemaakt dagen tot 
maanden na het optreden van de hersenbloeding, gaf een vijf keer zo hoog 
risico op het opnieuw optreden van een hersenbloeding, maar het risico op een 
nieuw herseninfarct was niet hoger. Dit risico op het opnieuw optreden van 
een hersenbloeding of herseninfarct was niet anders voor mensen waarbij 
 plaatjesaggregatieremmers wel of niet werden herstart. Hieruit kunnen we 
concluderen dat de aanwezigheid van een DWI-positieve laesie op de MRI scan 
na een hersenbloeding een groter risico geeft op het krijgen van een nieuwe 
hersenbloeding, maar niet op een herseninfarct, en dat dit risico niet wordt 
beïnvloed door het wel of niet herstarten van plaatjesaggregatieremmers. 
Aangezien het aantal deelnemers met nieuwe hersenbloedingen of hersen-
infarcten gedurende de studieperiode klein was, kan het zijn dat we niet genoeg 




adviseren wij dat toekomstige randomiseerde klinische studies de reproduceer-
baarheid van onze bevindingen moeten onderzoeken. Samenvattend, suggereren 
deze bevindingen dat DWI-positieve laesies een marker zijn van microvasculaire 
verstoppingen die geassocieerd zijn met een hoger risico op het herhaaldelijk 
krijgen van een hersenbloeding.  
In hoofdstuk 9 zoomen we in op DWI-positieve laesies ontstaan na een 
SVD-gerelateerde hersenbloeding met gegevens van de FETCH studie. Wij 
onderzochten of deze laesies geassocieerd zijn met de onderliggende SVD of 
dat ze gerelateerd zijn aan de gevolgen van de acute hersenbloeding. Van alle 
138 deelnemers met beschikbare diffusie-gewogen MRI scans gemaakt tot 
maximaal 86 dagen na de hersenbloeding, hadden er 30 deelnemers in totaal 
54 DWI-positieve laesies (22%). Deze 54 DWI-positieve laesies waren gelijk 
verdeeld over de linker- en de rechter hemisfeer. Daarnaast was de prevalentie 
van DWI-positieve laesies gelijk op MRI scans gemaakt in de acute en in de 
non-acute fase van de hersenbloeding. In totaal lagen 5 van de 54 DWI-positieve 
laesies in gebieden nabij de hersenbloeding. Deelnemers met een DWI-positieve 
laesie op de MRI werden vaker gediagnosticeerd met cerebrale amyloid 
angiopathie (CAA). Deze DWI-positieve laesies bij deelnemers met CAA 
waren vaker gelokaliseerd in de hersenschors dan in andere hersengebieden.. 
Klinische karakteristieken en MRI markers van SVD waren gelijk tussen 
deelnemers met een DWI-positieve laesie en deelnemers zonder laesies op 
de MRI scan. Echter hadden deelnemers met een DWI-positieve laesie een drie 
keer zo groot volume van de hersenbloeding in vergelijking met deelnemers 
zonder laesies op de MRI scan. Op basis van deze resultaten kunnen we 
concluderen dat de locatie van DWI-positieve laesies na een SVD-gerelateerde 
hersenbloeding niet bepaald wordt door de locatie van de hersenbloeding. 
Bovendien was het ontstaan van DWI-positieve laesies niet gerelateerd aan de 
tijd tussen de MRI scan en het begin van de symptomen. Op basis van deze 
bevindingen suggereren we dat DWI-positieve laesies na een SVD-gerelateerde 
hersenbloeding een continu proces zijn als gevolg van de onderliggende SVD, 




In dit proefschrift hebben wij aangetoond dat hoewel MRI markers van SVD 
veroorzaakt door een verstopping of door het scheuren van een klein bloedvaatje 
er verschillend uit kunnen zien op de MRI scan, ze in sommige gevallen ten 
dele een gemeenschappelijke oorzaak hebben. Toekomstig onderzoek moet 
uitwijzen wat de precieze pathofysiologische mechanismen zijn die leiden tot 
het ontstaan van de verschillende typen MRI markers van SVD. Hiervoor 
zouden bijvoorbeeld longitudinale MRI studies in mensen of dieren die gebruik 





List of main abbreviations
References
Research data management 
About the author
List of publications 
Portfolio
Acknowledgements
Dissertations of the Vascular disorders 
of movement research group





List of main abbreviations
List of main abbreviations 
95% CI = 95% confidence interval
Aβ = amyloid β
A-CMI = acute cortical microinfarct
AD = Alzheimer disease
ADC = apparent diffusion coefficient
BMI = body mass index
CAA = cerebral amyloid angiopathy
CADASIL = cerebral autosomal dominant arteriopathy with subcortical infarcts and leu-
koencephalopathy
CBF = cerebral blood flow 
CMB = cerebral microbleeds
C-CMI = chronic cortical microinfarct
CI = confidence interval
CMI = cortical microinfarct
CSF = cerebrospinal fluid
CT = computed tomography 
DTI = diffusion tensor imaging
DWI = diffusion-weighted imaging
DWI+ = diffusion-weighted imaging-positive
e.g. = exempli gratia, “for example”
FETCH = Finding the ETiology in spontaneous Cerebral Hemorrhage 
FLAIR = fluid-attenuated inversion recovery
FLASH = fast low angle shot
FSL = FMRIB Software Library
GRE = axial gradient-recalled echo
HR = hazard ratio 
ICD = International Classification of Diseases
ICH = intracerebral hemorrhage
ICV = intracranial volume
i.e. = id est, “in other words”
IQR = interquartile range
MARS = Microbleed Anatomical Rating Scale
MD = mean diffusivity 
mL = milliliter
mm = millimeter
MMSE = Mini-Mental State Examination
MNI = Montreal Neurological Institute 
MP2RAGE = Magnetization Prepared 2 Rapid Acquisition Gradient Echoes
MRI = magnetic resonance imaging
mRS = modified Rankin Scale 
NOS = Newcastle-Ottawa Scale
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Radboudumc = Radboud university medical center
RESTART = REstart or STop Antithrombotics Randomized Trial
RR = risk ratio
RUN DMC = Radboud University Nijmegen Diffusion tensor and Magnetic resonance 
imaging Cohort 
RUN DMC – InTENse = RUN DMC – Investigating The origin and EvolutioN of cerebral 
small vessel disease 
SPM = Statistical Parametric Mapping
STRIVE = STandard for Reporting Vascular changes on nEuroimaging
SVD = small vessel disease
SWI = susceptibility-weighted imaging
TBV = total brain volume 
TIA = transient ischemic attack 
WMH = white matter hyperintensities 
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Research data management
Research data management 
All research data that are presented in this thesis were archived according to the 
FAIR (Findable, Accessible, Interoperable and Reusable) principles. 
Data presented in chapters 3-6 is based on the results of human studies 
completed at the Radboudumc in Nijmegen, including the RUN DMC and the 
RUN DMC – InTENse study. These studies were approved by the local medical 
ethics committee on Research Involving Human Subjects Region Arnhem-Ni-
jmegen, Nijmegen, the Netherlands. We guaranteed the privacy of the 
participants by the use of individual subject codes. This code was stored 
separately from the study data. 
Data from the RUN DMC study was obtained between 2006 and 2015. All clinical 
data and MRI scans are archived on a Radboudumc server. Scripts, including a 
description and output files are stored on Radboudumc department server 
(\\umcms011\neuro_onderzoek$\RUNDMC_SI\DWI_RUNDMC). Diffusion images 
and coregistered MRI scans generated for the purpose of this study are stored 
on the Radboudumc department server (X:\RUNDMC\MRI-data). 
Data from the RUN DMC – InTENse study was obtained between March 2016 
and November 2017. All clinical data was stored online in a Castor EDC database. 
This was stored on the Radboudumc department server (\\umcms011\neuro_
onderzoek$\RUNDMC_SI) in the form of an Excel output file. DICOM files and 
processed MRI scans are stored on the Radboudumc department server (X:\
RUNDMC_SI\MRI). Excel data files used for statistical data analysis are stored 
on the Radboudumc department server (R:\RUNDMC_SI\DWI_InTENse\
Datasets), as well as R scripts used for statistical data analyses (R:\RUNDMC_SI). 
Case reports are currently stored in boxes at an external archiving facility: UTS 
Verkroost b.v., Bijsterhuizen 11-31, 6546 AR Nijmegen. The data will be saved for 
15 years (until November, 2035). 
Data presented in chapters 3 and 9 is based on the results of a multicenter 
human study completed at the University Medical Centers in Utrecht, Leiden 
and Nijmegen. This study was approved by the Medical Ethics Review 
Committee of the University Medical Center Utrecht, and by all participating 
centers. Data from the FETCH study was obtained between October 2013 and 
December 2018. Data was stored in an online Castor EDC database, of which an 
Excel output file was stored on the Radboudumc server (R:\FETCH\Castor). 
Raw DICOM files are stored at an online Multicenter Research DICOM Server 
242
Appendices
(https://mc-rds.umcutrecht.nl/mcrds/app/template/Login.vm#!). Excel data files 
as well as R scripts used for statistical data analysis in this thesis are stored on 
the Radboudumc department server (R:\FETCH).
Data presented in chapter 8 is based on the results of the RESTART randomized 
clinical trial completed at the Royal Infirmary and 122 hospitals in the United 
Kingdom. This study was approved by the Scotland A Research Ethics Committee. 
Participants were recruited between May 22, 2013 and May 31, 2018. Excel data 
files as well as R scripts used for statistical data analysis in this thesis are stored 
on the Radboudumc department server (R:\RUNDMC_SI\Kim\RESTART\).
All data are accessible only by authorized persons and on request available from 
the corresponding author. 
243
About the author
About the author 
Kim Wiegertjes was born on January 28, 1993 
in Wageningen. She attended grammar school 
at the Pantarijn in Wageningen and graduated 
in 2011. She studied Psychology in Nijmegen 
and obtained her bachelor’s degree in 2014 
after finishing her Bachelor internship at the 
research group Pain and Nociception Neuro - 
science (Dr. C. M. van Rijn). In September 2014, 
she started the Research Master Cognitive 
Neuroscience at the Donders Institute for Brain, 
Cognition and Behavior, with the specialization 
‘Learning, memory and plasticity’. Meanwhile, she followed the Radboud Honours 
Program Reflections on Science, in which she explored the field of ‘brain-reading 
research’ as a member of the interdisciplinary think tank Wider Implications of 
Cognitive Neuroscience. She performed her master internship on longitudinal 
brain changes and cognitive consequences in cerebral small vessel disease at 
the department of Neurology at the Radboud university medical center (Prof. Dr. 
FE de Leeuw). After obtaining her master’s degree in Cognitive Neuroscience, 
she started her PhD project in September 2016, which resulted in this thesis. 
She has presented her results on many international conferences. In September 
2019, she initiated an internship at the center for Clinical Brain Sciences in 
Edinburgh, under the supervision of professor Rustam Al-Shahi Salman and 
professor Joanna Wardlaw. In order to complete this internship, she was awarded 






1. Jolink WMT*, Wiegertjes K*, Rinkel GJE, Algra A, de Leeuw FE, Klijn CJM. 
Location-specific risk factors for intracerebral hemorrhage: systematic 
review and meta-analysis. Neurology. 2020 Sept; 95(13): e1807-e1818. 
2. Ter Telgte A*, Wiegertjes K*, Gesierich B, Marques JP, Huebner M, de Klerk 
JJ, Schreuder FBHM, Araque Caballero MA, Kuijf HJ, Norris DG, Klijn CJM, 
Dichgans M, Tuladhar AM, Duering M*, de Leeuw FE*. Contribution of 
acute infarcts to cerebral small vessel disease progression. Ann Neurol. 
2019 Oct;86(4):582-592.
3. Wiegertjes K*, Ter Telgte A*, Oliveira PB, van Leijsen EMC, Bergkamp MI, 
van Uden IWM, Ghafoorian M, van der Holst HM, Norris DG, Platel B, Klijn 
CJM, Tuladhar AM, de Leeuw FE. The role of small diffusion-weighted 
imaging lesions in cerebral small vessel disease. Neurology. 2019 Oct;93(17): 
e1627-21634.
4. Ter Telgte A, van Leijsen EMC, Wiegertjes K, Klijn CJM, Tuladhar AM, de 
Leeuw FE. Cerebral small vessel disease: from a focal to a global perspective. 
Nat Rev Neurol. 2018 Jul;14(7):387-398. 
5. Wiegertjes K, Voigt S, Jolink WMT, Koemans EA, Schreuder FBHM, van 
Walderveen MAA, Wermer MJH, Meijer FJA, Duering M, de Leeuw FE, Klijn 
CJM. Etiology of diffusion-weighted imaging lesions after intracerebral 
hemorrhage. (Submitted).   
6. Wiegertjes K, Chan KS, ter Telgte A, Gesierich B, Norris DG, Klijn CJM, 
Duering M, Tuladhar AM, Marques JP, de Leeuw FE. Assessing cortical 
cerebral microinfarcts on iron-sensitive MRI in cerebral small vessel 
disease. J Cereb Blood Flow Metab. 2021; 000-000.
7. Wiegertjes K, Dinsmore L, Drever J, Hutchison A, Stephen J, Valdés 
Hernandez MC, Bhatnagar P, Minks DP, Rodrigues MA, Werring DJ, de 
Leeuw FE, Klijn CJM, Al-Shahi Salman R, White PM, Wardlaw JM. Diffusion- 
weighted imaging lesions and risk of recurrent stroke after intracerebral 
hemorrhage. Journal of Neurology, Neurosurgery, and Psychiatry 2021; 1-6.
8. Wiegertjes K, Jansen MG, Jolink WMT, Duering M, Koemans EA, Schreuder 
FBHM, Tuladhar AM, Wermer MJH, Klijn CJM*, de Leeuw FE*. Differences 
in cerebral small vessel disease MRI markers between lacunar stroke and 




1. Konieczny MJ, Dewenter A, ter Telgte A, Gesierich B, Wiegertjes K, 
Finsterwalder S, Kopczak A, Hubner M, Malik R, Tuladhar AM, Marques JP, 
Norris DG, Koch A, Dietrich O, Ewers M, Schmidt R, de Leeuw FE, Duering 
M. Multi-shell diffusion MRI models for white matter characterization in 
cerebral small vessel disease. Neurology. 2021 Feb;96(5):e698-e708. 
2. Noz MP, ter Telgte A, Wiegertjes K, Tuladhar AM, Kaffa C, Kersten S, van der 
Heijden CDCC, Hoischen A, Joosten LAB, Netea MG, Duering M, de Leeuw 
FE, Riksen NP. Pro-inflammatory monocyte phenotype during acute 
progression of cerebral small vessel disease. Frontiers in Cardiovascular 
Medicine, section Atherosclerosis and Vascular Medicine. 2021.  
3. Gesierich B, Tuladhar AM, ter Telgte A, Wiegertjes K, Konieczny MJ, 
Finsterwalder S, Huebner M, Pirpamer L, Koini M, Abdulkadir A, Franzmeier 
N, zu Eulenburg P, Ewers M, Schmidt R, de Leeuw FE, Duering M. Alterations 
and test-retest reliability of functional connectivity network measures in 
cerebral small vessel disease. Hum Brain Mapp. 2020 Feb;41:2629–2641.
4. Ter Telgte A, Wiegertjes K, Gesierich B, Sri Baskaran B, Marques JP, Kuijf 
HJ, Norris DG, Tuladhar AM, Duering M, de Leeuw FE. The temporal 
dynamics of cortical microinfarcts in cerebral small vessel disease. JAMA 
Neurol. May 2020;77(5): 643-647.
5. Wilson D, Ambler G, Lee KJ, Lim JS, Shiozawa M, Koga M, Li L, Lovelock C, 
Chabriat H, Hennerici M, Wong YK, Ka-Fung Mak H, Prats-Sánchez L, 
Martínez-Domeño A, Inamura S, Yoshifuji Y, Arsava EM, Horstmann S, 
Purrucker J, Lam BYK, Wong A, Kim YD, Song TJ, Schrooten M, Lemmens 
R, Eppinger S, Gattringer T, Uysal E, Tanriverdi Z, Bornstein NM, Assayag 
EB, Hallevi H, Tanaka J, Hara H, Coutts SB, Hert L, Polymeris A, Seiffge DJ, 
Lyrer P, Algra A, Kappelle J, Al-Shahi Salman R, Jäger HR, Lip GYH, Mattle 
HP, Panos LD, Mas JL, Legrand L, Karayiannis C, Phan T, Gunkel S, Christ 
N, Abrigo J, Leung T, Chu W, Chappell F, Making S, Hayden D, Williams DJ, 
Kooj ME, Kyan DH, van Dam-Nolen DHK, Barbato C, Browning S, Wiegertjes K, 
Tuladhar AM, Maaijwee N, Guevarra C, Yatawara C, Medyk AM, Delmaire C, 
Köhler S, van Oostenbruggge R, Zhou Y, Xu C, Hilal S, Gyanwali B, 
Christopher C, Lou M, Staals J, Bordet R, Kandiah N, de Leeuw FE, Simister 
R, van der Lugt A, Kelly PJ, Wardlaw JM, Soo Y, Fluri F, Srikanth V, Calvet D, 
Jung S, Kwa VIH, Tengelter S, Peters N, Smith EE, Yakushiji Y, Orken DN, 
Fazekas F, Thijs V, Heo JH, Mok V, Veltkamp R, Ay H, Imaizumi T, Gomez- 
Anson B, Lau KK, Jouvent E, Rothwell PM, Toyoda K, Bae HJ, Marti-Fabregas 
J, Werring DJ. Cerebral microbleeds and stroke risk after ischaemic stroke 
or transient ischaemic attack: a pooled analysis of individual patient data 
from cohort studies. Lancet Neurol. 2019 Jul;18: 653–65.
247
List of publications
6. Noz MP, ter Telgte A, Wiegertjes K, Joosten LAB, Netea MG, de Leeuw FE, 
Riksen NP. Trained immunity characteristics are associated with progressive 
cerebral small vessel disease. Stroke. 2018 Dec;49(12):2910-1927.
7. Ter Telgte A, Wiegertjes K, Tuladhar AM, Noz MP, Marques JP, Gesierich B, 
Heubner M, Mutsaerts HM, Elias-Smale SE, Beelen MJ, Ropele S, Kessels RP, 
Riksen NP, Klijn CJM, Norris DG, Duering M, de Leeuw FE. Investigating 
the origin and evolution of cerebral small vessel disease: The RUN DMC – 






Oral presentations at international conferences 
Nov 2020 European Stroke Organisation Conference, Online
   Title: Diffusion-weighted imaging-positive (DWI+) lesions 
and risk of recurrent stroke after intracerebral hemorrhage: 
post-hoc analysis of the RESTART trial
Nov 2018  VasCog, Hong Kong
   Title: Diffusion-weighted imaging lesions and the risk of incident 
dementia in individuals with small vessel disease
May 2017 European Organisation Conference, Prague, Czech Republic
   Title: The differential evolution over time of acute small infarcts 
in patients with cerebral small vessel disease
Sep 2016  VasCog, Amsterdam
   Title: Connectivity with remote structures in individuals with 
cerebral small vessel disease and cognitive decline
May 2016 European Stroke Organisation Conference, Barcelona, Italy
   Title: Remote effects of cerebral small vessel disease are associated 
with cognitive decline
Awards
Dec 2019 Erasmus+ staff mobility grant for teaching and training
Courses
• Basiscursus Regelgeving en Organisatie voor Klinisch onderzoekers (BROK), 
Nijmegen
• Scientific integrity for PhD candidates, Nijmegen
• Scientific writing for PhD Candidates, Nijmegen
• Introduction in R, Nijmegen
• Multilevel and event history analysis using R, Nijmegen
• Structural and functional connectomics in neuroimaging, Munich, Germany
• Loopbaanmanagement voor Promovendi, Nijmegen 
• Solliciteren en Netwerken, Nijmegen





Hoewel een proefschrift vaak individueel tot stand komt, heb ik het geluk gehad 
om met veel verschillende en inspirerende mensen te mogen samenwerken 
de afgelopen jaren. Graag wil ik er daar een paar van in het bijzonder uitlichten. 
Niet alleen collega’s hebben een rol gespeeld tijdens mijn promotietraject, maar 
ook op persoonlijk vlak zijn er een aantal mensen die ik wil bedanken voor hun 
onvoorwaardelijk vertrouwen en hun steun. 
Om te beginnen wil ik graag alle deelnemers van de RUN DMC – InTENse  studie 
bedanken. Dankzij jullie zijn we weer een stap verder in het onderzoek naar 
small vessel disease. Jullie tomeloze enthousiasme en streven om bij te dragen 
aan wetenschappelijk onderzoek hebben mij telkens weer verbaasd. Hierdoor 
hebben jullie ervoor gezorgd dat ik – atypisch voor een onderzoeker – de data-
verzameling een van de leukste onderdelen aan mijn promotieonderzoek vond. 
Frank-Erik, al vroeg zag jij in mij wat ik misschien nog niet eens in mijzelf zag. 
Ik ben tot op deze dag nog steeds blij dat ik mocht aansluiten bij het toen nog 
– serial imaging project. Jouw vindingrijkheid en daadkracht hebben dit project 
gemaakt tot wat het is. Ondanks dat sommige mensen ons voor gek verklaarden, 
heb jij nooit enige twijfel gehad over de haalbaarheid of over de waarde van dit 
project. Daarnaast heb je mij geleerd dat van samenwerken je promotie traject 
altijd beter wordt. Jij hebt dan ook geen moeite met het delen van auteurschap, data 
of promovendi. Je vertrouwen werkt aanstekelijk, en ik heb hier nog steeds profijt 
van. Hieruit is dan ook een hele fijne samenwerking met Karin voort gekomen. 
Karin, ik ben nog altijd erg blij dat jij mijn promotieteam bent komen versterken. 
En ik spreek denk ik voor veel vrouwelijke onderzoekers als ik zeg dat je 
een voorbeeld voor ons bent. Je kunt haarscherp aanvoelen  wanneer er 
naast professioneel inzicht ook oog nodig is voor de persoonlijke kant. 
Dit maakt je naast een hele fijne promotor waarschijnlijk ook een heel goed 
 afdelingshoofd. Ondanks dat ik mij keer op keer heb afgevraagd hoe jij al je 
werk gedaan krijgt, wist je toch altijd de tijd te vinden om mee te denken of naar 
mijn stukken te kijken. Dank hiervoor! Ik hoop dat jullie deze samenwerking 
in de toekomst kunnen voortzetten, want: samen is beter dan alleen.
Annemieke, het begin van mijn promotietraject voelde alsof ik in een warm 
bad terecht kwam. Niet alleen had jij al een vliegende start gemaakt met de RUN 
DMC – InTENse studie, je zorgde er ook voor dat ik mij meer dan welkom voelde 
om als onderzoeker aan te sluiten bij dit project. Ik heb een enorme  bewondering 
voor jouw zorgvuldigheid en creativiteit als onderzoeker en weet zeker dat jij het 
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nog heel ver gaat schoppen. Ondanks dat we op sommige vlakken van elkaar 
verschillen konden we alles bespreken. Ik ga dit dan ook zeker missen nu jij 
naar de bergen in Oostenrijk bent verhuisd. Gelukkig bellen we elkaar nog 
steeds voor advies en kunnen we nog steeds net zo goed met elkaar meedenken 
als vroeger! 
Marco, you make every research project that you touch so much better. You 
have made the imaging part of the serial imaging study so much better. I am 
very inspired by how you are “the boss” and one of the PhD students at the 
same time. Your modesty is something many researchers can learn from. 
We were lucky to have you in Nijmegen for one year. 
Dan mijn copromotoren; Anil, als MRI-expert van onze afdeling ben jij 
onmisbaar. Ondanks je volle agenda wist jij altijd tijd vrij te maken voor advies 
en een kop koffie. Ik bewonder je enthousiasme en hoe jij jezelf op de kaart hebt 
gezet. Heel erg bedankt voor al je hulp en waardevolle input. Floris, jij hebt mijn 
introductie in de wereld van de bloedingen een stuk comfortabeler gemaakt. 
Jij hebt de gave om een veilige omgeving te creëren waarin er geen domme 
vragen bestaan. Hartstikke fijn dat je eigen PhD student hier nu ook gebruik 
van kan maken.
Dank aan de leden van de manuscriptcommissie, professor Kessels, professor 
Vernooij en dr. Meijer, voor het lezen en het beoordelen van dit proefschrift. 
Rustam, what started as a coincidental meeting on an airplane ended in a very 
interesting research project in Edinburgh. I am really grateful that I got to 
experience the beautiful nature of Scotland – from Corrour station to Pitlochry 
– and the inspiring environment of the Center for Clinical Brain Sciences. 
It was a true pleasure working with you. Thank you very much for having me 
and thank you for all of your kind words. I also want to thank my other colleagues 
in Edinburgh for the wonderful time, without you these months would have 
been a lot more boring. 
 
Kwok and José, your imaging expertise is of endless value. Kwok, thank you for 
your eternal patience and for giving me mini-lectures every meeting. Because 
of you the world of quantitative susceptibility mapping is not entirely 
uncommon territory for me anymore. I will never forget the dinner we had with 
you and your girlfriend in Hong Kong. José, thank you for providing support 




Wilmar, nietsvermoedend ben ik aan het begin van mijn PhD aangesloten bij 
jullie review en meta-analyse zonder te weten dat dit een heel lang proces zou 
gaan worden. Gelukkig liet jij je nooit uit het veld slaan en heb ik je leren kennen 
als een pragmatische en hardwerkende arts-onderzoeker. Ik heb altijd erg 
genoten van onze samenwerking en hoop dat ik je nog een keer ergens in 
Utrecht tegen het lijf mag lopen. 
Esther, ik had mij geen betere stagebegeleider en mentor kunnen wensen. 
We hebben elkaar ontmoet onder het genot van een biertje bij de studenten-
vereniging en daarna ben ik toevallig steeds in jouw voetsporen getreden. 
Jij besloot een PhD bij de Neurologie te gaan doen. Een tijdje later deed ik 
hetzelfde en werden we zelfs collega’s. Fijn dat ik altijd bij je aan kan kloppen 
voor advies. 
Allerliefste vasculaire onderzoekers! Anna, Esther, Hanneke, Jamie, Lotte, 
Marthe, Mayra, Mayte, Merel, Nienke, Resa, Maaike, Mijntje, Mina, Mengfei en 
Esther, heel erg bedankt voor de gezelligheid op de onderzoekskamer, alle leuke 
congressen, en voor al het andere wat de afgelopen jaren zo bijzonder heeft 
gemaakt. Zonder jullie was mijn promotieonderzoek nooit zo leuk geweest! 
Anna, ik ben heel blij dat jij vandaag aan mij zijde staat als paranimf. Fijn om 
soms even samen te zeuren over alles wat bij een onderzoek komt kijken. 
Ik denk dat ik deze uitlaatklep vandaag goed kan gebruiken! Hanna, Melina, 
Jan-Willem en Marieke, ik ben heel blij dat jullie ons vanuit Amsterdam zijn 
komen versterken. Zo worden termen als vliegschaamte ook nog eens gebruikt 
in het minder vooruitstrevende Nijmegen. Melina, ik vind het super leuk dat 
je naar Lent gaat verhuizen. Hopelijk kunnen we vaak nog samen van een 
 speciaalbiertje genieten of een dansje tijdens de vierdaagse. 
Ik wil graag ook alle co-auteurs en leden van het vasculaire team bedanken 
voor jullie waardevolle bijdrage. Dank ook aan alle studenten die ik heb mogen 
begeleiden, jullie hebben mij meer geleerd dan ik aan jullie. In het bijzonder wil 
ik jou bedanken, Michelle. Wat was ik blij dat ik je heb weten te overtuigen bij 
ons stage te lopen. Naast dat we het op persoonlijk vlak goed met elkaar konden 
vinden, vond ik het samenwerken met jou ook heel fijn. Ik vond het super 
bijzonder dat we tegelijkertijd in het Verenigd Koninkrijk waren, en dat je mij 
ook nog eens bent komen opzoeken in Schotland. Ik wens je veel plezier de 
komende jaren met je eigen promotieonderzoek.    
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DJC Passie, wat hebben wij veel meegemaakt. Hoewel ik tijdens onze 
studententijd dacht dat het nooit meer beter ging worden, heb ik het idee dat 
onze vriendschap in de afgelopen tien jaar alleen maar meer is verdiept. 
Bedankt voor alle steun en de wekelijkse ontspanning op woensdag. Ik kijk heel 
erg uit naar alle bijzondere momenten die we samen nog mogen gaan 
meemaken. Dat jullie er vandaag bij zijn is de kers op de taart.
Iris, bedankt voor het brengen van (disco) lichtjes in ons leven. Die hebben het 
thuiswerk leven een stuk opgevrolijkt. Ik kijk nu al uit naar de vele dubbel dates 
in de Nederlandse wijngaarden.
Anke en Barbarien, ik vind het heel fijn dat we ons oneindige empathische 
vermogen samen kunnen delen. Dankzij jullie kan ik nooit meer ergens mijn 
fiets alleen in de regen achterlaten zonder mij schuldig te voelen. Ik denk dat ik 
heel veel aan jullie plaatsvervangende zenuwen zal hebben vandaag. Anouk, 
door jou komt er ook een kleine stukje Serra terug in mijn proefschrift. Super 
leuk dat je er vandaag bij bent! 
Lieve dodo’s, jullie kennen mij als geen ander en kunnen als de beste mee 
denken over wat ik nou eigenlijk wil in mijn leven. Het zal toch wel aan al die 
jaren Psychologie liggen, maar jullie kunnen mij precies een zetje in mijn rug 
geven, of juist ervoor zorgen dat ik rust neem wanneer dit nodig is. Ik ben heel 
trots op onze bijzondere vriendschap en zal er alles aan doen om die te 
behouden. Lieve Boy, toen ik jou de eerste keer ontmoette had ik nooit gedacht 
dat je uit zou groeien tot een van mijn beste vrienden. Jouw kennis over 
solliciteren en het bewandelen van het carrière pad gaat mij nog heel veel 
brengen, dank daarvoor. Roy, ik ben heel blij dat je na al die jaren Australië weer 
in Nijmegen woont. Ondanks de afstand hebben we onze vriendschap goed 
weten te bewaren. Ik vond het super leuk dat je mij bent komen opzoeken in 
Schotland, en heb heel veel zin om samen met jou ook de rest van de wereld 
nog te ontdekken. 
Ook wil ik mijn schoonfamilie graag bedanken. Lia, Martin en Lisette. Bedankt 
voor het mij laten kennis maken met een stukje Drenthe. Ook al is de Drentse 
taal voor mij af en toe niet te begrijpen, ik heb altijd het gevoel gehad meer dan 
welkom te zijn bij jullie. Ik hoop nog lang te kunnen genieten van alle knuffels 
met Hugo. Hopelijk is het na vandaag een beetje duidelijk waar ik mij mee bezig 
heb gehouden de afgelopen jaren.
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je nog heel lang mijn zus, vriendin, én collega zijn!
Lieve Jan, hier sta je misschien op de laatste plaats maar in mijn leven heb 
je overduidelijk de eerste plek. Ik ben heel dankbaar voor hoeveel vrijheid en 
steun je mij hebt gegeven de afgelopen jaren. Zonder jou was de afgelopen 
vier jaar veel stressvoller verlopen. Jij wist altijd op het juist moment voor de 
broodnodige ontspanning of afleiding te zorgen. Gelukkig weet ik één ding 
zeker, met jou wordt het leven nooit saai. Ik kijk er nu al naar uit om als we 
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For a successful research institute, it is vital to train the next generation of 
young scientists. To achieve this goal, the Donders Institute for Brain, Cognition 
and Behavior established the Donders Graduate School for Cognitive Neuro - 
science (DCCN), which was officially recognized as a national graduate school 
in 2009. The Graduate School covers training at both Master’s and PhD level 
and provides an excellent educational context fully aligned with the research 
program of the Donders Institute. 
The school successfully attracts highly talented national and international 
students in biology, physics, psycholinguistics, psychology, behavioral science, 
medicine and related disciplines. Selective admission and assessment centers 
guarantee the enrollment of the best and most motivated students.
The DCCN tracks the career of PhD graduates carefully. More than 50% of 
PhD alumni show a continuation in academia with postdoc positions at top 
institutes worldwide, e.g. Stanford University, University of Oxford, University 
of Cambridge, UCL London, MPI Leipzig, Hanyang University in South Korea, 
NTNU Norway, University of Illinois, North Western University, Northeastern 
University is Boston, ETH Zürich, University of Vienna etc. 
Positions outside academia spread among the following sectors:
- specialist in a medical environment, mainly in genetics, geriatrics, psychiatry 
and neurology
- specialist in a psychological environment, e.g. as specialist in neuropsychology, 
psychological diagnostics or therapy
- higher education as coordinators or lecturers
A smaller percentage enters business as research consultants, analysts or head 
of research and development. Fewer graduates stay in a research environment 
as lab coordinators, technical support or policy advisors. Upcoming possibilities 
are positions in the IT sector and management positions in pharmaceutical 
industry. In general, the PhD graduates almost invariably continue with high- 
quality positions that play an important role in our knowledge economy.
For more information on the DCCN as well as past and upcoming defenses 
please visit: http://www.ru.nl/donders/graduate-school/phd/

